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ABSTRACT 
A-type lamins are a group of type V intermediate filaments whose main members 
are lamin A and C. Lamins A/C are components of the nuclear lamina and are 
encoded by the LMNA gene. Lamins A/C have a variety of cellular functions, 
including maintaining the structural integrity of the nucleus and the regulation of 
signal transduction pathways, transcription factors and DNA replication. Mutations 
in LMNA give rise to a diverse spectrum of diseases, termed laminopathies, which 
include premature aging syndromes. 
In Chapter 3, I sought to understand the role of wild type lamin A in normal cellular 
aging. Lamin A C-terminal cysteine residues were irreversibly oxidized during the 
in vitro aging of human dermal fibroblasts (HDFs), which impaired the ability of 
lamin A to form disulfide bonds, causing loss of function. Furthermore, loss of 
these cysteine residues induced premature senescence, suggesting that these 
cysteine residues are important for lamin A function during cellular aging.  
In Chapter 4, I extended previous findings implicating A-type lamins in the control 
of cell cycle progression. Loss of A-type lamins or its nucleoplasmic binding 
partner, LAP2α, caused delayed G1/S-phase progression, reduced cellular 
proliferation and cell cycle exit. Proliferative defects could not be rescued via 
treatment with anti-oxidants.   
In Chapters 5 and 6, I addressed the role of wild type mature lamin A/C in the 
DNA damage response (DDR). A-type lamins interact with the DDR mediator 
protein 53BP1 via its Tudor domain. Loss of LMNA caused endogenous DNA 
damage and loss of 53BP1 protein levels. Furthermore, loss of LMNA resulted in 
defective DNA repair that ultimately led to increased sensitivity to DNA damage. 
Together, the data presented here extends previous findings implicating A-type 
lamins in cell cycle progression and provides novel insights into the cellular roles 
of A-type lamins in cellular aging and the DNA damage response. 
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CHAPTER 1: INTRODUCTION 
 
1.1 The nucleus: overview 
The nucleus is the keystone of all eukaryotic cells and functioned as one of the 
first evolutionary steps towards multicellularity (Pennisi, 2004; Lopez-Garcia and 
Moreira, 2006). The nucleus is responsible for a multitude of processes, including 
DNA replication, RNA production and the bi-directional transport of 
macromolecules (Lamond and Earnshaw, 1998). The compartmentalisation of 
these processes provides a means by which to regulate these and other 
metabolic processes in the nucleus, a step which is a necessary requisite for the 
evolution of complex organisms (Pennisi, 2004). Structurally, the nucleus is 
constructed of a three-dimensional interphase chromatin structure that lies within 
an internal nucleoplasm, all of which is enveloped by a double membrane, which 
comprises the inner nuclear membrane (INM) and the outer nuclear membrane 
(ONM) (Figure 1.1) (Maidment and Ellis, 2002; Worman and Courvalin 2005). The 
INM provides a physical attachment point to segregate chromatin into highly 
specific and defined chromosomal territories (Kind and van Steensel, 2010). 
Moreover, whilst the INM contains a unique set of proteins, the ONM is 
contiguous with the rough endoplasmic reticulum (RER) and thus shares similar 
protein content (Burke and Stewart, 2006). This double membrane creates a 
perinuclear space that is an extension of the ER lumen (Burke and Stewart, 
2006). The double membrane is punctuated by a multi-protein complex called the 
nuclear pore complex (NPC) that tightly controls transport between the 
nucleoplasm and cytoplasm (Gorlich and Kutay, 1999; Lim and Fahrenkrog, 
2006). Underlying the inner nuclear membrane is a filamentous meshwork called 
the nuclear lamina, containing A- and B-type lamins and lamin-binding proteins 
(Hutchison and Worman, 2004; Broers et al., 2006). 
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Figure 1.1. Overview of the structure of the nucleus. See text for details 
(Maidment and Ellis, 2002). 
 
1.2 Structure, assembly and regulation of the nuclear lamins 
1.2.1 Lamin genes 
At least one lamin gene is found in all metazoans, with the exception of unicellular 
organisms (Cohen et al., 2001). Although no lamin genes have been identified in 
plants, electron microscopy of tobacco BY-2 cells has observed a highly 
organised filamentous protein structure underlining the INM that interconnects 
NPCs, suggesting that lamin-like proteins exist in plants (Fiserova et al., 2009; 
Fiserova and Goldberg, 2010; Graumann and Evans, 2011). Typically, 
invertebrates express only one lamin gene, which is a B-type lamin (Hutchison et 
al., 2001). One exception is Drosophila melanogaster, which expresses one B-
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type lamin (Dm0) and one A-type lamin gene (lamin C) (Schulze et al., 2009). In 
contrast, vertebrates typically contain two B-type lamins genes and one A-type 
lamin genes (Hutchison et al., 2001). Again, one exception to this generality is 
Xenopus, which contains three B-type lamin genes (Melcer et al., 2007). 
 
Seven different lamin polypeptides are encoded by three genes in humans 
(Hutchison and Worman, 2004). Firstly, the human LMNA gene on chromosome 
1q21.2 is a 12 exon gene that encodes four A-type lamins, produced by 
alternative splicing: lamin A, lamin C, lamin AΔ10 and lamin C2 (Hutchison et al., 
2001). The two major gene products are lamin A and C, whose protein sequences 
are identical for the first 566 amino acids but vary in their C-terminal, with lamin C 
containing five unique C-terminal amino acids and lamin A an additional 98 amino 
acids (Burke and Stewart, 2006). The lamin AΔ10 isoform lacks the amino acids 
encoded by exon 10, whilst lamin C2 is a male germline-specific isoform that is 
identical to lamin C except that its N-terminal contains a short non-helical segment 
arising from alternative splicing of mRNA initiated from a different start site 
(Furukawa et al., 1994; Alsheimer and Benavente, 1996; Machiels et al., 1996).  
 
Two genes encode three separate B-type lamins. The LMNB1 gene on 
chromosome 5q23.3–q31.1 encodes for lamin B1, whilst LMNB2, located on 
chromosome 19p13.3, encodes two alternatively spliced isoforms, lamin B2 and 
lamin B3 (Höger et al., 1990; Biamonti et al., 1992; Furukawa and Hotta, 1993; Lin 
and Worman, 1995; Wydner et al., 1996). Parenthetically, B-type lamins are the 
likely ancestral lamin, with A-type lamins arising as a result of a gene duplication 
of a B-type lamin gene during evolution and acquirement of an extra exon, which 
enables the last endoproteolytic cleavage step in the processing of prelamin A 
(see 1.2.5) (Goldberg et al., 2010). 
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1.2.2 Structure 
The nuclear lamina was first identified by electron microscopy as a fibrous layer 
underlying the inner nuclear membrane (INM) and largely determines the overall 
structure of the nucleus during interphase (Fawcett, 1966; Burke and Stewart, 
2002).The nuclear lamina consists of the nuclear lamins, which are classified as 
either A- or B-type depending on their sequence homology, structural features, 
biochemical properties, or their tissue expression specificity (Broers et al., 2006; 
Mattout et al., 2006). Lamins are type V intermediate filaments (IFs), having a 
typical tripartite domain structure, which includes an unstructured ‘head’ domain, 
an α-helical ‘rod’ domain and a globular ‘tail’ domain (Figure 1.2) (Hutchison and 
Worman, 2004). The α-helical rod domain is divided into four coiled-coil domains 
(1A, 1B, 2A, and 2B), separated by three flexible linker regions (L1, L12, L2), and 
characterised by the presence of heptad repeats within coil 1b (Hutchison and 
Worman, 2004). The nuclear targeting of lamins is facilitated by the presence of a 
NLS in the tail domain that interacts with importins and permits nuclear import 
(Broers et al., 2006). With the exception of lamin C, lamins are characterized by 
the presence of a CAAX motif at the very C-terminus, which is involved in the 
processing of the prepeptide to the propeptide (see 1.2.6) (Rusinol and Sinensky, 
2006). Lamins also contain an S-type Ig-like fold between the rod domain and C-
terminal, which is involved in various lamin-protein interactions as well as lamin-
DNA interactions (Dhe-Paganon et al., 2002; Krimm et al., 2002).  
 
Figure 1.2. General structure of lamin polypeptides. See text for details, 
Y259X point mutation is shown (adapted from Hutchison and Worman, 2004). 
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1.2.3 Lamin assembly 
The initial step in the assembly of nuclear lamins is the formation of lamin dimers 
(Stuurman et al., 1998). Lamins form obligate in-parallel in-register homodimers of 
~50nm in length, which are formed from the interaction between two α-helical rod 
domains of each monomer. The homodimers then assemble longitudinally into 
polar head-to-tail tetrameric protofilaments, and these protofilaments then 
associate laterally in an anti-parallel half-staggered manner to form ~25nm 
beading filaments (Stuurman et al., 1998). These beading filaments are unstable 
in vitro and eventually form well-ordered paracrystalline arrays in vitro, which are 
not usually found in vivo (Herrmann and Aebi, 2004). Paracrystal formation 
suggests that in vitro lamin polymerization cannot fully recapitulate in vivo lamin 
polymerization, which therefore hints at other lamin-binding proteins being 
responsible for in vivo lamin assembly (Stuurman et al., 1998; Hutchison et al., 
2001). Despite this, it was generally believed that lateral assembly of 
protofilaments produced 10nm lamin filament formation in vivo, and two sets of 
parallel 10nm filaments could then form at right angles to each other to produce 
an orthogonal network, with a repeat distance of ~50nm (Stuurman et al., 1998). 
However, this theory has recently been called into question (Goldberg et al., 
2008). Using field emission scanning electron microscopy (feSEM), the authors 
showed that the lamina consists of only one 8–10 nm filament running parallel to 
another filament, rather than two sets at right angles. Moreover, the repeat 
distance was only ~15nm, not 50nm, as previously stated (Goldberg et al., 2008). 
 
Although A- and B-type lamins interact in vitro, further evidence is needed to 
determine whether the complex nuclear lamina of mammalian somatic cells 
contains lamin heteropolymers or only homopolymers in vivo (Schirmer and 
Gerace, 2004). During mitosis, A- and B-type lamins exhibit different solubility 
properties. A-type lamins becoming solubilised, whilst B-type lamins remain 
membrane-bound, suggesting that lamin heterodimers may not form in vivo. In 
support of this, quantitative FRET (fluorescence resonance energy transfer) 
analysis concluded that lamins may exist as homopolymers with subsequent 
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interactions between both A- and B-type lamin homopolymers (Delbarre et al., 
2006). Further to this, using high resolution microscopy it has been shown that A- 
and B-type lamins form separate filamentous networks within mammalian cells 
(Shimi et al., 2008). Despite the A- and B-type lamin networks being quite 
separate they do overlap and interact in places, which support the previous 
biochemical and FRET data outlined above (Shimi et al., 2008). 
1.2.4 Developmental regulation of lamins 
A- and B-type lamins are differentially regulated during development (Broers et 
al., 2006). At least one B-type lamin is expressed in all cell types throughout all 
developmental stages (Hutchison, 2002). Underlining the importance of B-type 
lamins in development, a mouse model with an insertional mutation in Lmnb1 
developed lung and bone defects causing death at birth, even though the mice 
continue to express lamin B2 (Vergnes et al., 2004). Furthermore, RNAi depletion 
of lamin B1 or lamin B2 in Hela cells demonstrated B-type lamins are essential for 
cell survival (Harborth et al., 2001). In contrast, A-type lamins are typically 
expressed in differentiated cells types and, in mice, lamins A and C are expressed 
between days 10-12 during embryogenesis, chiefly in the primordial muscle cells, 
suggesting that A-type lamins are not essential for development (Stewart and 
Burke, 1987, Rober et al., 1989). Moreover, embryonic stem cells (ESCs) do not 
express A-type lamins, further suggesting that A-type lamins have specific roles in 
differentiated tissues (Stewart and Burke 1987; Houliston et al., 1988; Röber et 
al., 1989; Constantinescu et al., 2006). As A-type lamin expression is preceded by 
differentiation, it has been suggested that A-type lamins are responsible for 
maintaining a differentiated state, rather than an active role in cell fate 
determination per se (Goldman et al., 2002). In keeping with this role, Lmna-/- 
mice exhibit no developmental defects but display severely retarded postnatal 
growth characterised by muscular dystrophy and cardiomyopathy (Sullivan et al., 
1999). In humans, the presence of a homozygous Y259X mutation results in no 
functional lamin A/C protein, which caused death via respiratory failure after 
premature birth (Figure 1.2) (van Engelen et al., 2005).  
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1.2.5 Transcriptional regulation of lamins 
A-type lamins are primarily regulated at the level of transcription, however, there 
is some evidence to suggest that they may be regulated at a post-transcriptional 
level (Lanoix et al., 1992; Alsheimer and Benavente 1996; Pugh et al., 1997). 
Various studies have defined several regulatory elements in the LMNA proximal 
promoter that are important in determining activity of the LMNA promoter. Firstly, 
there is a GC box that may bind Sp1/Sp3 transcription factors and an AP-1 motif 
that is able to bind the c-Jun and c-Fos transcription factors (Nakajima and Abe 
1995; Tiwari et al., 1998; Muralikrishna et al., 2001). Furthermore, a GT-rich motif 
within the promoter region has the capacity to bind to both the Sp1/Sp3 
transcription factors and the transcriptional coactivator CREB-binding protein 
(CBP) (Janaki Ramaiah and Parnaik, 2006). The LMNA promoter also contains a 
retinoic acid responsive element that promotes transcription upon retinoic acid 
treatment and also binds the transcription factors c-Jun and Sp1/Sp3 (Lebel et al., 
1987; Okumura et al., 2000; Okumura et al., 2004). In addition to the promoter 
region, there are two regulatory regions within intron 1 of LMNA, footprinted 
region A (FPRA) and B (FPRB), which may bind hepatocyte nuclear factor-3β and 
the retinoic acid receptor β (RXRβ) transcription factors that have been suggested 
to control cell-type-specific transcription of LMNA (Arora et al., 2004). 
Interestingly, intron 1 of LMNA has a p53-binding site and is a transcriptional 
target of activated p53 in response to mitomycin C in HCT116 cells, a colon 
carcinoma cell line (Rahman-Roblick et al., 2007). 
 
Recently, a novel study has shown that lamin B1 transcripts are targeted by the 
microRNA mir-23 (Lin and Fu, 2009). No study to date has addressed the role of 
microRNA control over LMNA transcripts. Indeed, possible miRNAs that target 
LMNA transcripts can be seen here:  
http://refgene.com/search?q=4000&act=Search+GeneID%2C+Symbol+or+Acc%23 
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From this, one miRNA that targets LMNA transcripts is hsa-mir-30c-1, which is 
expressed in HL-60 leukaemia cells (Kasashima et al., 2004). In accordance, HL-
60 cells are devoid of lamin A and C protein levels and have very low mRNA 
levels (due to spontaneously differentiating cells), therefore seemingly validating 
the targeting miRNA, hsa-mir-30c-1 (Paulin-Levasseur et al., 1988). Future 
studies into post-transcriptional regulation of lamin A/C transcripts will therefore 
be of interest, especially in cancers. 
1.2.6 Processing of prelamin A 
Lamins A, B1 and B2 are synthesised as precursor proteins that enter the nucleus 
via their NLS before extensive post-translational processing (Lehner et al., 1986; 
Lutz et al., 1992; Davies et al., 2009). The processing pathway occurs within the 
nucleus, rather than the cytoplasm, via a group of enzymes anchored within the 
INM (Barrowman et al., 2008). The processing pathway is initially dictated by a C-
terminal CAAX motif (C = cysteine, A = any aliphatic amino acid, X = S, M, C, A, 
Q, L), which is present in all A- and B-type lamins except lamin C (Rusinol and 
Sinensky, 2006). Prelamin processing begins with the addition of a 15-carbon 
farnesyl lipid via a thioester linkage to the thiol group of the cysteine within the 
CAAX motif by a protein farnesyltransferase (Figure 1.3) (Davies et al., 2009). It is 
believed that farnesylation of the CAAX motif in lamins assists in their targeting to 
the nuclear envelope as evidence has shown that farnesylation increases the 
hydrophobicity of prelamin A and farnesyl-prelamin A binds avidly to membranes 
(Hennekes and Nigg, 1994; Silvius and l’Heureux, 1994). Indeed, inhibition of 
farnesylation with lovastatin caused nonfarnesylated prelamin A to accumulate in 
nucleoplasmic aggregates away from the nuclear envelope (Lutz et al., 1992). 
Once at the nuclear envelope, prelamins can be further processed and 
incorporated into the nuclear lamina (Holtz et al., 1989; Kitten and Nigg, 1991).  
 
The second step, after farnesylation, is the removal of the –AAX from the CAAX 
motif by the zinc metalloproteinases Rce1 (Ras-converting enzyme 1) or 
Zmpste24 (Zinc metalloprotease related to the STE24 homolog in yeast) (Figure 
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1.3) (Bergo et al., 2002, Pendas et al., 2002; Corrigan et al., 2005). The newly 
exposed isoprenylcysteine is methylated by isoprenylcysteine carboxy 
methyltransferase (ICMT) (Figure 1.3) (Davies et al., 2009). Both these steps are 
dependent upon the preceding steps. Prelamin A is unique to the group of 
prelamins as it undergoes an additional endoproteolytic step that cleaves the last 
15 amino acids, including the farnesylcysteine methyl ester, from the C-terminal to 
produce mature lamin A (Figure 1.3) (Davies et al., 2009). This step is carried out 
only by Zmpste24, which recognises the conserved RSYLLG sequence, 
producing mature lamin A which then integrates into the nuclear lamina (Corrigan 
et al., 2005).  
 
The CAAX motif is conserved through vertebrate evolution, which suggests that 
the post-translational modifications to prelamin A have important functions. 
However, data from a variety of mouse models has called into question the 
relevance of the prelamin A processing pathway. Mice genetically engineered to 
express prelamin A only (no lamin C), mature lamin A only (no lamin C) and lamin 
C only (no lamin A) all appear phenotypically normal (Fong et al., 2006; Coffinier 
et al., 2010; Davies et al., 2010). At the cellular level, MEFs expressing only 
mature lamin A displayed a trivial increase in dysmorphic nuclei even though 
more lamin A was localised in the nucleoplasm (Coffinier et al., 2010). 
Importantly, the results suggest that by-passing the prelamin A processing 
pathway is compatible with survival (Coffinier et al., 2010). Moreover, it suggests 
that prelamin A processing is dispensable for lamin A incorporation into the 
nuclear lamina, a finding that underlines a prior study that has shown that 
microinjected mature lamin A incorporates into the nuclear lamina (Pugh et al., 
1997). MEFs from mice that express lamin C only were also normal at the cellular 
level,  with lamin C localised to the nuclear envelope independently of lamin A, a 
finding that is in contrast to previous findings (Pugh et al., 1997; Vaughan et al., 
2001; Fong et al., 2006). Thus, it appears that lamins A or C are largely 
dispensable, together with the post-translational pathway that produces lamin A, 
at least in mice. One possibility is that both proteins may have redundant 
functions that may subsidise for loss of the other. Paradoxically, although by-
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passing the prelamin A processing pathway appears to be compatbilte with 
survival, mutations in enzymes responsible for prelamin A processing give rise to 
a range of diseases in mice, including cardiomyopathy (in mice that express 
nonfarnesylated prelamin A) and premature aging syndromes (in mice null for 
Zmpste24 or in mice expressing progerin or nonfarnesylated progerin) (see 1.8). 
In cells with ZMPSTE24 deficiency, prelamin A undergoes the first three 
processing steps, but cannot undergo the last proteolytic cleavage step, causing 
prelamin A to be permanently carboxymethylated and farnesylated (Figure 1.3). In 
HGPS, prelamin A is translated with an internal 50 amino acid deletion that 
includes the last endoproteolytic cleavage site. Therefore, despite having a 
functional Zmpste24 protein, prelamin A is both carboxymethylated and 
farnesylated and, due to the deletion, slightly smaller in size than prelamin A 
found in cells with ZMPSTE24 deficiency (Figure 1.3). The alterations to the 
prelamin A processing pathway shown here cause devastating premature aging 
syndromes, underlining that although by-passing the pathway altogether is 
compatible with survival, when the pathway is engaged any mutations within 
components of the pathway can have deleterious consequences for the organism 
(see 1.8). Future work may reveal distinct functions of the prelamin A processing 
pathway to help explain its evolutionary conservation. 
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Figure 1.3. Processing pathway of wild type prelamin A and in disease. (a) Wild type prelamin A undergoes a series of post-
translational processing steps before mature lamin A is formed. (b) Prelamin A found in Zmpste24-null cells is permanently 
farnesylated and carboxymethylated. (c) HGPS cells contain an internal deletion of 50 amino acids that removes the second 
endoproteolytic cleavage site, resulting in prelamin A that is both farnesylated and carboxymethylated, with the mutant product 
termed progerin. (Davies et al., 2009) 
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1.3 Lamina function  
Far from merely being a structural component of the nucleus, lamins have a 
diverse range of cellular roles that influence a vast array of nuclear functions. 
Whilst it is beyond this thesis to describe all their functions in great depth, I will 
briefly cover the most relevant, providing the most salient points. 
1.3.1 Tensegrity element 
Whilst B-type lamins are ubiquitously expressed, A-type lamins are expressed 
only when ESCs differentiate, which is correlated with reduced nuclear 
deformability, suggesting that, analogous to intermediate filaments, A-type lamins 
have a structural role within the cell (Pajerowski et al., 2007). A-type lamins 
therefore confer structural stability to the nucleus and protect chromatin, which 
has led them to be described as a ‘tensegrity element’, which may be defined as 
“...a lightweight load-bearing structure that can re-adopt its initial shape after 
deformation...” (Hutchison, 2002; Hutchison and Worman, 2004). Underlining this, 
Lmna-/- MEFs exhibit impaired mechanical properties leading to reduced viability 
under mechanical stress, as well as de-regulated expression of genes associated 
with mechanical stress (Lammerding et al., 2004; Houben et al., 2007). 
Additionally, ectopic expression of lamin A in Xenopus oocytes, which normally 
only contain B-type lamins, increases the stiffness of the nuclei, reaffirming  the 
mechanical properties A-type lamins exert on nuclei (Schape et al., 2009). Lastly, 
it has long been evidenced that a multitude of mutations in LMNA give rise to 
dysmorphic nuclei, again suggesting that A-type lamins are involved in the 
structural integrity of nuclei (Broers et al., 2006). 
1.3.2 Component of the nucleo-cytoskeletal structural framework 
A-type lamins are a component of a physical link between the nucleus and the 
cytoskeleton (Burke and Roux, 2009). This nucleo-cytoskeletal link is called the 
LINC complex and comprises SUN proteins, which reside at the INM, and 
nesprins, which primarily reside in the ONM (Burke and Roux, 2009). SUN1 and 
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SUN2 proteins and nesprins-1,-2 and -3α interact via their KASH domains in the 
perinuclear space (Hodzic et al., 2004; Worman and Gundersen, 2006; Burke and 
Roux, 2009). Nesprins interact with both the intermediate filament and the 
microfilament cytoskeletons via direct actin binding and plectin (Starr and Han, 
2003; Tzur et al. 2006). Nesprin-1α is smaller in size than other nesprins so is 
localised to the INM where it interacts with lamins A/C and emerin (Broers et al., 
2006; Wilhelmsen et al., 2006). Similarly, SUN1 and SUN2 may also interact with 
A-type lamins at the INM, but their retention at the INM is not dependent on A-
type lamins (Crisp et al., 2006). Mutations that cause defects to components of 
the LINC complex can lead to impaired cell migration, nuclear positioning and 
decreased mechanical stress resistance (Houben et al., 2007; Ji et al., 2007; Lee 
et al., 2007; Houben et al., 2009) 
1.3.3 Chromatin scaffold  
It its simplest form, A-type lamins may function as a chromatin scaffold within the 
nucleus due to their ability to interact directly with polynucleosomes particles, 
chromatin, core histones and DNA via the lamin A/C Ig-like domain (Yuan et al., 
1991; Luderus et al., 1992; Glass et al., 1993; Luderus et al., 1994; Taniura et al., 
1995). Functionally, this scaffold role would also allow multiprotein complexes to 
interact with and regulate chromatin (Stierle et al., 2003). A-type lamins may also 
interact with chromatin indirectly via binding to barrier-to-autointegration factor 
(BAF), which itself associates with chromatin-interacting LEM-domain containing 
proteins (Andres and Gonzalez, 2009).  
 
The spatiotemporal modulation of gene expression is essential for the life cycle of 
a cell. Therefore, to accomplish specific gene expression patterns, chromatin 
within eukaryotes is spatially arranged as either heterochromatin or euchromatin 
(Hubner and Spector, 2010). Whilst euchromatin is correlated with actively 
transcribed genes, densely packaged heterochromatin has been correlated with 
gene silencing, with cytological analyses of heterochromatin localisation revealing 
that it resides close to the INM (Akhtar and Gasser, 2007). Thus, above a simple 
14 
 
role for A-type lamins as a mere chromatin scaffold, it has been proposed that the 
A-type lamins and the nuclear lamina may segregate chromatin into active and 
inactive domains via interactions that anchor chromatin at the nuclear lamina 
(Sullivan et al., 1999; Goldman et al., 2004; Kind and van Steensel, 2010). 
Indeed, in situ expression studies and microarray analyses have shown that 
disruption to A- and B-type lamins causes deregulated gene expression, as well 
as expression of the lamin A mutant progerin (Vergnes et al., 2004; Frock et al., 
2006; Malhas et al., 2007; Scaffidi and Misteli, 2008; Tang et al., 2008; Malhas et 
al., 2009). Furthermore, the use of the DamID technology with genome-wide 
sequencing has defined regions of the genome that are in contact with the nuclear 
lamina (Pickersgil et al., 2006; Guelen et al., 2008). From these studies, there are 
>1300 of these lamina-associated domains (LADs) in human fibroblasts, which 
range from between 0.5 to 10 Mb in size and contain genes that are expressed at 
relatively low levels, although there a small number of genes that are the 
exception and are still active in these domains (Guelen et al., 2008). LADs have 
been shown to have exquisitely sharp borders that are marked by sequences that 
promote binding of insulator proteins such as CTCF (Guelen et al., 2008). 
Interestingly, depletion of the Drosophila B-type lamin, Dm0, leads to the 
translocation of repressed gene clusters from the nuclear exterior to the nuclear 
interior where they become transcriptionally active (Shevelyov et al., 2009). In 
parallel to these studies, lamin A promotes transcriptional repression in both yeast 
and mammalian cells when it is tethered to specific promoters (Lee et al., 2009). 
Furthermore, the use of artificially tethered reporters has shown that if genes are 
directed towards the nuclear periphery then they are generally repressed, 
although the extent to which genes are silenced is thought to be dependent on 
both the local chromatin context and the regulatory sequences (Finlan et al., 
2008; Kumaran and Spector, 2008; Reddy et al., 2008).  
 
Lastly, lamins may also influence the positioning of chromosome territories 
(Figure 1.4) (Bridger et al., 2007). Chromosomes occupy distinct territories in 
interphase nuclei, although the positioning of territories is not static but rather a 
highly dynamic process whereby whole individual chromosomes or single genes 
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undergo rearrangements depending on the gene expression demands of the cell 
(Hubner and Spector, 2010). The gene-poor chromosome 18, which is normally 
found at the nuclear periphery, is localised within the nuclear interior in MEFs from 
Lmnb1-/- mice (Malhas et al., 2007). Similarly, in cells from patients with mutations 
in A-type lamins, chromosomes 13 and 18 were also relocalised towards the 
nuclear interior, suggesting that both A- and B-types can influence positioning of 
whole chromosomes (Meaburn et al., 2007; Mewborn et al., 2010). Furthermore, 
the nuclear periphery position of chromosome 4 is lost in human cells null for 
lamin A/C, further supporting a role for lamins in chromosome positioning (Masny 
et al., 2004). 
 
 
 
Figure 1.4. Chromosome territories in mammalian cells. (a-b) Images of three 
(a) and twenty-three (b) chromosomes were obtained after by 3D-FISH and 
chromosome painting. (c) Cartoon representation of the chromosome territories in 
an interphase nucleus. (d) Gene-poor regions are localized towards the nuclear 
periphery, whilst gene-rich regions are localized towards the interior. (Adapted 
from Hubner and Spector, 2010) 
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1.3.4 Transcription and proliferation 
A variety of evidence suggests that A-type lamins have an active role in gene 
transcription, both directly and indirectly (Heessen and Fornerod, 2007). Firstly, 
expression of a dominant negative lamin A mutant in CHO or Xenopus nuclei 
inhibits the activity of RNA pol II (Spann et al., 2002). Furthermore, RNAi 
depletion of lamin B1 or lamin A/C overexpression in Hela cells caused inhibition 
of RNA pol II transcription (Kumaran and Spector, 2008; Shimi et al., 2008; Tang 
et al., 2008).  
 
Data from a number of groups has shown that lamins interact with several 
transcription factors, which therefore implicates lamins in a number of cell 
signaling pathways that influence gene transcription (Heessen and Fornerod, 
2007). Oct-1 is a transcription factor that interacts with lamin B1 and is 
sequestered at the nuclear envelope away from Oct-1 target genes (Imai et al., 
1997). However, its dissociation from the nuclear lamina is associated with the up-
regulation of pro-aging genes (Imai et al., 1997). The interaction between A-type 
lamins and transcription factors have been far more extensively studied (Andres 
and Gonzalez, 2009). The most notable is the interaction between lamin A/C and 
its nucleoplasmic binding partner, LAP2α, and the tumour suppressor pRb 
(Dechat et al., 2000; Markiewicz et al., 2002). This complex anchors 
hypophosphorylated pRb within the nucleus and therefore implicates A-type 
lamins in the pRb-E2F pathway and control of the G1/S-phase transition. Indeed, 
loss of either lamin A/C or LAP2α in MEFs causes increased cellular proliferation 
due to deregulated pRb levels and/or phosphorylation status of pRb, which in turn 
promotes E2F-dependent gene transcription necessary for S-phase entry 
(Johnson et al., 2004; Naetar et al., 2007; Naetar and Foisner, 2009).  
 
Lamin A/C also interact directly with TonEBP, SREBP1, Mel18, MOK2 and c-Fos, 
the latter being a member of the AP-1 family of transcription factors (Dreuillet et 
al., 2002; Lloyd et al., 2002; Zhong et al., 2005; Ivorra et al., 2006; Favale et al., 
2007; Dreuillet et al., 2008; Harper et al., 2009). c-Fos has a DNA-binding domain 
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and a heterodimerisation domain, that allows it interact with other AP-1 family 
members (e.g. c-Jun) (Eferl and Wagner, 2003). Lamin A/C sequesters c-Fos at 
the nuclear envelope in serum-starved cells, thereby preventing AP-1 mediated 
gene transcription (Ivorra et al., 2006; Gonzalez et al., 2008).  However, upon 
mitogenic stimulation, ERK1/2 interacts with lamins A/C and phosphorylates c-
Fos, which releases it from the nuclear envelope, allowing it to promote 
transcription of target genes (Ivorra et al., 2006; Gonzalez et al., 2008). More 
recently, it was shown that upon mitogen stimulation, ERK1/2 displaces pRb from 
lamin A, facilitating its phosphorylation and inactivation, promoting G1/S-phase 
transition (Rodriguez et al., 2009).  
 
A-type lamins have been implicated in the regulation of transcription indirectly, via 
interactions with numerous lamin-binding proteins that themselves influence 
transcription. For example, firstly, the INM protein emerin is an A-type lamin 
binding protein that interacts with β-catenin via its APC-like domain (Markiewicz et 
al., 2006). β-catenin is a transcriptional cofactor of TCF/LEF and downstream 
effector of the canonical Wnt signaling pathway, which has roles in development 
and maintenance of stem cell niches (Clevers, 2006). Emerin acts so as to restrict 
the nuclear accumulation of β-catenin, thereby preventing its transcriptional 
activity (Markiewicz et al., 2006). In human cells null for emerin, from a patient 
with X-linked Emery Dreifuss muscular dystrophy, β-catenin accumulates in the 
nucleus, promoting cellular proliferation (Markiewicz et al., 2006).  
 
Secondly, A-type lamins interact with INM proteins that contain a LEM (LAP2, 
Emerin, MAN1) domain, a 42 amino acid motif located in the nucleoplasm-facing 
N-terminus of these INM proteins (Broers et al., 2006). These LEM-domain 
proteins interact with a variety of transcriptional regulators, which therefore 
indirectly implicates A-type lamins in transcriptional control: the chromatin-
interacting protein barrier-to-autointegration factor (BAF); germ-cell less (GCL), a 
transcription factor that binds to the DP3 subunit of E2F-DP heterodimeric 
transcription factors thus blocking E2F-DP-dependent gene expression in a  pRb-
independent manner; the death promoting transcriptional repressor Btf; the 
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transcriptional regulator Lmo7; the splicing factor YT521-B (Bengtsson and 
Wilson, 2004; Mansharamani and Wilson, 2005; Andres and Gonzalez, 2009).  
1.3.5 DNA replication 
The role of nuclear lamins in DNA replication has long been suggested, although 
the exact nature of this role is somewhat disputed (Broers et al., 2006). Early 
evidence came from studies using cell-free extracts from Xenopus eggs, in which 
deletion mutants of Xenopus lamin B3 or human lamin A or immunodepletion of 
Xenopus lamin B3 prevented lamina assembly and subsequently inhibited DNA 
replication (Ellis et al., 1997; Spann et al., 1997). The conclusion of both studies 
was that disrupting the nuclear lamina inhibited DNA replication. However, the 
temporal role of lamins in DNA replication is still unclear as findings from further 
studies showed that preventing lamina assembly inhibits the initiation of DNA 
replication, whilst the disruption of the lamina in nuclei that have already begun 
DNA replication does not affect further DNA synthesis (Ellis et al., 1997; Izumi et 
al., 2000). Furthermore, the nucleoplasmic lamin aggregates did not interfere with 
preassembled replication complexes (Izumi et al., 2000). There is therefore some 
inconsistency into the exact role of lamins in DNA replication. To complicate 
matters further, it has been reported that lamin B1 colocalises with sites of DNA 
replication foci during mid to late S-phase in mouse 3T3 cells (Moir et al., 1994). 
In contrast to this, lamin A/C has been shown to colocalise with sites of early 
replication in human fibroblasts, suggesting that lamin A/C has an organising role 
in early DNA replication sites, which also notably contained the pocket proteins 
pRb and p130 (Kennedy et al., 2000). More recently, it has been shown that 
PCNA interacts with the Ig-like fold in the C-terminus of A- and B-type lamins 
(Shumaker et al., 2008). 
1.3.6 Epigenetics 
In order to gain insights into the mechanistic basis of HGPS (see 1.5.2), research 
has found that cells from these patients exhibit considerable epigenetic changes 
(Scaffidi and Misteli, 2006; Shumaker et al., 2006; Liu et al., 2011). Firstly, HGPS 
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cells have gross loss of peripheral heterochromatin, underlining previous 
suggestions that A-type lamins act as a chromatin scaffold (Shumaker et al., 
2006). Furthermore, Lmna-/- MEFs also display loss of some peripheral 
heterochromatin (Sillivan et al., 1999; Nikolova et al., 2004). Secondly, a variety of 
epigenetic histone marks are altered in HGPS cells, including reduced levels of 
trimethylated H3K9, reduced levels of trimethylated H3K27 and increased levels 
of trimethylated H4K20 (Scaffidi and Misteli, 2006; Shumaker et al., 2006). 
Mechanistically, these epigenetic alterations in HGPS may be mediated by 
chromatin remodelling proteins, such as the NuRD complex, components of which 
are reduced both in HGPS cells and in cells from old individuals (Pegoraro et al., 
2009). Additionally, ING proteins interact with histones as well as histone 
deacetylases (HDACs) and histone acetyltransferases (HATs) to alter chromatin 
structure. It was recently shown that ING1 is a lamin A binding protein and 
exhibits reduced levels in HGPS cells (Han et al., 2008). Together, these studies 
suggest that A-type lamins influence epigenetic changes to chromatin indirectly 
via interactions with various chromatin remodelling proteins.  
 
The functional relevance of these epigenetic alterations to the pathology of HGPS 
has yet to be fully understood. However, recent data from another prelamin A 
processing mutant may help understand how epigenetic changes are associated 
with premature aging. It was shown that Zmpste24-/- MEFs display a grossly 
altered epigenetic landscape, with hypermethylated rRNA and hypoacteylated 
histones HB and H4, which was correlated with altered gene expression profiles 
that affect cellular proliferation and metabolic processes that are known to be 
impaired in Zmpste24-/- MEFs (Varela et al., 2005; Osorio et al., 2010). Moreover, 
these changes occur naturally during normal aging, suggesting some mechanistic 
links between premature aging and the normal aging process. 
1.3.7 DNA damage response 
DNA repair was first explored in Hutchinson-Gilford Progeria Syndrome (HGPS) 
some 38 years ago, before it was known that the disease was caused by a 
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mutation in LMNA (Epstein et al., 1973). This study found that HGPS cells 
exhibited a failure to rejoin DNA ends in response to DNA damage induced by IR. 
Surprisingly, this finding was not followed up for some time. Recently, the link 
between A-type lamins and the DDR was explored using Zmpste24-/- MEFs and 
HGPS patient cells (Liu et al., 2005; Varela et al., 2005). In both these cells 
prelamin A exists permanently in a carboxymethylated and farnesylated form, 
which is correlated with gross changes in nuclear architecture (Davies et al., 
2009). In response to a range of genotoxic stresses (IR, UV, camptothecin 
mitomycin C and etoposide), Zmpste24-/- MEFs showed reduced survival when 
assessed by colony-forming assay, suggesting that prelamin A effects numerous 
repair pathways (Liu et al., 2005). Both Zmpste24-/- MEFs and HGPS cells exhibit 
increased levels of endogenous DNA damage as assessed by increased levels of 
γ-H2AX (Liu et al., 2005, Varela et al., 2005; Scaffidi and Misteli, 2006). 
Furthermore, the recruitment of DNA repair factor 53BP1, a component of the 
NHEJ pathway, was delayed by ~ 2 hours in both Zmpste24-/- MEFs and HGPS 
cells in response to IR, suggesting that the presence of unprocessed prelamin A 
inhibits the upstream signaling events necessary for the recruitment of 53BP1 (Liu 
et al., 2005). Additionally, 53BP1 complexes take longer to dissociate in 
Zmpste24-null MEFs and HGPS cells, suggesting impaired DNA repair in these 
cells. Transient overexpression of wild type Zmpste24 in Zmpste24-/- MEFs 
reversed these effects, drawing a direct link to prelamin A as being the primary 
cause (Liu et al., 2005). The impaired recruitment of 53BP1 in GFP-LAΔ50 
transfected Hela cells in response to cisplatin treatment was also confirmed in a 
separate study (Manju et al., 2006). In parallel to this, it was also observed that 
the number of Rad51 foci, a marker of homologous recombination, was reduced 
in response to DNA damage in both Zmpste24-/- MEFs and HGPS cells (Liu et al., 
2005). The DDR apical kinases, ATM and ATR, were both activated in HGPS and 
restrictive dermopathy (RD) cells (human fibroblasts harbouring a homozygous 
mutation in Zmpste24) as well as their downstream effector kinases, Chk1 and 
Chk2 (Liu et al., 2006).  
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The DNA repair defects observed in RD and HGPS cells may be partly 
attributable to the incorrect localisation of the NER pathway protein XPA at 
progerin-induced DSBs (Liu et al., 2007). Furthermore, the MRN complex 
component Rad50 could not be correctly localised to endogenous DSBs in HGPS 
and RD cells, underlining that progerin-induced XPA localisation to DSBs inhibits 
correct DSB recognition (Liu et al., 2007). In response to camptothecin XPA did 
not localise to DNA lesions, thus suggesting that the incorrect localisation of XPA 
is specific to DSBs generated by progerin. Together, these studies indicate that 
the production of mutant lamin A activates DNA damage response pathways 
caused by the production of endogenous DNA damage.  
 
Recently, a study has shown that Lmna-/- MEFs exhibit reduced ability to process 
dysfunctional telomeres, which has been correlated with the loss of 53BP1 protein 
levels by proteasomal degradation in these cells (Gonzalez-Suarez et al., 2009). 
53BP1 is a mediator protein of the DDR, involved directly in DNA repair and 
signalling (Fitzgerald et al., 2009). Therefore, as a modulator of 53BP1 levels, A-
type lamins have been implicated in the DDR (Gonzalez-Suarez et al., 2009). 
1.3.8 Mitosis 
Mammalian cells employ an ‘open’ method of mitosis, that is, the nuclear 
envelope must be disassembled and then reassembled during mitosis. As 
mentioned briefly above, A- and B-type lamins exhibit different properties during 
this disassembly/reassembly process (Cohen et al., 2001). The nuclear envelope 
is first disassembled during late prophase via phosphorylation, and hence 
depolymerisation, of lamins by cdk1 and protein kinase C (PKC) in combination 
with the physical action of microtubules pulling the nuclear envelope apart (Broers 
et al., 2006). Whereas A-type lamins are depolymerised and dissociate from the 
nuclear lamina during early prophase, B-type lamins dissociate in late prophase, 
which is when full nuclear envelope breakdown occurs (Broers et al., 2006; 
Dechat et al., 2010). After nuclear envelope breakdown, A-type lamins become 
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solubilised within the cytoplasm whereas the majority of B-type lamins are 
insoluble and remain nuclear membrane-bound, which disperses into the ER.  
 
Lamins are dephosphorylated by protein phosphatase 1a during the telophase-G1 
transition, which allows their reassembly into the nuclear lamina (Thompson et al., 
1997; Hutchison et al., 2001). Nuclear envelope reassembly has been shown to 
exhibit a spatiotemporal hierarchy of protein assembly around the chromosome 
surfaces (Broers and Ramaekers, 2004). Firstly, LAP2α and BAF assemble at the 
ends of chromosomes, followed by LBR, emerin and LAP2β (Broers et al., 2006). 
Next, B-type lamins polymerise and associate with chromosomes during mid-to-
late telophase via a membrane-bound anchor, most likely LBR and LAP2β, which 
interacts with the B-type lamin rod domain (Hutchison, 2002). However, the exact 
timing of when B-type lamins reassemble into a nuclear membrane structure has 
been disputed using various cell models (Broers et al., 1999; Moir et al., 2000; 
Lopez-Soler et al., 2001; Broers et al., 2006). In contrast to B-type lamins, the 
majority of A-type lamin assembly occurs during late telophase once the nuclear 
envelope and NPCs are assembled (Dyer et al., 1999; Broers et al., 2006). A 
small fraction of A-type lamins has been shown to associate with chromosomes 
earlier in Hela cells than in mouse cells, colocalising with emerin in the central 
core region of chromosomes (Dechat et al., 2004; Dechat et al., 2007). 
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1.4 Lamina-Associated Proteins (LAPs) 
The lamina-associated proteins (LAPs) are a diverse group of LEM-domain 
containing INM proteins that were originally characterised by their resistance to 
biochemical extraction (Senior and Gerace, 1988; Foisner and Gerace, 1993; 
Gerace and Foisner, 1994). The LAP1 family is encoded for by the LAP1 gene 
and produces three splice isoforms, A, B and C (Foisner and Gerace, 1993). 
LAP1 isoforms are type II INM proteins that are developmentally regulated and 
interact with both A- and B-type lamins (Martin et al., 1995; Maison et al., 1997). 
The LAP2 family of proteins is the best characterised of the LAPs (Broers et al., 
2006). There are six isoforms of the alternatively spliced LAP2 gene, α, β, γ, δ, ε, 
and ζ (Dechat et al., 2000b). Four of these, LAP2β, γ, δ and ε, are type II INM 
proteins that contain N-terminal LEM domains and a single transmembrane (TM) 
domain (Figure 1.5). Two LAP2 proteins, LAP2α and ζ, do not contain TM 
domains and are thus nucleoplasmic (Figure 1.5). Whilst LAP2ζ shares the first 
219 N-terminal amino acids of LAP2β, γ, δ and ε, LAP2α contains a unique large 
C-terminal domain (Figure 1.5) (Dechat et al., 2000b).  
 
The LAP2 proteins that are targeted to the INM, LAP2β, γ, δ and ε, are expressed 
throughout development, are essential for cellular survival (for LAP2β) and 
primarily bind B-type lamins (Furukawa et al., 1995; Furukawa et al., 1998; Lang 
et al., 1999; Dechat et al., 2000b; Harborth et al., 2001). However, it has also 
been shown that Xenopus XLAP2β is able to interact in vitro with both A- and B-
type lamins, although this has yet to be shown for human LAP2β (Lang and 
Krohne, 2003). Functionally, LAP2β has roles in nuclear reassembly and interacts 
directly with DNA via its LEM-like domain in its N-terminal and indirectly with DNA 
via its LEM domain interaction with BAF (Ulbert et al., 2006; Margalit et al., 2007). 
Moreover, LAP2β interacts with chromatin protein HA95 via its C-terminal region 
(Martins et al., 2003; Ulbert et al., 2006). These studies have led to the suggestion 
that LAP2β may regulate higher order chromatin structure. Indeed, it has been 
suggested that LAP2β may repress transcription via interactions with the germ 
cell less (GCL), a transcriptional repressor, and histone deacetylase (HDAC), 
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which is known to silence gene transcription (Sadoni et al., 1999; Nill et al., 2001; 
Zink et al., 2004; Somech et al., 2005). Another LAP2 isoform, LAP2ζ, acts so as 
to inhibit LAP2β-mediated transcriptional repression by competition for BAF 
(Shaklai et al., 2008). It will be of interest to determine the inter-relationships 
between the various LAP2 isoforms and how they regulate one another functions. 
 
The molecular function of the LAP2 isoform, LAP2α, also suggests that the LAP2 
proteins are involved in higher order chromatin structure during cell cycle-
dependent nuclear structure dynamics and transcriptional regulation (Vlcek and 
Foisner, 2007). Firstly, several lines of evidence suggest that LAP2α regulates 
chromatin structure. LAP2α is localised to the nucleoplasm during interphase, 
where it preferentially binds A-type lamins both in vitro and in vivo (Dechat et al., 
2000a; Markiewicz et al., 2002). During mitosis, LAP2α localises to telomeric 
chromosome regions in a phosphorylation dependent manner along with LAP2β, 
BAF and emerin (Vlcek and Foisner, 2007). LAP2α associates with chromosomes 
early during nuclear envelope reassembly, before LAP2β-bound membranes and 
the bulk of lamins have assembled around chromosomes (Vlcek et al., 1999; 
Vlcek et al., 2001; Gajewski et al., 2004). LAP2α contains both LEM and LEM-like 
domains that allows interaction with DNA both indirectly (via BAF) and directly, 
respectively (Dechat et al., 2000b). LAP2α and BAF are highly mobile within the 
nucleoplasm during interphase, as assessed by FRAP, suggesting that LAP2α-
lamin A/C-BAF interactions may be involved in the dynamic organisation of 
chromatin (Vlcek and Foisner, 2007).  
 
The most compelling evidence for a role of LAP2α in transcriptional regulation is 
based on its interaction with the tumour suppressor, pRb (see 1.6.4) (Markiewicz 
et al., 2002). LAP2α-lamin A/C complexes tether hypophosphorylated pRb within 
the nucleoplasm (Markiewicz et al., 2002; Pekovic et al., 2007). Therefore, it is 
likely that LAP2α-lamin A/C complexes govern the G1/S-phase transition by 
controlling pRb localisation and possibly phosphorylation status. Active pRb 
blocks E2F-dependent gene transcription via a variety of methods including the 
recruitment of the SWI/SNF chromatin remodelling complex, polycomb group 
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proteins, histone deacetylases as well as histone and DNA methyltransferases 
(Stevaux and Dyson, 2002; Frolov and Dyson, 2004; Korenjak and Brehm, 2005; 
Galderisi et al., 2006). pRb is inactivated by the sequential phosphorylation by 
cyclin-cdk complexes during G1-phase (Korenjak and Brehm, 2005). The LAP2α 
C-terminal domain interacts with the pocket C domain of pRb, whilst ChIP 
analyses have shown LAP2α to be present at E2F-dependent gene promoters, 
suggesting that LAP2α-lamin A/C complexes may physically repress E2F-
dependent transcription by interaction with pRb (Dorner et al., 2006).   
 
 
Figure 1.5. Domain structure of LAP2 isoforms. Of the six alternatively spliced 
isoforms of LAP2 in mammalian cells, LAP2β,γ,δ and ε isoforms display sequence 
similarity and differ via small insertions in the nucleoplasmic domain (shaded 
green boxes) and contain TM domains which span the INM. LAP2α has a 
common N-terminal (yellow), which contains the conserved LEM domain (hatched 
box), and a unique C-terminal (blue) without a TM domain. (Dechat et al., 2000) 
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1.5 Envelopathies 
The importance of the nuclear envelope is perhaps best exemplified by its 
implication in the pathogenesis of a variety of diseases. Mutations within genes 
that encode nuclear envelope proteins are termed envelopathies (Burke and 
Stewart, 2006). Whilst I will not go into great detail here, a thorough review of 
these diseases is provided by Broers et al., 2006 and Worman and Bonne, 2007. 
Envelopathies include an autosomal recessive form of cerebellar ataxia (where 
nesprin 1 is mutated), PHA and HEM/Greenberg skeletal dysplasia (lamin B 
receptor, LBR), X-linked Emery Dreifuss muscular dystrophy (EDMD, emerin), 
dilated cardiomyopathy (LAP2α), and three skeletal diseases: osteopoikilosis, 
Buschke-Ollendorff syndrome and melorheostosis (all MAN1), (Broers et al., 
2006; Worman and Bonne, 2007).  
1.5.1 Laminopathies 
Mutations in both A- and B-type lamins give rise to a wide spectrum of diseases 
collectively called laminopathies, which are themselves a subsection of 
envelopathies (Gruenbaum et al., 2005; Broers et al., 2006; Burke and Stewart, 
2006; Mattout et al., 2006; Worman and Bonne, 2007). Primary laminopathies 
arise from mutations within LMNA, LMNB1, or LMNB2, whilst secondary 
laminopathies arise from disease-causing mutations within ZMPSTE24. Disease-
causing mutations within LMNA were first identified in 1999, however mutations 
within the two lamin B genes have only recently been discovered. Duplication of 
LMNB1 causes adult-onset autosomal dominant leukodystrophy (ADLD) and 
Barraquer-Simmons syndrome is a sporadic acquired partial lipodystrophy 
resulting from mutation within LMNB2 (APL) (Hegele et al., 2006; Padiath et al., 
2006). 
 
By comparison, there are now more than 255 mutations that have been 
documented within LMNA (http://www.dmd.nl/lmna_home.html). Mutations within 
LMNA give rise to a remarkable number of different clinical disease phenotypes 
that have been loosely grouped together in terms of phenotypic characteristics 
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(Figure 1.6). Those that affect striated muscle include autosomal dominant 
Emery-Dreifuss muscular dystrophy (AD-EDMD), dilated cardiomyopathy with 
conduction system defect (DCM-CD1) and limb girdle muscular dystrophy 1B 
(LGMD 1B) (Bione et al., 1994; Bonne et al., 1999; Fatkin et al., 1999; Bonne et 
al., 2000; Muchir et al., 2000). Charcot-Marie-Tooth syndrome type 2b (CMT2B1) 
is an autosomal recessive axonal disease caused by mutations within LMNA (De 
Sandre-Giovannoli et al., 2002; Chaouch et al., 2003; Tazir et al., 2004). A third 
group of laminopathies are those involving lipodystrophies. Lipodystrophies are a 
heterogeneous group of disorders characterised by complete or partial loss of 
adipose tissue and is often associated with insulin-resistant diabetes mellitus; one 
of these caused by LMNA mutations is Dunnigan-type familial partial 
lipodystrophy (FLPD) (Kobberling and Dunnigan, 1986; Garg et al., 1999; Hegele 
et al., 2000; Reitman et al., 2000; Lelliott et al., 2002; Agarwal and Garg, 2006). 
Finally, the fourth group may be classified as premature aging disorders; these 
include atypical Werner’s syndrome, mandibuloacral dysplasia type A (MADA), 
restrictive dermopathy (RD) and Hutchinson-Gilford progeria syndrome (HGPS) 
(Novelli et al., 2002; Chen et al., 2003; Cao and Hegele, 2003; De Sandre-
Giovannoli et al., 2003; Eriksson et al., 2003; Hegele, 2003; Navarro et al., 2004; 
Filesi et al., 2005; Levy et al., 2005; Moulson et al., 2005; Toth et al., 2005).  
 
‘Secondary’ laminopathies are caused by mutations in proteins that are 
responsible for processing prelamin A (Broers et al., 2006). The only mutations 
documented thus far in the genes of this processing pathway are in ZMPSTE24, 
which causes both MAD and RD (Broers et al., 2006). 
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Figure 1.6. Disease-causing lamin A/C mutations. Comprehensive diagram showing the positions of mutations in LMNA and the 
laminopathy they cause (Burke and Stewart, 2006). 
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1.5.2 Hutchinson-Gilford Progeria Syndrome (HGPS) 
Hutchinson-Gilford Progeria Syndrome (HGPS) is a rare devastating premature 
aging laminopathy, with a reported incidence of 1:4-8 million (Novelli and D’Apice, 
2003; Pollex and Hegele, 2004; Martin, 2005). Patients usually die between 12-15 
years with the majority (~90%) of patients dying from stroke or coronary failure 
(Hennekam, 2006). HGPS patients appear normal at birth, but within one year 
exhibit several features that are associated with normal aging, such as alopecia, 
atherosclerosis, osteolysis, lipodystrophy, scleroderma and speckled skin 
pigmentation (Pollex and Hegele, 2004). However, HGPS patients do not exhibit 
cognitive degeneration, cataract formation or any increase in tumour 
susceptibility, which therefore redefines HGPS a segmental progeroid syndrome, 
as all the age-related symptoms are not fully recapitulated (Mounkes and Stewart, 
2004).  
 
The genetic causes of HGPS had long been a mystery since its first diagnosis 
over a century ago. However, in 2003, three independent groups showed that 
mutations in LMNA were responsible for this disease. Classical autosomal 
dominant HGPS arises from a de novo germline mutation in LMNA that only 
affects lamin A but not lamin C (Eriksson et al., 2003; De Sandre-Giovannoli et al., 
2003; Cao and Hegele, 2003). The most common HGPS-associated mutation is 
the de novo point mutation 1824C>T, which results in a silent base substitution 
G608G (GGC>GGT) within exon 11 (Eriksson et al., 2003). In addition, two other 
de novo mutations were found to cause HGPS, G608S (GGC>AGC) and a 
heterozygous base substitution in exon 2, E145K (GAG>AAG) (Eriksson et al., 
2003). The G608G mutation activates a cryptic splice within exon 11 of LMNA, 
resulting in a loss of 150 nucleotides from mature mRNA. This translates as an 
internal 50 amino acid deletion near the C-terminus, resulting in a mutant lamin A 
protein product termed progerin (Eriksson et al., 2003). This deletion removes the 
second endoproteolytic cleavage site, preventing the final processing step to 
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mature lamin A, thus progerin is both carboxymethylated and farnesylated (Figure 
1.3) (Goldman et al., 2004).  
 
Progerin acts in a dominant negative fashion with progerin transcript levels ~40% 
of total lamin A transcripts, indicating that use of the splice site is incomplete 
(Reddel and Weiss, 2004). As A-type lamins are involved in a vast array of 
cellular functions, research has focussed on which of these functions are altered 
in HGPS fibroblasts. Progerin is less mobile within the nucleus and primarily 
localises to the nuclear envelope due to the presence of a farnesyl group, which 
anchors it within the INM (Dahl et al., 2006). Progerin exerts its toxic effect at the 
nuclear envelope by disrupting A- and B-type lamin homopolymer formation 
(Delbarre et al., 2006). Furthermore, fibroblasts from HGPS patients display a 
characteristic set of nuclear envelope defects and abnormalities, such as 
blebbing, NPC clustering and loss of peripheral heterochromatin (Eriksson et al., 
2003; Goldman et al., 2004). Downstream of these nuclear alterations, HGPS 
cells exhibit defects in mitosis, altered cell cycle profiles with reduced S-phase 
content, reduced cellular proliferation, increased endogenous DNA damage, 
deregulated gene expression profiles, an altered epigenetic landscape and 
defects in cellular signalling (Scaffidi and Misteli, 2006; Shumaker et al., 2006; 
Cao et al., 2007; Dechat et al., 2007; Han et al., 2008; Andres and Gonzalez, 
2009; Pegoraro et al., 2009). Together, this research highlights deleterious effects 
that mutant lamin A production has on a wide range of cellular functions, 
indicating the important roles that A-type lamins play in normal cells. 
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1.6 The DNA damage response 
1.6.1 Sensing DNA damage and activating the DDR 
The first critical step in the DDR is the sensing of the damage itself. Early studies 
identified the PCNA-like protein complex Rad9-Hus1-Rad1 and Rad17 as 
potential sensors (Volkmer and Karnitz, 1999; Weiss et al., 2000). Rad17 shares 
homology with the five subunits of replication factor C (RFC) and during 
replication RFC binds DNA which in turn recruits PCNA to form a sliding clamp to 
stabilise DNA polymerases. Therefore, by analogy, during DNA damage, it has 
been postulated that Rad17 binds to DNA ends and recruits the Rad9-Hus1-Rad1 
complex (Green et al., 2000).  
 
Several lines of evidence now suggest that the Mre11-Rad50-NBS1 (MRN) 
complex is a bona fide sensor in the DDR and recent advances into its biological 
function has led it to be labelled “...a flexible scaffold that acts as a combined 
sensor, signaling and effector complex via dynamic states that control biological 
outcomes to DSBs...” (Williams et al., 2010). Structurally, the MRN complex is a 
heterohexamer, consisting of dimers of its three constituents (Figure 1.7a,b). The 
first component of the complex is the SMC family member, Rad50, which contains 
an ABC ATPase domain at both the N- and C-terminals. The collapse of the 
intervening sequence between ATPase domains results in the formation of an 
anti-parallel coiled-coil which extends from the ‘head’ domain and forms a Zn-
hook domain at the apex of the Rad50 coiled-coil (Hopfner et al., 2002). The next 
component, Mre11, which binds to Rad50 to form the core ‘head’ complex (M2R2), 
has N-terminal phosphoesterase and C-terminal DNA-binding domains and 
participates in both ssDNA endonuclease and 3’-5’ dsDNA exonuclease activities 
that are essential for the DNA repair process (Trujillo et al., 1998; Hopfner et al., 
2001; Williams et al., 2007). The last component of the MRN complex is NBS1 
(also known as nibrin or p95), which forms a flexible adaptor linkage to the Mre11-
Rad50 core complex, acting as a signaling and protein-interaction module. NBS1 
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contains an N-terminal phospho-protein binding domain and a C-terminal Mre11-
binding domain, tethering its signalling capabilities to Mre11 and Rad50.  
 
It is possible to divide the roles of the MRN complex into three distinct biological 
functions: sensing DNA damage, catalysing DNA processing and signaling. The 
MRN complex is recruited to DNA ends independently of any other protein, 
suggesting that it is the initial primary DNA damage sensor. In response to DNA 
damage, the MRN complex functions as a macromolecular dimer (Williams et al., 
2009). Each Mre11 monomer interacts with one Rad50 monomer at the 
intersection of its globular and coiled-coil domains, and together two subunits 
generate the M2R2 head domain (Figure 1.7b) (Williams et al., 2010). The Mre11-
Rad50 head domain senses and binds broken DNA ends and bridges the gap 
between strands (Figure 1.7c-d). Furthermore, the Rad50 Zn-hooks can bridge 
homologous sister chromatids during homologous recombination repair (Figure 
1.7c-d). Whilst this mechanism describes the sensing of broken DNA ends, the 
MRN complex is also responsible for the initial processing of DNA ends. 
 
 
 
 
 
 
Figure 1.7. Structure of the MRN complex and mode of action model. (a) 
Domain structure of Mre11, Rad50 and NBS1. (b) The MRN complex consists of 
a heterohexamer, with two subunits each of Mre11, Rad50 and NBS1. The head 
domain consists of an Mre11 dimer and two Rad50 ABC ATPase domains, whilst 
the coil and hook domains are composed of the remaining residues of Rad50. 
NBS1 associate with Mre11 and forms a flexible adaptor region, which is essential 
for various signaling functions. (c-d) Proposed model for MRN function. See text 
for details (taken from Lamarche et al., 2010; Williams et al., 2009, 2010). 
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Predictably, as a DNA damage sensor, mutations in components of the MRN 
complex lead to various disease phenotypes. NBS1 is mutated in Nijmegen 
breakage syndrome (NBS), a rare autosomal-recessive disease characterized by 
microcephaly, growth retardation, immunodeficiency, hypersensitivity to ionizing 
radiation and predisposition to cancer (Carney et al., 1998; Matsuura et al., 1998; 
Varon et al., 1998). Mutations in Rad50 also lead to an NBS-like phenotype 
(Waltes et al., 2009). Furthermore, hypomorphic Mre11 mutations lead to 
radiosensitivity and genomic instability in ataxia-telangiectasia like disorder 
(ATLD) (Stewart et al., 1999).  
 
These disease phenotypes overlap with those of ataxia telangiectasia (AT), a 
disease characterised by cerebellar ataxia, telangiectasia, immune defects and 
lymphoid cancer predisposition. AT is caused by mutations in the protein ATM 
(ataxia telangiectasia mutated), a serine/threonine protein kinase in the 
phosphoinositide 3-kinase (PI3K)-related protein kinase (PIKK) family (Lavin, 
2008).  The similar phenotypes observed for mutations in the MRN complex and 
ATM reflects their role as early components of the DDR and their role in sensing 
DNA damage. Indeed, for some time it was believed that ATM was the primary 
sensor of DNA damage. However, recent evidence implicates MRN as being 
upstream of ATM activation and thereby underlines the second function of the 
MRN complex, its ability to initiate the DDR signaling cascade.  
 
The primary signaling mechanism of the MRN complex is carried out by NBS1, 
which interacts with the HEAT-repeats of ATM via its C-terminus and is required 
for the recruitment of ATM to DNA breaks (Falck et al., 2005; You et al., 2005). 
Moreover, once activated, ATM may phosphorylate NBS1 on Ser-278 and Ser-
343 residues (Difilippantonio and Nussenzweig, 2007).  How the recruitment of 
ATM to the MRN complex activates ATM is a question of on-going debate. Initial 
evidence suggested ATM was activated by conformational relaxation changes in 
DNA structure surrounding a DNA break (Bakkenist and Kastan, 2003). Later 
reports however have shown that a functional MRN complex is required for 
complete ATM activation (Uziel et al., 2003; Lee and Paull, 2004, 2005). 
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Furthermore, ATM activation is inhibited in both NBS and ATLD cells in response 
to DNA damage, underlining its dependency on the MRN complex (Uziel et al., 
2003). 
 
Regardless of the mode of its activation, upon DNA damage ATM dissociates 
from a constitutive dimer into activated monomers, whereby they can 
phosphorylate a range of cellular substrates (e.g. p53, Chk2, BRCA1) involved in 
a diverse range of cellular processes, including DNA repair, cell cycle control and 
transcriptional control (Bakkenist and Kastan, 2003; Matsuoka et al., 2007). ATM 
undergoes autophosphorylation on a least three residues, S367, S1899 and 
S1987, with phosphorylation of S1987 important for the transition from inactive 
dimer to active monomer (Bakkenist and Kastan, 2003; Kozlov et al., 2006). The 
autophosphorylation of ATM leads to its widespread and rapid phosphorylation 
throughout the nucleus and in this manner is able to propagate the damage 
signal. Whether ATM autophosphorylation is a cause or consequence of its 
activation remains to be determined, as there are several conflicting reports 
(Lavin, 2008). 
 
In concert with phosphorylation, ATM also undergoes acetylation at Lys3016, 
which leads to its DNA damage-dependent activation (Sun et al., 2005, 2007). 
Building on this, further studies have revealed that ATM exists in its inactive state 
in a complex with the acetyltransferase Tip60. Upon DNA damage Tip60 binds 
histone H3K9me3 residues around the DNA break, which facilitates acetylation of 
ATM, thereby activating it (Sun et al., 2009). It therefore appears that the 
concerted efforts of autophosphorylation, acetylation and MRN binding have the 
cumulative effect of activating ATM during DNA damage.  
 
Related to ATM is another DNA damage kinase of the PIKK family, ATR (ATM 
and Rad3 related). Whilst ATM is activated in response to double strand breaks in 
vivo, ATR is activated by UV and agents that cause replication stress (Abraham, 
2001; Li and Zou, 2005). The importance of ATR to organismal survival is 
demonstrated by ATR knockout mice, which results in embryonic lethality (Brown 
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et al., 2000; de Klein et al., 2000). Furthermore, hypomorphic mutations in human 
ATR give rise to the autosomal recessive disorder Seckel syndrome, which 
shares characteristics with AT (O’Driscoll et al., 2003). Both ATM and ATR 
preferentially phosphorylate SQ/TQ residues, thus they share similar target 
substrates (Matsuoka et al., 2007; Stokes et al., 2007). In human cells, ATR exists 
in a stable heterodimer with ATRIP (ATR-interacting protein) (Cortez et al., 2001). 
In response to UV damage or replication stress, generation of single-stranded 
DNA (ssDNA) is bound by replication protein A (RPA) to prevent the formation of 
higher order structures. RPA coated ssDNA then recruits the ATR-ATRIP 
heterodimer and activated ATR phosphorylates downstream targets such as 
Chk1, which is responsible for phosphorylating Cdc25A, thus inhibiting the firing of 
replication origins (Zou and Elledge, 2003; Sancar et al., 2004).  
 
Together with ATM and ATR, the other major PIKK in mammalian cells is DNA-
PK, which consists of a trimer of DNA-PK catalytic subunit (DNA-PKcs) and a 
dimer of Ku70/Ku80 (Sancar et al., 2004).  DNA-PK plays an important role in the 
response to double strand breaks and the non-homologous end joining pathway 
as well as phosphorylating target substrates (see 1.7.6.3). 
1.7 Repair mechanisms and pathways 
Due to its very nature, DNA can be damaged in a variety of ways, including base 
damage (reduced, oxidized, or fragmented bases), DNA backbone damage 
(abasic sites and single- or double-strand DNA breaks), and cross-links (DNA-
protein cross-links and inter-strand or intra-strand cross-links) (Hoeijmakers, 
2001; Jackson and Bartek, 2009; Ciccia and Elledge, 2010). As a result of these 
genomic insults, evolution has provided various repair pathways (some of which 
may only repair one single type of DNA lesion) that are responsible for 
maintaining genomic stability and the fidelity of DNA that can be broadly 
categorised into six different, but partly overlapping, DNA repair pathways: direct 
repair, base excision repair (BER), mismatch repair (MMR), nucleotide excision 
repair (NER), repair of inter-strand cross-links (ICLs), double-strand break (DSB) 
37 
 
repair (Sancar et al., 2004). Here, I will briefly summarise the first five of these 
pathways, but explore the last, DSB repair, in more detail.  
1.7.1 Mismatch repair (MMR) 
MMR is responsible for removing mispaired, inserted or deleted nucleotides (1-10 
bases) during replication when the DNA polymerase exonuclease 3’-5’ proof-
reading fails, and in doing so MMR increases the fidelity of DNA replication ~1000 
fold (Kunkel and Erie, 2005; Jun et al., 2006; Hsieh and Yamane, 2008). Defects 
in the MMR pathway are linked to microsatelittle instability (MI), which is 
implicated in most cancers including hereditary nonpolyposis colorectal cancers 
(HNPCC) (Hoeijmakers, 2001). 
 
In eukaryotes, there are two complexes that initiate the MMR pathway (Figure 
1.8). Firstly, the MutSα dimer (composed of MSH2 and MSH6) recognises 1-2 
base insertion/deletions and single base-base mismatches. Secondly, the MutSβ 
dimer (composed of MSH2 and MSH3) may recognise base insertions/deletions 
with two or more bases (Larrea et al., 2010). Interaction of these dimers with 
mismatched DNA initiates the interaction of MutL heterodimers to the mismatched 
DNA. There are three MutL heterodimers in eukaryotes: MutLα (composed of 
MLH1 and PMS2), MutLβ (composed of MLH1 and MLH3) and MutLγ (composed 
of MLH1 and PMS1) (Kunkel and Erie, 2005; Jascur and Boland, 2006; Jun et al., 
2006). Whilst the MutLα and MutLβ heterodimers have endonuclease activities, 
the resulting nick can be utilized various exonucleases including Exo1 (Kunkel 
and Erie, 2005; Jascur and Boland, 2006; Jun et al., 2006). Alternatively, Exo1-
independent strand displacement synthesis may occur via DNA pol δ (Kadyrov et 
al., 2009). The DNA is then resynthesised by the concerted actions of replication 
factor C (RFC), proliferating cell nuclear antigen (PCNA) and DNA pol δ (Modrich, 
2006). 
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Figure 1.8. Eukaryotic mismatch repair pathway. Mismtached bases are 
recognised by MutSα or MutSβ, before recruitment of either MutLα, β or γ proteins 
depending on the type of mismatch. Further processing allows resynthesis of the 
DNA strand (Larrea et al., 2010). 
1.7.2 Base excision repair (BER) 
BER is responsible for the removal of damaged bases and is initiated by a 
plethora of DNA glycosylases, which each deal with a specific type of damaged 
base. Glycosylases flip the damaged base out of the DNA helix to form an abasic 
site (AP site) (Fromme at al., 2004). The damaged base is cleaved from the 
sugar-phosphate backbone by APE1 (Fortini and Dogliotti, 2007). Depending on 
the type of lesion, BER proceeds by either short- or long-patch pathways. In the 
short-patch pathway (where a single nucleotide is replaced), DNA pol β performs 
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a one-nucleotide gap-filling reaction and removes the 5'-terminal baseless sugar 
residue via its lyase activity, which is then followed by sealing of the remaining 
nick by the XRCC1–ligase3 complex (Hoeijmakers, 2001). In contrast, in the long-
patch pathway (where 2-10 nucleotides are newly synthesised), a large complex 
involving DNA pol δ/ε and proliferating cell nuclear antigen (PCNA) together with 
the FEN1 endonuclease to remove the DNA flap and DNA ligase 1 for sealing 
(Figure 1.9) (Sancar et al., 2004). 
 
Figure 1.9. Overview of base excision repair (BER) pathway in mammalian 
cells. Damaged bases are recognised by DNA glycosolases, followed by the 
action of an endonuclease, gap filling and then ligation.  
40 
 
1.7.3 Nucleotide Excision Repair (NER) 
NER is the major mechanism for removal of a variety of structurally and 
chemically unrelated bulky DNA lesions such as chemical adducts and the 
dimerized pyrimidine bases induced by UV radiation (Hanawalt, 2007; 
Hoeijmakers, 2009). Defects in NER cause diseases such as xeroderma 
pigmentosum (XP), Cockayne Syndrome (CS), and trichothiodystrophy (TTD) 
(Thoma and Vasquez, 2003). There are two major NER sub-pathways: global 
genomic repair (GGR), which eliminates lesions from the entire genome, and 
transcription coupled repair (TCR), which efficiently removes lesions from the 
transcribed strand of active genes. Both sub-pathways follow the same basic 
repair steps and require more than 25 proteins for DNA damage recognition, dual-
incision, excision, repair synthesis, and ligation (Thoma and Vasquez, 2003). In 
GGR, DNA damage-induced helical distortion is recognized by the XPC and XPD 
(or UV-DDB) protein complexes. In TC-NER, damage is recognised by the CSB 
and CSA proteins, which respond to the stalling of RNA polymerase II (Hanawait 
and Spivak, 2008). In both cases, the next step involves the recruitment of 
transcription factor IIH (TFIIH). The two helicase subunits of TFIIH, XPB and XPD, 
both act to unwind DNA, allowing damage recognition by xeroderma 
pigmentosum group A (XPA), whilst RPA arrives at the same time to help in 
verifying the presence of DNA lesions (Nouspikel, 2009). Endonuclease 
xeroderma pigmentosum group G (XPG) and the xeroderma pigmentosum group 
F-excision-repair cross-complementing group 1 (XPF–ERCC1) complex are 
responsible for the 3' and 5' DNA incisions, respectively, creating a single-
stranded oligonucleotide ~ 24-32 nucleotides in length (Coin et al., 2008; 
Hoeijmakers, 2009). Binding of XPG induces the release of XPC, whereas XPF–
ERCC1 triggers excision of the damaged DNA and the release of XPA and TFIIH 
(Coin et al., 2008). Subsequently, the newly formed gap in the DNA is filled by 
DNA polymerase δ/ε, replication factor C (RFC), proliferating cell nuclear antigen 
(PCNA), RPA and DNA ligase I or a complex of XRCC1 and DNA ligase III 
(Figure 1.10) (Park and Choi, 2006). 
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Figure 1.10. Overview of the nucleotide excision repair (NER) pathway in 
mammalian cells. UV-induced DNA damage is proceesed by one of two 
branches of NER, namely global genome repair (GGR) or transcription-coupled 
repair (TCR). The two pathways converge when TFIIH is recruited, which then 
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facilitates the recruitment of downstream factors necessary for damage sensing 
and repair. See text for details (Hoeijmakers, 2009). 
1.7.4 Inter-strand crosslink (ICL) repair  
Inter-strand crosslinks may be caused by a range of chemicals (e.g. nitrogen 
mustards, mitomycin C, cisplatin) and result from the formation of covalent 
linkages between DNA strands to create a bi-directional block to replication 
polymerases (Smogorzewska et al., 2010). To counteract this life-threatening 
lesion, the Fanconi Anemia (FA) pathway has evolved to target this specific form 
of DNA damage (Liu et al., 2010). FA is a rare inherited disease characterised by 
genomic instability, congential malformations, bone marrow failure and cancer 
predisposition (Alter et al., 2003; Wang et al., 2007). Cells from FA patients are 
hypersensitive to DNA inter-strand crosslinking (ICL) agents such as mitomycin C 
(MMC) and cisplatin. There are thirteen distinct Fanconi anemia genes that have 
been shown to interfere with the DNA-replication-dependent repair of lesions 
involving crosslinked DNA at stalled replication forks. Furthermore, it seems likely 
that all thirteen are needed for efficient ICL repair (Niedernhofer et al., 2005; 
Moldovan and D’Andrea., 2009). Central to the FA pathway is the FANCI-
FANCD2 (ID) complex (Garcia-Higuera et al., 2001; Smogorzewska et al., 2007). 
The ID complex is chromatin bound, and when it encounters a DNA replication 
structure stalled due to a DNA crosslink, it becomes phosphorylated by the 
ATR/ATRIP kinase, which is localized through recognition of RPA at the lesion 
(Zou and Elledge, 2003). Phosphorylation of both FANCI and FANCD2 is required 
for ID function (Andreassen et al., 2004; Ho et al., 2006; Ishiai et al., 2008). Upon 
phosphorylation, eight FA proteins (A, B, C, E, F, G, L, and M) are assembled into 
the nuclear FA core complex that mono-ubiquitylates its two substrates, FANCI 
and FANCD2, a reaction that also requires the FA-associated proteins FAAP100 
and FAAP24 (Garcia-Higuera et al., 2001; Taniguchi et al., 2002; Ciccia et al., 
2007; Collis et al., 2008). The ubiquitylated ID complex then accumulates at the 
site of damage and directs repair (Smogorzewska et al., 2007; Raschle et al., 
2008; Knipscheer et al., 2009). Exactly how it does it this unclear. However, using 
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a cell-free system, it has been suggested that monoubiquitylation of FANCD2 is 
required for the unhooking of the ICL (Knipscheer et al., 2009). Unhooking 
involves incisions on both sides of the ICL, followed by bypass synthesis over the 
lesion on the remaining intact strand using a translesion polymerase. Both the 
incision step and the bypass polymerase step are dependent upon ubiquitylation 
of the ID complex (Raschle et al., 2008; Knipscheer et al., 200;). Double strand 
breaks generated by unhooking are resected and one of them initiates 
homologous recombination to complete ICL repair (Figure 1.11) (Moldovan and 
D’Andrea, 2009; Kee and D’Andrea, 2010). 
1.7.5 Single-strand break (SSB) repair 
Single-strand breaks may form in response to ROS, IR and as a result of inherent 
BER processes (Caldecott, 2008). Initial sensing of SSBs is carried by the zinc 
finger domains of PARP1 and PARP2, whose binding to DNA causes their 
activation and they subsequently synthesise poly(ADP-ribose) (PAR) chains at the 
sites of damage, notably on histones H1, H2B and PARP1 itself. The assembly is 
transient and rapid, with the PAR chains disassembled by PARG (Schreiber et al., 
2006). Recent evidence suggests that the addition of PAR chains (PARylation) 
leads to local chromatin relaxation, which is necessary for the recruitment of other 
chromatin modifying enzymes and DNA repair proteins (Ahel et al., 2008; Ahel et 
al., 2009; Chou et al., 2010; Larsen et al., 2010; Polo et al., 2010; Smeenk et al., 
2010). XRCC1 is recruited to PAR chains and facilitates the recruitment of 
downstream effectors such as Xip1 such as DNA polymerase b, PNK, and the 
nucleases APE1, APTX, and APLF (Caldecott, 2008). The processed ends are 
then directed into the short- or long-patch BER pathways. 
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Figure 1.11. Model of ICL repair highlighting the involvement of the FANC 
proteins. Inter-strand crosslinks, produced either by crosslinking reagents or the 
convergance of two replisomes, are recognised by the FA complex, which triggers 
the ubiquitylation of FANCD2 and FANCI. Nucleases then excise the ICL, which is 
subsequently repaired by homologus recombination before replication restart 
(Nierdernhofer et al., 2005). 
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1.7.6 Double strand break (DSB) repair 
Among the various forms of DNA damage that are inflicted by mutagens, DSBs 
are the most dangerous cytotoxic lesions. DSBs can be caused by ionizing 
radiation, radiomimetic chemicals, ROS, and mechanical stress on chromosomes 
(Mackinnon and Caldecott, 2007; Jackson and Bartek, 2009). DSBs can also be 
the result of normal V(D)J recombination or abnormal replication fork arrest and 
collapse (Polo and Jackson, 2011). Defects in DSB repair result in genomic 
instability and apoptosis at the cellular level, and lead to increased predisposition 
to cancer in animal models and in people (Halazonetis et al., 2008; Jackson and 
Bartek, 2009). DSBs are repaired using two main pathways, either by homologous 
recombination repair (HRR), which usually occurs in S and G2-phases, or non-
homologous end-joining (NHEJ) mechanisms, which normally occurs in G1-phase 
(Hiom, 2010; Kass and Jasin, 2010).  Cells have evolved interwoven mechanisms 
for the detection of DSBs and recent work has implicated a variety of cellular 
processes in the complex task of both signalling and repairing DSBs, such as 
post-translational modifications (phosphorylation, acetylation, ubiquitylation, 
SUMOylation), transcriptional silencing and altered chromatin dynamics (Ciccia 
and Elledge, 2010). 
 
1.7.6.1 γ-H2AX-dependent signalling cascade in response to DSBs 
In addition to the MRN complex, DSBs can be sensed by PARP, Ku70/80 and 
RPA (with processing) (Uziel et al., 2003; Falck et al., 2005; Ciccia and Elledge, 
2010; Polo and Jackson, 2011). Furthermore, MRN and Ku70/80 contribute to full 
ATM and DNA-PKcs activation (Falck et al., 2005; Al-Hakim et al., 2010). 
Following DSB formation, the MRN complex component NBS1 binds ATM via its 
C-terminal domain. Once ATM has been activated it phosphorylates an extensive 
network of cellular substrates, such as proteins involved in DNA repair and cell 
cycle progression (Matsuoka et al., 2007; Derheimer and Kastan, 2010). One of 
the first substrates to be phosphorylated by ATM is histone variant H2AX on 
Ser139, which can also be phosphorylated by two other PIKKs, ATR and DNA-PK 
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(Rogakou et al., 1999; Burma et al., 2001; Stiff et al., 2004; Attikum and Gasser, 
2009). The H2AX variant constitutes ~ 10-15% of total H2A in higher eukaryotes 
and upon DNA damage its phosphorylation may spread up to 1-2 megabases 
from the DSB in an asymmetrical manner, a process which is responsible for the 
retention of downstream DDR proteins rather than their initial recruitment 
(Rogakou et al., 1998; Celeste et al., 2003; Stucki and Jackson, 2006; Berkovich 
et al., 2007; Meier et al., 2007; Savic et al., 2009; Iacovoni et al., 2010). Coupled 
to γ-H2AX production is the dephosphorylation of Y142 of H2AX, which appears 
to be a prerequisite for Ser139 phosphorylation (Cook et al., 2009; Xiao et al., 
2009). Another substrate of ATM, MDC1 (mediator of the DNA-damage 
checkpoint 1) then sequentially binds γ-H2AX via its C-terminal BRCT repeats 
(Goldberg et al., 2003). Further to this, MDC1 also interacts with the NBS1 N-
terminal FHA domain. Upon DNA damage, MDC1 is phosphorylated by casein 
kinase 2 (CK2) at SDT (Ser-Asp-Thr) repeats in its N-terminal. These 
phosphorylated repeats serve as a ligand for the NBS1 FHA domain, which helps 
to maintain MRN-ATM at sites of DNA damage and allows further accumulation of 
γ-H2AX at regions flanking the DSB (Chapman and Jackson, 2008  Melander et 
al., 2008; Spycher et al., 2008). The MDC1 FHA domain can also bind ATM, thus 
it is clear that MDC1 serves as a platform for the assembly of proteins integral to 
the DDR (Lou et al., 2006). This positive feedback mechanism allows further 
retention of downstream proteins at sites of DNA damage and has therefore led 
MDC1 to be termed the “...master regulator...” of the DDR (Stucki and Jackson, 
2004). The RING-finger E3 ubiquitin ligase protein RNF8 also binds MDC1 
phospho-TQ sites via its N-terminal FHA domain and ubiquitylates H2A and H2AX 
at DSBs via K63-linkages (Huen et al., 2007; Kolas et al., 2007; Mailand et al., 
2007). Another ubiquitin ligase, RNF168, recognises ubiquitin chains and 
catalyses the further K63 ubiquitylation of H2A and H2AX (Doil et al., 2009; 
Stewart et al., 2009). The recently identified E3 ubiquitin ligase, HERC2, 
facilitiates assembly of the RNF/Ubc13 complex by interacting withn the FHA 
domain of RNF8 in a phopsphorylation-dependent manner (Bekker-Jensen et al., 
2010; Bekker-Jensen and Mailand, 2010).  The K63 ubiquitin chains serve as a 
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recruitment signal for the BRCA1-A complex via the UIM motif in RAP80 (Figure 
1.12) (Huen and Chen, 2010). The RNF8-RNF168 axis is also responsible for the 
recruitment of the mediator protein 53BP1 to sites of DNA damage. Therefore, 
histone ubiquitylation is essential for the assembly of DNA repair factors at DSBs 
(Bekker-Jensen and Mailand, 2010). 
 
As another level of complexity to these assembly events, recent advances have 
shown a role for SUMOylation as a regulatory post-translational modification in 
the DDR to add the aforementioned acetylation, phosphorylation and 
ubiquitylation modifications (Galanty et al., 2009; Morris et al., 2009). It was 
shown that two SUMO ligases, PIAS1 and PIAS4, localise to DSBs, with PIAS1 
responsible for SUMOylating BRCA1 and stimulating its E3 ubiquitin ligase 
activity, whilst PIAS4 is responsible for SUMOylating the RNF8/Ubc13 complex 
thereby stimulating its ubiquitin ligase activity (Galanty et al., 2009; Morris et al., 
2009).  
 
Typically, proteins involved in the antagonistic post-translational modification (e.g. 
de-ubiquitylation, de-SUMOylation, de-phosphorylation) localise to the DSB 
microenvironment simultaneously. Recently, the de-ubiquitylating enzyme (DUB) 
OTUB1 was shown to inhibit RNF168-dependent ubiquitylation by direct inhibition 
of Ubc13 (Nakada et al., 2010). Therefore, the apparently overt complexity of 
DDR protein assembly has been suggested to facilitate exquisite fine control of 
DNA repair mechanisms as the requirement for different repair choices play out 
(Figure 1.12) (Cicca and Elledge, 2010). 
 
 
Figure 1.12. γ-H2AX-dependent signalling cascade following DNA damage. 
Following IR, PARP1/2 and MRN are recruited to the DSB. MRN and Tip60 
activate ATM, which in turn phosphorylates p53, Chk2 and H2AX. MDC1 binds γ-
H2AX, which is responsible for the recruitment of downstream substrates RNF8, 
RNF168, BRCA1 and 53BP1. See main text for details. (Ciccia and Elledge, 
2010) 
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1.7.6.2 Homologous recombination (HR) 
The HR repair pathway is an accurate repair process that depends on an intact 
sister chromatid as a template. Initial sensing is carried out by the MRN complex 
and is associated with a DSB signalling cascade involving histone modifications. 
Furthermore, the Mre11 component of the MRN complex acts together with CtIP,  
Exo1 and helicases to stimulate the resection of the 5’ ends of the DSB to 
generate 3’ ssDNA overhangs (Mimitou and Symington, 2008, Zhu et al., 2008; 
Nicolette et al., 2010). It should be noted that Mre11 possess intrinsic 3’-5’ 
exonuclease activity and only through interaction with other factors, notably CtIP 
and Exo1, can it promote initial 5’-3’ resection necessary for homologous 
recombination (Huertas, 2010, Lamarche et al., 2010; Nicolette et al., 2010). Once 
resection is complete, RPA binds immediately to ssDNA and BRCA2 facilitates 
the replacement of RPA by the Rad51, a DNA-dependent ATPase, to form 
nucleoprotein filaments (Kass and Jasin, 2010). Formation of this nucleoprotein 
filament facilitates strand exchange during which the ssDNA invades the 
homologous duplex DNA template to generate a D-loop structure. D-loop 
formation can then be resolved by multiple mechanisms. The first is called 
synthesis-dependent strand annealing (SDSA) and involves the extension of the 
3’ end of the D-loop by repair synthesis leading to its annealing with the resected 
strand of the second end (Figure 1.13) (Heyer et al., 2010). The second 
mechanism involves the production of a Holliday junction if the two sisters 
exchange, which can be resolved by nucleolytic processing by Gen1 and the 
Slx1-Slx4 nuclease complex (Hiom, 2010). Resolution of the Holliday junction 
results in either crossover or non-crossover products, with the former having 
deleterious effects, such as loss of heterozygosity (Figure 1.13) (Kass and Jasin, 
2010). However, typically HR is an accurate repair pathway (i.e. forming non-
crossover products) if a sister chromatid is present, faithfully restoring the DSB 
(Ciccia and Elledge, 2010). 
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1.7.6.3 Non-homologous end joining (NHEJ) 
The first step of NHEJ is the binding of the Ku70/80 heterodimer to the double-
stranded ends of the DSB (Mahaney et al., 2009; Roberts et al., 2010). Whilst 
Ku70/70 possesses some end processing ability, it also functions to recruit DNA-
dependent protein kinase catalytic subunit (DNA-PKcs), a step that translocates 
Ku70/80 inwards (Roberts et al., 2010). Binding of DNA-PKcs to DNA stimulates 
its own autophosphorylation, an event that induces a large conformational change 
in DNA-PK, leading to its dissociation from DNA either before or after end 
processing events (Sibanda et al., 2010). After DNA-PKcs binding, further 
proteins are recruited to process the DNA ends, one of which is the 
endonuclease, Artemis, which is phosphorylated by DNA-PK. Another protein 
recruited is the polynucleotide kinase, phosphatase (PNKP), which is responsible 
for removing 3’-phosphate groups and adds 5’-phosphate groups to DNA ends 
(Koch et al., 2004). The MRN complex and DNA polymerases µ and λ, which fills 
in missing nucleotides, are also required for the end processing of DSBs. Lastly, 
DNA-PK recruits the x-ray repair cross-complementing protein 4 (XRCC4) and 
DNA ligase IV complex as well as XLF, which are involved in the ligation of the 
DSB (Figure 1.13) (Mahaney et al., 2009). Whilst DSBs with flushed 5’-
phosphorylated ends or complementary overhangs are re-ligated effectively, 
where nucleotides have become altered, lost or need processing then genetic 
material may be lost after this re-ligation step, therefore defining the NHEJ 
pathways as typically error-prone (Hiom, 2010). 
 
1.7.6.4 Alternative non-homologous end joining (alt-NHEJ) and single-strand 
annealing (SSA) 
When the classical NHEJ pathway is blocked, then Ku70/80-dependent NHEJ 
cannot proceed and cells may use alternative NHEJ pathways (sometimes called 
microhomology mediated end joining, MMEJ) (McVey and Lee, 2008). Although 
the exact mechanism is unknown, it appears that limited end resection by MRN 
and CtIP occurs prior to DNA ligation. Furthermore, this may be aided by small 
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microhomologies that may help to align broken strands of DNA (Simsek and 
Jasin, 2010). 
 
A distinct pathway separate from HR is single-strand annealing (SSA). If there are 
repetitive DNA sequences on either side of a DSB then, following resection, the 
strands can be annealed by Rad52, followed by the removal of DNA flaps by 
XPF/ERCC1 (Hartlerode and Scully, 2009). The action of EPF/ERCC1 results in 
the loss of genetic material from between the repetitive sequences and hence this 
repair pathway is inherently error-prone.  
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Figure 1.13. DSB repair pathways in mammalian cells. DSBs are principally 
repaired by either homologous recombination (HR) or non-homologous end-
joining (NHEJ). See text for details (Ciccia and Elledge, 2010). 
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1.8 p53-binding protein (53BP1) 
The p53 binding protein, 53BP1, together with proteins such as BRCA1, MDC1 
and TopBP, has been classified as a mediator of the DNA damage response 
(Wang et al., 2002). 53BP1 was first identified as a p53-interacting protein using a 
yeast two hybrid assay with the p53 central domain as bait (Iwabuchi et al., 1994). 
Since then various studies have underlined its importance in the in the DDR via its 
impact on checkpoint activation and its role in DNA repair. 
1.8.1 Structure of 53BP1 
53BP1 is a large protein (1972 amino acids) with an N-terminal region rich in 
phosphorylation sites. The C-terminal domain consists of an oligomerisation 
domain (OD), a region required for γ-H2AX interaction, a Tudor domain and a 
tandem BRCT domain (Figure 1.14) (Fitzgerald et al., 2009). 
 
Figure 1.14. Domain structure of 53BP1 and two other mediators of the DDR, 
MDC1 and BRCA1 (Fitzgerald et al., 2009). 
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The N-terminal region of 53BP1 has been shown to be rich in both IR-dependent 
and IR-independent phosphorylation sites, with 32 potential SQ/TQ sites (Ward et 
al., 2003; Jowsey et al., 2007; Fitzgerald et al., 2009; Lee et al., 2009). The role of 
IR-dependent phosphorylation of 53BP1 is discussed below. 53BP1 also contains 
41 SP/TP sites, which are targets for CDK phosphorylation, but the exact role for 
these CDK sites remains to be determined (Jowsey et al., 2007; Fitzgerald et al., 
2009).  
1.8.2 53BP1 in checkpoint control  
A role for 53BP1 in both the intra-S-phase and G2/M-phase checkpoints has been 
suggested (DiTullio et al., 2002; Fernandez-Capetillo et al., 2002; Wang et al., 
2002). In the latter study, U2OS cells depleted of 53BP1 exhibited ineffective 
checkpoint arrest, with a defective G2/M checkpoint only apparent in response to 
low doses of IR (Wang et al., 2002). In contrast, subsequent reports have failed to 
detect any defective intra-S-phase and G2/M-phase checkpoints (Iwabuchi et al., 
2006).  
 
53BP1 is a phosphorylation target of ATM/ATR in response to DNA damage 
(Ward et al., 2003). Moreover, in 53BP1-depleted cells, the phosphorylation of 
downstream targets including Chk2, BRCA1 and SMC1 was shown to be inhibited 
(DiTullio et al., 2002; Wang et al., 2002). 53BP1 also potentiates the 
autophosphorylation ATM at Ser1982, although the exact mechanism of how it 
carries out this function remains unclear (Wilson and Stern, 2008). 
1.8.3 53BP1 in DNA repair 
53BP1 has been implicated as a facilitator in the NHEJ repair pathway and in the 
absence of 53BP1 cells exhibit increased genomic instability (Adams and 
Capenter, 2006; Nakamura et al., 2006). Specifically, mice null for 53BP1 exhibit 
defects in class switch recombination (CSR) and V(D)J recombination, two 
processes that produce DNA intermediates with DSBs (Manis et al., 2004; Ward 
et al., 2004; Difilippantonio et al., 2008). Long-range rearrangements from distal 
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gene segments were diminished in 53BP1-null thymocytes, suggesting that 
53BP1 is involved in promoting NHEJ during V(D)J recombination by facilitating 
the mobility of broken DNA ends (Difilippantonio et al., 2008). Indeed, 53BP1 
increases the mobility of uncapped telomere ends (achieved by using TRF2-
deficient cells) therefore increasing their capacity to be fused (Dimitrova et al., 
2008). The ability of 53BP1 to modulate chromatin mobility has also implicated it 
in the repair of heteromchromatin, which is repaired relatively late in the repair 
process due to remodelling events (Noon et al., 2010). 
 
Recently, a role for 53BP1 in the choice between DSB repair pathways (HR vs 
NHEJ) has been established (Nakamura et al., 2006; Xie et al., 2007). Whilst 
53BP1 promotes NHEJ, disruption to 53BP1 activity leads to increased HR 
pathway choice (Nakamura et al., 2006; Xie et al., 2007). Furthermore, 
importantly, loss of 53BP1 leads to the increased viability of Brca1-null cells and 
Brca1Δ11/Δ11 mice, which express a truncated form of the protein (Cao et al., 2009; 
Bouwman et al., 2010). Moreover, Brca1Δ11/Δ1153bp1-/- mice develop normally and 
do show premature aging or increased cancer rates. In this context, loss of 53BP1 
in Brca1-deficient cells leads to increased HR, which is initiated by DNA end 
resection (Bouwman et al. 2010; Bunting et al., 2010). This therefore suggests 
that 53BP1 promotes the NHEJ pathway by inhibiting DNA end resection, thus 
inhibiting HR (Boulton, 2010). Limiting resection may be important for the long 
duration needed for long-range rejoining events during NHEJ (Goodarzi et al., 
2010). The molecular mechanism for 53BP1 inhibition of the HR remains to be 
determined, though it has been postulated that BRCA1 ubiquitylation of CtIP may 
enhance its ability to promote resection (Boulton, 2010). 
1.8.4 Recruitment of 53BP1 to sites of DNA damage 
53BP1 is recruited to DSBs via both γ-H2AX-dependent and independent 
mechanisms (Yuan et al., 2010; Pei et al., 2011). The γ-H2AX dependent 
mechanism was described previously. However it remains to be clarified how 
histone ubiquitylation regulates the recruitment of 53BP1 to DSBs as 53BP1 does 
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not contain any ubiquitin binding domains (Bekker-Jensen and Mailand, 2010). 
One possibility is that there is an ubiquitin-binding protein that may facilitate 
53BP1 recruitment to DSBs, or that 53BP1 does have some intrinsic ubiquitin 
binding ability. Interestingly, 53BP1 associates with the de-ubiquitylating enzyme 
USP28. Another theory posits that histone ubiquitylation promotes local chromatin 
relaxation, which in turn exposes histone residues. Accordingly, 53BP1 has been 
shown to bind both H3K79me2 and H4K20me2 via its Tudor domain (Huyen et 
al., 2004; Botuyan et al., 2006). Until recently, it was believed that H4K20me2 
levels did not change upon DNA damage, indicating that de novo histone 
methylation is not promoting 53BP1 recruitment (Fitzgerald et al., 2009). This 
therefore suggested that alterations in the chromatin structure imposed during 
DNA damage promoted the exposure of H3K79me2 and H4K20me2 residues that 
bind 53BP1 (Fitzgerald et al., 2009). This proposal has been challenged very 
recently by the finding that a methyltransferase, MMSET, actually causes local 
accumulation of methylated H4K20, which is undetectable by western blot due to 
the high background levels of this modification in cells (Pei et al., 2011). Down-
regulation of MMSET or mutation of critical residues in its methyltransferase 
domain inhibited 53BP1 recruitment to IRIF, but not the formation of γ-H2AX or 
recruitment of MDC1 and RNF8 (Pei et al., 2011). MMSET recruitment to IRIF 
does seem to require both γ-H2AX and MDC1 with MMSET interacting with 
MDC1 in a DNA damage-dependent manner, which was correlated with its 
phosphorylation at S102 by ATM (Pei et al., 2011). Importantly, MMSET 
recruitment to IRIF was not affected by RNF8, suggesting that 53BP1 may be 
recruited to DSBs by both RNF8-dependent and independent mechanisms (Pei et 
al., 2011).  
 
53BP1 may also be recruited to DSBs in a γ-H2AX-independent manner, as 
exemplified using H2AX-null cells (Celeste et al., 2003). 53BP1 interacts with the 
MRN complex, via NBS1, and requires the MRN complex for transient tethering at 
DSB sites (Lee et al., 2010; Yuan and Chen, 2010).  
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1.9 DNA damage checkpoints 
In response to genotoxic insults, cells must initiate checkpoints to attenuate cell 
cycle progression and arrest replication, therefore preventing DNA lesions from 
being converted to inheritable mutations (Zhou and Elledge, 2000; Lukas et al., 
2004; Bartek and Lukas, 2007). Cell cycle arrest is essential to allow DNA repair 
or, if the damage is beyond repair, engage an apoptotic or senescence pathway. 
After DNA damage, the two apical PIKKs, ATM and ATR, are activated and are 
responsible for downstream signaling events that play the central roles in initiating 
the checkpoints (Li and Zou, 2005; Cimprich and Cortez, 2008). As mentioned 
previously, ATM is activated primarily in response to DNA double-strand breaks, 
whereas ATR is activated by a broad array of DNA damage and replication 
interference (Jackson and Bartek, 2009). ATM and ATR phosphorylate two major 
signal-transducing kinases, Chk1 and Chk2, which in turn regulate downstream 
targets, such as Cdc25 and p53, to control cell cycle progression and DNA 
synthesis (Shiloh, 2003; Bartek and Lukas, 2007). The Cdc25 family of 
phosphatases are key targets of Chk1 and Chk2 and three isoforms exist in 
mammalian cells, A, B and C (Aressy and Ducommun, 2008). Whilst Cdc25A 
controls cell cycle progression through S-phase and mitosis, Cdc25B and C 
control mitotic entry. The spatiotemporal regulation of damage signals is 
integrated into three distinct cell cycle checkpoints: G1/S-phase, intra-S phase and 
G2/M-phase. Before describing each of these, it is noteworthy to highlight that 
DNA damage checkpoints operate at two levels. The initial checkpoint response 
causes a rapid cell cycle arrest and generally proceeds by the phosphorylation of 
target substrates (e.g. Cdc25) to impede cell cycle progression. The second layer 
to this checkpoint activation is a delayed and sustained response from the cell 
cycle machinery, as a result of transcriptional activation in response to DNA 
damage (Lukas et al., 2004). This slower response is essential as it allows the 
integration of the DDR signals over time (Figure 1.15).  
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Figure 1.15 Checkpoint signaling initiates both a transient and sustained 
cell cycle arrest. DNA damage induces both a rapid transient cell cycle arrest via 
protein-protein signalling, and also a transcriptional program to enforce and 
sustain the cell cycle arrest. The apical PIKKs ATM and ATR, together with the 
Chk1 and Chk2 kinases initiate a cascade of signalling ensuring activation of cell 
cycle checkpoints (Lukas et al., 2004). 
1.9.1 G1/S-phase checkpoint 
Damage induced during G1-phase initiates a checkpoint that prevents the initiation 
of DNA replication in the presence DNA lesions. The cellular target of active 
unphosphorylated Cdc25A is the cdk2-cyclin E complex. Cdc25A 
dephosphorylates the cdk2-cyclin E complex, which maintains its active state, 
thus promoting cell cycle progression. In response to DNA damage, Chk1 and 
Chk2 phosphorylate Cdc25A, which in turn is ubiquitylated by the SCFβTrcP 
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ubiquitin ligase, thus inducing its degradation via the ubiquitin-proteasome 
pathway (Mailand et al., 2000). The CDK2-cyclin E complex is therefore 
hyperphosphorylated, at Tyr15 of CDK2, rendering it inactive and hence 
promoting a G1/S-phase arrest (Mailand et al., 2000; Bartek and Lukas, 2001; 
Falck et al., 2001). This rapid p53-independent pathway of phosphorylation and 
ubiquitylation is responsible for the initial early response to DNA damage. 
However, for a sustained cell cycle arrest, DNA-damage dependent transcriptional 
activation of p53 is necessary. Both ATM/ATR and Chk1/Chk2 can phosphorylate 
p53 in response to DNA damage at various residues (Milczarek et al., 1997). As 
well as phosphorylation, p53 undergoes a myriad of other post-translational 
modifications that, together, results in its stabilisation and the activation of its 
DNA-binding domain, enhancing its transcriptional ability (Vousden and Prives, 
2009).  One target of p53-dependent transcription is the cell cycle inhibitor, 
p21WAF1, which suppresses CDK2-cyclin E, therefore reinforcing the G1 
checkpoint arrest initiated by Cdc25A destruction (Figure 1.15) (Poehlmann and 
Roessner, 2010). Interestingly, it has been shown recently that p53 undergoes 
oscillations driven by the continued activation of ATM due to the persistence of 
DNA damage in a feedback mechanism involving WIP1 phosphatase and MDM2 
E3 ubiquitin ligase (Batchelor et al., 2008; Loewer et al., 2010). This suggests a 
regulatory feedback mechanism where DNA damage can signal to cell cycle 
regulators, thereby facilitating crosstalk between the two pathways. 
1.9.2 Intra-S-phase checkpoint 
DNA damage encountered during S-phase results in the destruction of Cdc25A, 
therefore inhibiting the loading of Cdc45 onto DNA pre-replication complexes 
(Bartek and Lukas, 2001; Falck et al., 2001). This pathway initiates and sustains 
the intra-S-phase checkpoint response that can last several hours and is 
independent of both p53 and p21 (Bartek and Lukas, 2001). 
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1.9.3 G2/M-phase checkpoint 
The G2/M checkpoint prevents cells from entering mitosis with DNA lesions and 
therefore transmitting the damage to daughter cells (Lukas and Bartek, 2004). 
The G2/M checkpoint functions in a similar fashion to the G1/S checkpoint with an 
initial rapid transient response and a delayed sustained response. The initiating 
step for mitotic entry is the activation of the CDK1-cyclin B1 complex by 
dephosphorylation. Activated CDK1-cyclin B1 activates Cdc25C and inactivates 
Wee1, therefore forming two positive feedback loops. In response to DNA 
damage, Chk1 and Chk2 phosphorylate Cdc25C and therefore prevent the 
dephosphorylation of the CDK1-cyclin B1 complex necessary for mitotic entry 
(Figure 1.15).  
1.10 The importance of the DDR in human physiology 
1.10.1 The DDR and cancer 
Defects in genes that encode members of the DDR are found in most cancer 
types. Furthermore, the broad range of diseases caused by mutations in DDR 
proteins exemplifies their importance to human physiology (Hoeijmakers, 2009; 
Jackson and Bartek, 2009: Kerzendorfer and O’Driscoll, 2009; Negrini et al., 
2010; Ciccia and Elledge, 2010; Hanahan and Weinberg, 2011). For example, 
defects in the nucleotide excision repair pathways proteins XPA-XPG can cause 
xeroderma pigmentosum, a disease characterised by hypersensitivity to UV and 
which results in a 2000-fold higher risk of skin cancer in patients than the general 
population (Hoeijmakers, 2009). Defects in the mismatch repair pathway are 
associated with hereditary non-polyposis colon cancer, whilst mutations in the 
base excision have been associated with colorectal tumours (Negrini et al., 2010). 
Mutations in DDR genes that predispose patients to the development of various 
cancers are characterised by chromosomal instability (CIN) and include BRCA1, 
BRCA2, BRIP1, Rad50, NBS1, WRN, BLM and REQL4 (Jackson and Bartek, 
2009).  
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Hereditary cancers caused by mutations in DDR genes support the mutator 
hypothesis of cancer development, which posits that “...genomic instability is 
present in precancerous lesions and drives tumour development by increasing the 
spontaneous mutation rate...” (Loeb, 1991; Kinzler and Vogelstein, 1997; 
Halazonetis et al., 2008; Negrini et al., 2010). Therefore, patients with hereditary 
mutations in DDR proteins may exhibit increased genomic stability and cancer 
development if a single event leads to loss of any remaining wild type allele 
(Negrini et al., 2010). Interestingly, the evidence for mutations in DDR genes 
found in sporadic cancers is severely lacking. The past few years have seen the 
fruition of high-throughput cancer genome sequencing studies that have detailed 
the mutations and chromosomal rearrangements in various cancer types (Sjoblom 
et al., 2006; Wood et al., 2007; Ding et al., 2008; Jones et al., 2008; Parsons et 
al., 2008; Parsons et al., 2011; Varela et al., 2011). An analysis of five of these 
studies by Negrini et al., (2010) showed a paucity of mutations in DDR genes 
(Sjoblom et al., 2006; Wood et al., 2007; Ding et al., 2008; Jones et al., 2008; 
Parsons et al., 2008). The authors of this analysis go on to argue that the mutator 
hypothesis predicts that mutations in DDR genes would be frequent in sporadic 
cancer development, which is in stark contrast to the high-throughput sequencing 
data. Therefore, they suggest that the CIN seen in sporadic cancers may be 
explained by the oncogene-induced DNA replication stress model, which 
postulates that the oncogene-induced collapse or replication forks results in DSBs 
and genomic instability (Bartkova et al., 2005; Bartkova et al., 2006; Di Micco et 
al., 2006; Halazonetis et al., 2008; Negrini et al., 2010). However, this model is by 
no means complete, for example telomere erosion and epigenetic modifications 
are not taken into account by high-throughput sequencing. Furthermore, recessive 
mutations in DDR genes are necessary for loss-of-function in most cases, which 
would be rare events in sporadic cancers. Thus, further work is needed to identify 
genes responsible for CIN in sporadic cancers and define the role of the DDR in 
cancer progression   
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1.10.2 The role of the DDR in premature aging 
Defects in several DNA repair proteins lead to various premature aging 
phenotypes, some of which also exhibit increased cancer incidences 
(Hoeijmakers, 2009). In general, defects in genes that encode DNA repair 
proteins involved in preventing mutagenesis are generally associated with a 
predisposition to cancer. Alternatively, defects in genes that encode proteins that 
protect cells from the cytotoxic effects of DNA damage exhibit low rates of cancer 
and a premature aging phenotype (Garinis et al., 2008). For example, mutations 
in the GG-NER pathway protein XPA give rise to xeroderma pigmentosum, which 
is characterised by cancer predisposition but not a premature aging phenotype 
(Ciccia and Elledge, 2010). In contrast, mutations in the TC-NER pathway give 
rise to Cockayne Syndrome, a segmental premature aging disorder. Both humans 
and mouse models do not show increased rates of cancer despite this pathway 
being involved in the DNA repair process. It has been suggested that the 
premature aging phenotype and low incidences of cancer is because the TC-NER 
pathway constitutes only a small part of all the DNA repair pathways. However, 
defects in this pathway do induce cell death and thus prevents these mice from 
developing cancer (Hoeijmakers, 2009). This example highlights the balance 
between anti-aging and anti-cancer pathways that cells must engage to protect 
the genome. In the case of Cockayne Syndrome, the anti-cancer pathway results 
in increased cell death and senescence, which promotes aging, but prevents 
tumour formation (Garinis et al., 2008). 
1.10.3 The role of DNA damage in cellular senescence 
Senescent cells exhibit a range of different cellular characteristics compared to 
replicative cells, including gene expression profiles, ROS levels, telomere length 
and morphology (Campisi, 1998). Cells will undergo replicative senescence due to 
the erosion of telomere ends, i.e. telomere-dependent senescence (Toussaint et 
al., 2000; Passos et al., 2007). This process is non-stress induced. However, if 
cells are exposed to oxidative stress, then a variety of DNA damage occurs, 
including oxidized bases, SSBs and DSBs. DSBs trigger a DNA damage 
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response that, if persistent, can activate senescence via the p53 and pRb tumour 
suppressors (Campisi, 2005). Thus, cells may undergo senescence as a 
response to persistent DSBs, which is telomere-independent and may be called 
stress induced premature senescence (SIPS) (Passos et al., 2007). As mentioned 
above, oncogene-induced DNA replication stress causes activation of the DDR , 
resulting in oncogene-induced senescence (OIS), a process that acts as a barrier 
to malignant progression (Bartkova et al., 2005; Braig et al., 2005; Bartkova et al., 
2006; Di Micco et al., 2006; Bartek et al., 2007). Functionally, senescence 
represents an example of limited investment in long-term somatic maintenance 
and repair function (Kirkwood, 2005). On one hand, senescent cells cannot initiate 
tumours once they have exited the cell cycle, yet their presence within the cellular 
milieu has negative consequences on surrounding cells as they behave in an 
“...antisocial manner...”, secreting growth factors and proteases that both 
encourage nearby tumors to metastasize and degrade tissue function (Campisi, 
2005).  
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1.11 Aging  
1.11.1 Overview 
Organismal aging, as a process, has been succinctly described as the “...overall 
decline in the functional capacity of various organs to maintain baseline tissue 
homeostasis and to respond adequately to physiological needs under stress...” 
(Sahin and DePinho, 2010). The underlying causes of aging are therefore likely to 
be numerous and complex depending on the tissue type. For example, how does 
brain tissue, a largely non-proliferative tissue age compared to intestinal tissue, 
which is highly proliferative? To answer such questions, some 300 theories of 
aging have been postulated (Kirkwood, 2005). It is generally believed that 
stochastic damage to proteins and DNA, as a result of both endogenous (radical 
oxygen and nitrogen species) and exogenous (e.g. radiation, chemicals) reagents, 
accumulates during an organism’s lifetime to contribute to tissue decline and 
aging (Campisi, 2003; Hasty et al., 2003). Therefore, mechanisms to repair this 
damage are at the centre of the aging phenotype as deterioration of their function 
over time causes deleterious effects on tissue homeostasis and tumour 
suppression (Kirkwood, 2006; Garinis et al., 2008). Underlining  this, mutations in 
genes involved in preserving genomic stability can give rise to various premature 
aging syndromes, with some displaying increased risk of cancer (Jackson and 
Bartek, 2009; Sinclair and Oberdoerffer, 2009; Ciccia and Elledge, 2010). 
However, the stochastic damage model of aging has been challenged by the 
finding that mutations in the insulin/insulin-like growth (IGF) factor signalling 
pathway actually extend lifespan in C.elegans, Saccharomyces cerevisiae and 
Drosophila melanogaster (Schumacher et al., 2008). In mice, various genetic 
changes that lead to extended lifespan are all characterised by downregulation of 
the IGF signalling pathway, suggesting that this pathway is central to organismal 
aging (Monnat Jr, 2007; Schumacher et al., 2008). In addition genetic 
components of the target of rapamcyin (mTOR) pathway and the mitochondrial 
electron transport chain may also extend lifespan if they are downregulated (Vijg 
and Campisi, 2008). In addition, dietary restriction can extend lifespan by 
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dampening the three pathways mentioned above. Organisms thus seem to exhibit 
a degree of plasticity in terms of longevity that may be influenced by intrinsic and 
extrinsic factors (Kirkwood, 2006; Vijg and Campisi, 2008). 
 
From an evolutionary perspective, various hypotheses exist as to why organisms 
age (Kirkwood, 2002). One prevailing hypothesis is the ‘disposable soma theory’, 
which posits that aging results from a trade-off between reproduction and somatic 
maintenance/repair (Kirkwood, 2002). This theory suggests that extrinsic mortality 
is a central driver of longevity. Thus, for short-lived organisms, with high extrinsic 
mortality, there is little selective pressure to invest energy in maintenance/repair 
pathways necessary to preserve somatic cells. In contrast, long-lived organisms 
require functional maintenance/repair pathways to preserve somatic tissues and 
ensure longevity (Kirkwood, 2002). Therefore, in the case of humans, eliminating 
extrinsic hazards means that aging can be seen as the persistence of genotypes 
that have escaped natural selection (Campisi, 2003). In essence, aging is a result 
of the decline in the force of natural selection (Campisi, 2003). In this context, it is 
important to consider another evolutionary theory of aging, the concept of 
‘antagonistic pleiotropy’ (Campisi, 2003). This posits that a gene, genetic pathway 
or process may be beneficial to an organism in young age, but deleterious to an 
organism in old age (Campisi and D’Adda di Fagagna, 2007). In this scenario, 
because the force of natural selection diminishes with age, genes that benefit an 
organism in early life but have deleterious effects in later life are not selected 
against, allowing their generational persistence (Campisi, 2003). One such 
mechanism that exhibits antagonistic pleiotropy is cellular senescence, which may 
act as a tumour suppressor in young age, yet contribute to the decline in tissue 
homeostasis in old age (Campisi and D’Adda di Fagagna, 2007). 
1.11.2 Cellular aging and senescence 
Most somatic cells have a limited capacity to divide in vitro, first recognised nearly 
fifty years ago (Hayflick and Moorhead, 1961). After a finite number of divisions, 
somatic cells enter a permanent G1-phase arrest termed cellular senescence 
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(Campisi, 2003). Despite their non-proliferative state, senescent cells are still 
viable and metabolically active within their tissue niche. Senescent cells have 
several notable features that distinguish them from non-senescent cells. This 
senescent phenotype includes apoptosis resistance, altered gene expression 
profiles with the notable upregulation of several CKIs, the formation of 
senescence-associated heterochromatin foci (SAHF), senescence-associated 
DNA damage foci (SDFs), the secretion of pro-inflammatory cytokines termed the 
senescence-associated secretory phenotype (SASP) and an increase in 
senescence-associated β-galactosidase activity (SA β-gal) as well as a loss of 
proliferative markers such as PCNA and BrdU incorporation (Campisi and D’Adda 
di Fagagna, 2007; Coppe et al., 2010; Freund et al., 2010). 
 
Although senescence has been extensively characterised using a variety of cell 
types in vitro, its relevance to aging in vivo has recently emerged (Minamino and 
Komuro, 2008). Using senescence markers as described above, several studies 
have shown that tissues from human, primates and rodents contain senescent 
cells that increase with the age of the tissue, most notably in renewable tissues 
(Janzen et al., 2006; Krishnamurthy et al., 2006; Molofsky et al., 2006; Jeyapalan 
et al., 2007). Importantly, senescent cells have been shown at sites of age-related 
diseases such as osteoarthritis and atherosclerosis and their presence has also 
been shown inhibit liver fibrosis (Vasile et al., 2001; Krizhanovsky et al., 2008). 
Thus, understanding in vitro senescence pathways and mechanisms will help 
unravel how and why senescence contributes to aging in vivo. 
 
Senescence can either derive from telomere-dependent or independent 
mechanisms (Touissant et al., 2000; Campisi and D’Adda di Fagagna, 2007). 
Telomere-dependent senescence results from telomere erosion with each cell 
division and this is termed replicative senescence, whilst telomere-independent 
mechanisms (e.g. sub-lethal exposure to oxidative stress and radiation or 
telomere uncapping) lead to stress-induced premature senescence (SIPS) 
(Toussaint et al., 2000).  
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1.11.2.1 Telomere-dependent or replicative senescence 
To counter the problems of having linear chromosomes, i.e. how to prevent end 
degradation and recognition of the ends as double strand breaks, cells have 
evolved telomeres, structures that adorn the ends of chromosomes (Blasco, 
2007). In germline cells and some cancers, telomeres are maintained by the 
enzyme telomerase (O’Sullivan and Karlseder, 2010). However, telomerase is not 
expressed in most normal cells and progressive telomere shortening occurs as 
somatic cells divide in vitro, which culminates in permanent cell cycle arrest 
termed replicative senescence (Toussaint et al., 2000; de Lange, 2005). Cells that 
fail to undergo replicative senescence in the presence of dysfunctional telomeres 
display gross genomic instability, which in turn promotes malignant tumorigenesis 
(Artandi and DePinho, 2000). Overexpression of TERT, the catalytic subunit of 
telomerase, in somatic human cells allows infinite cell divisions, underlining that 
telomerase expression circumvents replicative senescence (Bodnar et al., 1998). 
A correlation between increased telomere length and longevity has been reported 
in centenarians, suggesting that telomere length is an important determinant of 
human aging (Atzmon et al., 2010). Moreover, reduced telomere length has been 
correlated with increased risk of cardiovascular disease, dementia and aging of 
the immune system (Blasco, 2007; Sahin and DePinho, 2010). Various segmental 
and unimodal premature aging syndromes are associated with dysfunctional 
telomere maintenance, such as the Werner’s syndrome, ataxia telangiectasia 
(AT), dyskeratosis congenita, Hutchinson–Gilford progeria syndrome (HGPS) and 
Bloom syndrome (Blasco, 2007; Sahin and DePinho, 2010). 
 
Whilst telomere shortening in humans is associated with replicative senescence, 
mouse cells, which contain long (>20 kb) telomeres and express telomerase, 
undergo only a few population doublings in culture before undergoing 
senescence, therefore suggesting that telomere shortening is not the primary 
cause of senescence in mouse cells (Campisi, 2005; Campisi and D’Adda di 
Fagagna, 2007). The early senescence of mouse cells is associated with the high 
levels of oxygen (20%) used in culture conditions, which causes irreversible DNA 
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damage (Parrinello et al., 2003). Importantly, culturing mouse cells at lower 
physiological oxygen levels (3%) allows unlimited proliferation (Parrinello et al., 
2003). Recently, ground-breaking studies utilising Tert-/- mice have yielded 
important insights into the role of telomeres in aging (Jaskelioff et al., 2011; Sahin 
et al., 2011). In the first study, the authors used a mouse model that allowed for 
the reactivation of telomerase in prematurely aged adult mice and showed that 
age-related decline phenotype of a number of tissues was reversed within 4 
weeks of reactivation (Jaskelioff et al., 2011). This study highlights that aging may 
be prevented be targeting telomere structure and or regulation. The second study 
from the same group showed that telomere dysfunction causes activated p53 to 
suppress the master regulators of mitochondria, the PGC-1 genes, which in turn 
leads to age-related mitochondrial dysfunction. Mitochondrial dysfunction then 
leads to oxidative stress by increased ROS levels, causing damage to both 
nuclear and mitochondrial DNA. This cycle contributes to the aging phenotype 
and provides a clear link between telomere loss and signalling events between 
the nucleus and mitochondria (Sahin et al., 2011). 
 
Structurally, telomeres are long repetitive stretches of tandem DNA repeats (5’-
TTAGGG-3’) that are bound by proteins that make up the shelterin complex 
(Figure 3.1) (de Lange, 2005; Blasco, 2007). In humans, these tandem repeats 
vary between chromosomes, but are typically 9-15 kb, whereas mouse cells have 
exceptionally long telomeres and can be up to 100 kb (O’Sullivan and Karlseder, 
2010). DNA polymerases cannot completely replicate the ends of DNA by lagging 
strand synthesis, a phenomenon termed the ‘end replication problem’, which 
results in the loss of 50-200 base pairs during each round of DNA replication. 
Thus, many cell divisions are required before telomere length is sufficiently 
shortened to elicit senescence promoting signals. However, as little as one 
shortened telomere is sufficient to trigger senescence (Martens et al., 2000; 
Hemann et al., 2001). 
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Telomeric DNA ends with a single-stranded 3’ G-rich overhang of 50-300 
nucleotides, which folds back onto duplex telomeric DNA forming a ‘T-loop’, a 
large circular structure (Figure 1.16) (de Lange, 2005; Blasco, 2007). The T-loop 
has been proposed to exist in two conformations: open and closed. The closed 
conformation forms a protective barrier to the end of the chromosome, preventing 
both telomerase access and the recognition of the end as a double strand break 
by ATM and ATR kinases.  
 
As telomeric DNA is quite distinct in its properties, a plethora of proteins known as 
the shelterin complex have evolved to facilitate its stability and regulation by 
interacting directly or indirectly with the telomeric DNA, such as TRF1, TRF2 (both 
of which bind the double-stranded telomeric DNA), POT1 (which attaches to the 
single-stranded overhang), Rap1, TIN2 and TIP1 (De Lange, 2005; Blasco, 2007). 
Together, the shelterin complex covers both the double and single-stranded DNA 
of telomeres and also participates in cell-cycle dependent interactions with a 
number of different proteins (Blasco, 2007). Furthermore, the shelterin complex 
also prevents the activation of DNA damage signaling pathways, with TRF2 
inhibiting ATM and POT1 inhibiting ATR (Figure 1.16).  
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Figure 1.16 Structure of human telomeres. The chromosomes end in a 
structure called a telomere. Telomeres consist of TTAGGG repeats that may 
extend for numerous kilobases, resulting in a G-rich leading strand and a C-rich 
lagging strand (top). The G-rich strand extends for 50-300nt, forming a 3’ G-
overhang or G-tail (top). Numerous proteins, assemble at telomeres, forming the 
‘shelterin complex’ (top and bottom). This complex protects the chromosome ends 
via the formation of a telomeric T-loop structure (bottom) (O’Sullivan and 
Karlseder, 2010). 
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1.11.2.2 Telomere-independent senescence or stress-induced premature 
senescence (SIPS) 
Human fibroblasts may also undergo telomere-independent senescence due to 
chronic DNA damage or telomere uncapping, oxidative damage due to ROS and 
activation of oncogenes (Campisi and D’Adda di Fagagna, 2007). Telomere-
independent senescence has also be termed ‘stress induced premature 
senescence (SIPS) (Toussaint et al., 2000). 
 
1.11.2.2.1 DNA damage 
Chronic activation of the DNA damage response may induce senescence without 
the loss of telomeres (Toussaint et al., 2000; Suzuki et al., 2001). The major 
cause of senescence due to DNA damage is the persistent presence of double 
strand breaks, which may arise from both exogenous and endogenous reagents, 
e.g. radiation or replication fork collapse. Activation of the DNA damage response 
(DDR) by DSBs induces cell cycle arrest via both p53-p21 and p16-pRb pathways 
(see 3.1.3) (Herbig et al., 2004; Jacobs and de Lange, 2004). Telomere 
uncapping or disruption to proteins involved in the shelterin complex may also 
activate DDR-dependent senescence independent of telomere length (Chen et al., 
2008). For instance, expression of dominant negative TRF2 mutants leads to 
dysfunctional telomeres, without telomere length shortening, and activates the 
DDR, leading to premature senescence (Takai et al., 2003). The importance of 
the DDR in aging is perhaps best exemplified by the range of different premature 
aging diseases associated with mutations in genes important to this pathway 
(Jackson and Bartek, 2009). Furthermore, a range of mouse models that have 
DDR proteins knocked-out exhibit premature aging phenotypes at both the 
organismal and cellular level, for instance Brca1, Ku80, Ku70, Xrcc4, DNA-PKcs, 
Ercc1, Xpf1 and Wrn (Lombard et al., 2005). 
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1.11.2.2.2 Oxidative damage 
The ‘free radical theory of aging’ posits that the balance between the production 
and elimination of intracellular reactive oxygen and/or nitrogen species 
(ROS/RNS) is the major determinant of cellular lifespan (Harman 1956). Whilst 
normal levels of intracellular ROS are required for signalling pathways, higher 
levels of ROS cause direct damage to a range of macromolecules, including 
lipids, protein, RNA and DNA (Blumberg, 2004). ROS are generated primarily in 
the mitochondria through aerobic respiration, the products of which include 
superoxide radical (O2-) and hydroxyl radical (OH-), and non-radical molecules like 
hydrogen peroxide (H2O2) (Kregel and Zhang, 2007). As an extension of the free 
radical theory of aging, a mitochondrial theory of aging has been proposed, which 
speculates that electrons leaking from the electron transport chain produce ROS, 
which in turn damages the mitochondrial DNA, leading to further increases in 
intracellular ROS levels and a decline in mitochondrial function (Wallace, 2005). 
As direct evidence for this, studies suggest that mitochondrial DNA damage is 
increased with aging (Hamilton et al., 2001; Hagen et al., 2004). Furthermore, an 
‘inflammatory theory of aging’ has been suggested which postulates that pro-
inflammatory gene expression is activated by the age-dependent increase in 
oxidative stress, which in turn leads to inflammation in a multitude of tissues and 
organs (Chung et al., 2006). Regardless of the theory, it is clear that intracellular 
ROS are also involved in pathogenesis of many age-related conditions, including 
cancer, atherosclerosis and neurodegenerative diseases (Haddad et al., 2004). 
 
Mammalian cells are armed with a number of sophisticated antioxidant defence 
mechanisms that function to balance excessive ROS and prevent accumulation of 
ROS-induced oxidative damage (Kregel and Zhang, 2007). Primary antioxidant 
enzymes, including catalase (CAT), superoxide dismutase (SOD) and glutathione 
peroxidase (GPX) function in a series of integrated reactions to convert ROS to 
more stable molecules, such as H2O and O2. Furthermore, a multitude of 
secondary enzymes act synergistically with small molecular weight antioxidants 
(e.g., GSH, NADPH, thioredoxin (Trx), vitamins E and C, and trace metals, such 
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as selenium) to form redox cycles that provide cofactors for primary antioxidant 
enzyme functions (Kregel and Zhang, 2007). Small molecular weight antioxidants 
can also function as direct scavengers of ROS. In addition, ROS activates many 
transcription factors involved in stress signalling pathways such as Sp-1, AP-1 
and NF-κB, which bind to anti-oxidant response elements (ARE) in gene 
promoters and regulate expression of stress response genes, some of which 
include those encoding the major anti-oxidant enzymes (Haddad, 2002). Another 
important aspect of redox homeostasis in cells involves the balance between 
reduced and oxidised forms of thiols. Protein thiols can serve as essential redox 
sensors in cells, which undergo reversible redox modifications in response to 
oxidative stress (Eaton 2006). Accumulating evidence suggests that thiol-based 
disulfide bridge formation represents a common strategy by which proteins 
respond to oxidative stress and mediate transient activation of protective stress 
responses (Linke and Jakob 2003). One important aspect of these protective 
stress responses is the ability of cells to undergo temporary growth arrest that 
allows time for repair of damaged DNA, regeneration of oxidized proteins and 
recovery of redox balance (Davies et al., 1999). At the cellular level, inability to 
recover the redox balance can lead to SIPS in human fibroblasts, which can be 
achieved experimentally by treatment with sub-lethal levels of oxidative stress 
such as H2O2 (Chen et al., 2004; Chen et al., 2005). Moreover, disruption to the 
anti-oxidant defence systems would thus also be predicted to induce SIPS. 
Indeed, inhibition of SOD1, which detoxified the superoxide anion, causes cells to 
undergo premature senescence (Blander et al., 2003). Conversely, increasing 
SOD1 levels actually increases cellular longevity in primary fibroblasts and 
reduces the rate of telomere shortening (Serra et al., 2003). 
 
1.11.2.2.3 Oncogenic induced senescence (OIS) 
Another form of telomere-independent senescence can be triggered by the 
expression of oncogenes, such as H-RASG12V (Serrano et al., 1997; Wei et al., 
1999; Gorgoulis and Halazonetis, 2010). Oncogene activation deregulates DNA 
replication, causing DSBs that trigger a sustained DDR, which causes cells to 
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enter senescence, preventing further proliferation (Bartkova et al., 2006; Di Micco 
et al., 2006). Evidence suggests that OIS operates in vivo as well as in vitro, 
underpinning this mechanism as an anti-tumorigenesis pathway (Gorgoulis and 
Halazonetis, 2010). OIS also induced large-scale chromatin changes, which may 
be visualised by the formation of several DNA-dense nuclear foci termed 
senescence-associated heterochromatin foci (SAHF) (Narita et al., 2003; Zhang 
et al., 2005; Di Micco et al., 2007). SAHF formation is under the control of the 
p16-pRb pathway and its proposed role is to repress local E2F-dependent gene 
transcription by promoting a repressive chromatin environment and also 
promoting global silencing via heterochromatin formation (Campisi, 2005).  
Recent evidence suggests that gene silencing and SAHF are two distinct 
pathways in OIS (Di Micco et al., 2011). Local gene silencing is dependent on the 
ATM-p53 pathway, which inhibits proliferation, whilst SAHF is governed by the 
ATR kinase and acts to dampen the DDR (Di Micco et al., 2011). The authors 
suggest that SAHF may therefore act to protect cell viability against apoptosis by 
reducing DDR signaling, although the physiological benefits of this remain to be 
determined.  
1.11.3 p53 and p16-pRb pathways 
The p53 and p16-pRb pathways are the two major tumour suppressor pathways 
that are engaged in response to senescence-inducing signals (Campisi, 2005). 
Various signals activate either one or both pathways, for example, oncogenic Ras 
activates both pathways. In the p53 pathway, DNA damage activates the 
CDKN2A locus, whose gene product ARF or p14 sequesters the E3 ubiquitin-
protein ligase HDM2, which itself promotes p53 degradation (Campisi and D’Adda 
di Fagagna, 2007). Thus, p53 levels are increased, which in turn promotes 
transcription of target genes, one of which includes p21, a potent CKI that 
enforces cell cycle arrest by suppressing the inactivating phosphorylation of pRb 
(Figure 1.17). Oncogenic signals may also lead to the engagement of the p16-
pRb pathway, usually by the induction of p16INK4A, the other product of the 
CDKN2A locus. p16INK4A is a potent CKI that inhibits pRb phosphorylation, thereby 
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enforcing G1-phase arrest and inhibiting E2F-dependent gene transcription, which 
is necessary for G1/S-phase progression. Crosstalk between the two pathways 
also serves to control cellular proliferation and enforce senescence. From the 
p16-pRb pathway, E2F induces ARF expression whilst pRb also regulates p53 
through a trimeric p53-HDM2-pRb complex (Campisi and D’Adda di Fagagna, 
2007).  
 
Figure 1.17 The p53 and p16-pRb pathways govern cellular senescence. 
Various signals such as dysfunctional telomeres, DNA damage, and excessive 
mitogenic signals (e.g. oncogenes) may trigger entry into senescence. Entry into 
senescence is channelled via the pRb or p53 pathways, however some signals 
(such as oncogenic Ras) engage both pathways. Moreover, there may be 
crosstalk between the pathways: p53 induces expression of p21, which inhibits 
pRB phosphorylation and E2F can induce ARF expression, which engages the 
p53 pathway (Campisi and D’Adda di Fagagna, 2007). 
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1.11.4 Aging: a trade-off between senescence and cancer  
Within the context of aging, senescence can be seen as a tumour suppressor 
pathway in young organisms, acting to halt the potential transformation of cells 
that might promote cancer and ultimately organismal death. However, as 
explained above, senescent cells also secrete a range of factors that have been 
shown to actually promote cancer progression by stimulating proliferation, 
promoting angiogenesis and inducing epithelial-to-mesenchymal transition (EMT), 
a process which has been shown to aid cancer metastasis and invasiveness 
(Krtolica et al., 2001; Coppe et al., 2006; Coppe et al., 2008; Thiery et al., 2009). 
The antagonistic pleiotropy of senescent cells highlights that one pitfall of tumour 
suppression is their contribution to age-related tissue decline and thus they have 
a central role in the aging process (Campisi, 2005). 
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1.12 The Cell Cycle 
1.12.1 Overview 
The cell cycle is a highly complex and meticulously coordinated set of 
unidirectional spatiotemporal events that govern the production of two daughter 
cells from one mother cell. The controlled regulation of the cell cycle is vital for 
organismal development and tissue regeneration and renewal. Extensive work 
over the past century has shed light on the exquisite control of the numerous 
steps of cell cycle, the molecular basis of which is highly conserved throughout 
evolution (Nurse, 2000). The cell cycle is divided into four phases: G1, S, G2 and 
M. G1-phase is the first gap phase whereby cells decide whether to divide or not, 
DNA replication then occurs during S-phase and the second gap phase, G2, 
prepares the cell for mitosis or M-phase (Figure 1.18). During G1-phase the 
integration of pro- and anti-growth signals dictates whether the cell passes a 
specialised commitment point, called the restriction point (Figure 1.18 ‘R’). If the 
cell passes the restriction point it is fully committed to DNA replication and 
completing a cell cycle (Vermuelen et al., 2003). If the cell decides not to pass the 
restriction point it may exit the cell cycle, either transiently or permanently, in a 
phase termed as G0. If a cell encounters problems during the cell cycle then 
checkpoints are activated that halt progression until the problem is either rectified. 
Importantly, deregulation of the cell cycle machinery may lead to chronic 
proliferation of cells, a fundamental trait of all cancers (Hanahan and Weinberg, 
2011). Whilst it would be impossible to describe all the proteins and mechanisms 
involved in the cell cycle in this thesis, I will cover some of the major proteins that 
are essential to drive this process.  
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Figure 1.18 The eukaryotic cell cycle. The cell cycle is divided into four stages: 
two gap phases (G1 and G2), S-phase and mitosis (M-phase) (Dehay and 
Kennedy, 2007). 
 
1.13 Cell cycle control 
1.13.1 Cdks and cyclins 
Central to the core of cell cycle regulation is the oscillatory action of the “...cell 
cycle engines...” cyclin dependent kinases (cdks) (Nurse, 2000). Cdks are 
serine/threonine protein kinases that are activated at specific stages of the cell 
cycle to phosphorylate targets substrates (Morgan, 1995). To date, nine cdks 
have been identified in mammals, five of which are active during the cell cycle 
(Vermeulen et al., 2003). Cdks may interact with more than one cyclin, which has 
been suggested to potentiate substrate selectivity for the cdk (Table 1) (Schafer, 
1998). Interestingly, the activity of cdk1 alone is sufficient to drive the cell cycle 
during the early development of cell lineages (Santamaria et al., 2007). 
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Cdk Cyclin Cell cycle phase activity 
Cdk4 Cyclin D1, D2, D3 G1 phase 
Cdk6 Cyclin D1, D2, D3 G1 phase 
Cdk2 Cyclin E G1/S phase 
Cdk2 Cyclin A S phase 
Cdk1 (Cdc2) Cyclin A G2/M phase 
Cdk1 (Cdc2) Cyclin B M phase 
Cdk7 Cyclin H CAK, all cell cycle phases 
Table 1. Cdk and cyclin complexes during the cell cycle. (Vermeulen et al., 
2003) 
Whilst cdk protein levels remain stable throughout the cell cycle, cyclin protein 
levels exhibit oscillatory fluctuations through the cell cycle. In this way cyclins are 
able to periodically activate cdks at the appropriate stage of the cell cycle and this 
mechanism provides the primary means of regulating the cell cycle (Figure 1.19) 
(Murray, 2004). The one exception is cyclin D, which is expressed in direct 
response to mitogenic signals and remains relatively high throughout the cell 
cycle (Assoian and Zhu, 1997). To date, sixteen cyclins have been identified in 
mammals, although not all are involved in cell cycle regulation (Johnson and 
Walker, 1999). Cyclins D1, D2 and D3 associate with cdk4 and cdk6 and regulate 
entry into G1 past the restriction point (Bartek et al., 1997). Another G1 cyclin, 
cyclin E associates with cdk2 and is essential for G1/S-phase progression. Cyclin 
A interacts with cdk2 and is required for S-phase progression, whilst the 
association between cyclin A associates and cdk1 during late G2 and early M-
phase promotes entry into mitosis (Bardin and Amon, 2001). During mitosis, cyclin 
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B associates with cdk1 and governs progression through M-phase (Arellano and 
Moreno, 1997).  
 
Figure 1.19. Activity of cdks through the cell cycle. Cdk activation requires 
interaction with a cyclin subunit (see Table 1) and phosphorylation of the cdk 
subunit by the CAK (Bardin and Amon, 2001). 
Recent data from knockout mice has questioned the absolute requirement for D-
type and E-type cyclins, cyclin D-dependent cdk4 and cdk6 and cyclin E-
dependent cdk2 in cell cycle progression (Sherr and Roberts, 2004). Genetic 
ablation of all these cell cycle genes suggests that a degree of compensation may 
exist in the absence of a specific cdk-cyclin complex. It has also been suggested 
that other cdks, removed from the core control of the cell cycle during evolution, 
may step-in if required, “...the defeated remains of (other) ancestrally dominant 
kinases can be glimpsed in both DNA replication (the Cdc7/Dbf4 kinase/activator 
couple) and in mitosis (Polo and others)...” (Murray, 2004). 
1.13.2 Phosphorylation events govern cdk activity 
As well as associating with cyclins, complete cdk activation is also dependent 
upon phosphorylation of the cdk subunit on conserved threonine and tyrosine 
residues (Arellano and Moreno, 1997). Cdk1 is the prototypic cdk, being originally 
identified as cdc2 in yeast (Draetta et al., 1988). Depending on the residue, 
phosphorylation of cdk1 may be either stimulatory or inhibitory. For full activation, 
cdk1 must be phosphorylated on threonine 161 (Thr160 for cdk2 and Thr172 for 
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cdk4) by the cdk7-cyclin H complex, known as the cdk-activating kinase (CAK). 
Threonine 161 of cdk1 is within a T-loop motif, which, in its inactive 
unphosphorylated state, folds so as to sterically block cyclin binding. Subsequent 
phosphorylation of Thr161 induces a conformational change in the T-loop to 
enhance binding of cyclins (Jeffrey et al., 1995). In contrast, inhibitory 
phosphorylation of cdk1 is carried out on threonine 15 and/or threonine 14 by the 
Wee1 and Myt1 kinases (Nurse, 2004). The Thr14/15 residues are within the cdk1 
kinase domain, and phosphorylation therefore inhibits its kinase ability. Wee1 
kinase action is necessary on cdk1-cyclin complexes as they enter the nucleus to 
prevent premature mitotic progression (Heald et al., 1993). Dephosphorylation of 
Thr14/15 by Cdc25 phosphatase is required for cdk1 activation and cell cycle 
progression (Lew and Kornbluth, 1996; Schafer, 1998). Three isoforms of Cdc25 
exist in mammalian cells: A, B and C (Aressy and Ducommum, 2008). Whilst 
Cdc25A controls cell cycle progression through S-phase and mitosis, Cdc25B and 
C control mitotic entry. Activated cdk1-cyclin complexes may phosphorylate both 
Wee1 and Cdc25C, which inactivates and activates them, respectively, therefore 
forming both a positive and negative feedback loop (Vermeulen et al., 2003). 
 
Cdk activity may also be regulated physically, either by interaction with the cdk or 
cdk-cyclin complex, by cdk inhibitors (CKIs). There are two distinct protein families 
in metazoans that encode CKIs, INK4 and Cip/Kip (Sherr and Roberts, 1999). The 
Cip/Kip protein family includes p21Waf1/Cip1/Sid1 (p21, encoded by CDKN1A), p27Cip2 
(p27, encoded by CDKN1B) and p57Kip2 (p57, encoded by CDKN1C) (Susaki and 
Nakayama, 2009). The Cip/Kip family function to modulate cdk4,6-cyclin and cdk 
2-cyclin complex activity by directly binding to both cdk and cyclin subunits (Sherr 
and Roberts, 1995; Hengst and Reed, 1998; Besson et al., 2008). Functionally, 
p21, p27 and p57 differ slightly in their specific biological roles depending on the 
cellular signals. For example, p21 has a well-established role in DNA synthesis 
and the DNA damage response. In the former it binds and inhibits PCNA (Waga 
et al., 1997).  In the latter, p21 is a transcriptional target of activated p53 in 
response to DNA damage, therefore enforcing cell cycle checkpoints in G1 and G2 
(Elledge, 1996; Gartel and Tyner, 1999). Furthermore, p21-/- MEFs exhibit a 
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failure to undergo DNA damage dependent cell cycle arrest (Deng et al., 1995). In 
contrast to p21, p27 functions in quiescent cells and mitogen-starved cells to 
enforce cell cycle exit and becomes rapidly degraded upon cell cycle entry 
(Besson et al., 2006). Crystal structures of p27 bound to the cyclin A-cdk2 
complex revealed that p27 inserts itself into the catalytic cleft on cdk2 therefore 
preventing catalytic activity (Russo et al., 1996). The cellular proliferation 
restraining function of p27 is particularly striking in p27-/- mice, which exhibit organ 
hyperplasia and increased body size (Fero et al., 1996). Results from this 
knockout mouse highlights the importance of CKIs in development and underline 
that effective cell cycle exit (i.e. for terminal differentiation) is essential for tissue 
homeostasis and ultimately organismal survival. 
 
The second protein family of CKIs consists of p15INK4b (encoded by CDKN2B), 
p16INK4a (encoded by CDKN2A), p18INK4c (encoded by CDKN2C) and p19INK4d 
(encoded by CDKN2D) (Gil and Peters, 2006; Kim and Sharpless, 2006). The 
INK4 family of CKIs inhibit G1 cdk4,6 in a mechanism distinct from the Cip/Kip 
CKIs, which have broader targets (Lukas et al., 1999). The INK4 family bind stably 
with cdk4,6 before they are able to interact with cyclins, therefore preventing their 
association and thus inhibits the phosphorylation of pRb and maintains cells in G1 
(see 1.14.1) (Brotherton et al., 1998; Russo et al., 1998; Murray, 2004). The 
expression of INK4 family proteins has been associated with permanent exit from 
the cell cycle into senescence (Campisi, 2005; Janzen et al., 2006). The induction 
of senescence plays an important role as an anti-tumorigenesis barrier and 
homozygous mutations in the INK4 CKIs are frequently found in various cancer 
subtypes (see 1.15) (Sharpless, 2005).  
1.13.3 Ubiquitin-mediated proteolysis confers unidirectionality upon the cell 
cycle 
Coupled to the activation of cdks is the ubiquitin proteolysis system (UPS), which 
is responsible for the timely destruction of cyclins through the cell cycle. The 
temporal irreversible destruction of cyclins during the cell cycle ensures that the 
83 
 
cell cycle may only proceed in one direction (Vodermaier, 2004). Two main 
ubiquitin ligases control the destruction of the cell cycle machinery: the SCF 
(Skp1–Cul1–F-box protein) complexes and the anaphase promoting 
complex/cyclosome (APC/C) (Vodermaier, 2004).  Functionally, the F-box subunit 
within the SCF complex regulates substrate specificity (Jin et al., 2004). To date, 
there are sixty-nine F-box proteins, each of these F-box ‘adaptors’ may interact 
with multiple substrates, therefore providing a vast range of potential targets for 
the SCF complex (Skaar and Pagano, 2009). In contrast, the APC/C complex has 
two ‘adaptor’ proteins, Cdh1 and Cdc20, which are activated at different points in 
the cell cycle, G0/G1 and M-phases respectively, and recognise substrates on the 
basis of a degradation motif (degron) in their target proteins (Cardozo and 
Pagano, 2007). 
 
APC/CCdc20 levels are low in G1-phase, but increase during S and G2-phases 
(Skaar and Pagano, 2009). In M-phase, APC/CCdc20 forms but only becomes 
active until chromosomes are attached to the spindle and the Spindle Assembly 
Checkpoint (SAC) is satisfied. Upon activation, it promotes metaphase to 
anaphase transition by targeting Securin and Shugoshin for degradation, and also 
targets p21 for degradation during prometaphase (Frescas and Pagano, 2008). 
APC/CCdh1 cooperates with APC/CCdc20 to reset the cell cycle (i.e. to low cdk 
activity) and inhibits cdk2 and cdk1 activity by targeting cyclin A and B for 
destruction as well as Cdc20 and Cdc25A, thereby inhibiting APC/CCdc20 activity. 
During G1, APC/CCdh1 also targets Skp2/Cks1, therefore preventing the premature 
degradation of SCFSKP2 targets such as p27 and thus acts to prevent G1 
progression (Figure 1.20) (Peters, 2006). From late G1 to the end of mitosis, cdk-
dependent phosphorylation of Cdh1 prevents its assembly into the APC/C core, 
which inhibits the activity of the APC/CCdh1 complex (Peters, 2006). Furthermore, 
the APC/CCdh1 complex is also inhibited by physical interaction with Emi1, allowing 
accumulation of mitotic cyclins (Figure 1.20). After the destruction of mitotic 
cyclins by APC/CCdc20 Cdh1 is activated to form the APC/CCdh1 complex and the 
APC/C subunit cycle may start again. 
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Two of the most widely studied SCF complexes are SCFSKP2 and SCFβ-TrCP1 
(Figure 1.20).  SCFSKP2 is responsible for ubiquitylating the CKI p27 in the 
presence of the accessory protein Cks1, but only when specific residues of p27 
are phosphorylated (Nakayama et al., 2004; Guardavaccaro and Pagano, 2006). 
SCFSKP2 also promotes the degradation of p21, therefore acting as a positive 
regulator of the cell cycle by activating cdk1 and cdk2 (which are active from late 
G1 to anaphase, which is denoted as C-phase in Figure 1.20) (Frescas and 
Pagano, 2009). In contrast, SCFβ-TrCP1 acts as both a positive and negative 
regulator of the cell cycle by targeting Emi1, Wee1, claspin and Cdc25A. The 
SCFβ-TrCP1-mediated targeting of Emi1 in early prometaphase is dependent upon 
the prior phosphorylation of Emi1, the APC/CCdh1 complex inhibitor, by both cdk1 
and Plk1 (Yamasaki and Pagano, 2004). 
 
Together, the concerted efforts of both the SCF and APC/C ubiquitin ligases, i.e. 
by regulating each other’s activity, in combination with the oscillatory cdk activity 
network, help drive the cell cycle and provide unidirectional regulatory layers to 
the process that, unchecked, could result in uncontrolled proliferation and cancer 
(see 1.15). 
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Figure 1.20. The ubiquitin-proteasome system (UPS) in the cell cycle. The combined actions of the APC/C and SCF ubiquitin 
ligases, in concert with the oscillatory nature of cdk activity, govern the cell cycle. Cdk-cyclin activity increases from late-G1 to 
anaphase (denoted as C-phase). APC/CCdh1 helps reset the cell cycle (i.e. low cdk activity) by targeting cyclins A and B, as well as 
Cdc20 and Cdc25A. APC/CCdc20 promotes metaphase to anaphase transition by targeting securing and Shugoshin for degradation. 
SCFSKP2 promotes degradation of the CKIs p21 and p27, whilst SCFβ-TrCP1 targets Cdc25A, Wee1 and Emi1 for degradation 
(Frescas and Pagano, 2009). 
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1.13.4 Nuclear localisation regulates cdk activity 
The subcellular localisation of the cell cycle machinery plays an important role in 
the spatiotemporal regulation of the cell cycle (Takizawa and Morgan, 2000). 
Cyclins E and A both exhibit constitutive nuclear localisation, probably reflecting 
their vital roles in S-phase, i.e. DNA replication and prevention of re-replication. In 
contrast, cdk-cyclin D1 complexes are exported from the nucleus to the cytoplasm 
for proteolysis after phosphorylation by GSK3β (Diehl et al., 1998). The 
intracellular trafficking of cdk1-cyclin B complexes is by far the most studied 
among the cell cycle complexes. During interphase, cdk1-cyclin B complexes are 
sequestered in the cytoplasm, but during G2-phase, are imported into the nucleus 
(Li et al. 1997). B-type cyclins contain a nuclear export signal (NES), which 
mediates an association with CRM1, the nuclear export protein, therefoe 
promoting its nuclear export and cytoplasmic localisation (Yang et al., 1998). 
Phosphorylation of cyclin B1 at prophase attenuates its nuclear export, whilst 
cyclin B2 remains in the cytoplasm until nuclear envelope breakdown.  
 
The mechanism of nuclear import for the various cyclins varies dramatically, 
suggesting that they have evolved import mechanisms based on their temporal 
function within the cell cycle. Strikingly, neither cyclins nor their interacting cdks 
contain any putative classical nuclear localisation signals (NLS) (Yang and 
Kornbluth, 1999). However, studies revealed that, for cyclin B1 and cyclin E, the 
import signal is contained within these cyclins, yet they use distinct mechanisms 
for import (Moore et al., 1999). Cyclin E interacts with the importin α adaptor 
subunit of the importin α-β heterodimer and in this way acts as a classical basic 
NLS-containing protein. Cyclin B1, by contrast, is imported via interaction with 
importin β in the notable absence of the importin α adaptor subunit (Moore et al., 
1999). It has been suggested that the non-classical import mechanism of cyclin 
B1 ensures a low import rate during interphase, therefore preventing inappropriate 
M-phase entry (Yang and Kornbluth, 1999). 
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1.14 Cell cycle phases 
1.14.1 G0 and G1-phase 
After cells have completed a cell division they are faced with the vital decision of 
whether to divide again or exit the cell cycle. The decision to engage another 
round of cell division is a highly regulated, multi-faceted process requiring the 
correct temporal functions of proteins to ensure the inheritance of preserved 
genomic material. Firstly, if the appropriate mitogenic signals are absent, cells 
enter G0. This state may be applied to cells that exited the cell cycle permanently, 
such as nerve or muscle cells, or transiently, regardless, in both cases the cells 
are said to be quiescent. The G0 state may also be applied to senescent cells, 
which are those cells that have exited the cells permanently but have engaged a 
different biochemical cellular program rendering them nonviable, therefore making 
them quite distinct from quiescent cells. As mentioned previously, the CKIs, 
including the Cip/Kip and INK4 families, have a prominent role in maintaining cells 
in a G0. For example, p15INK4b and p16INK4A inhibit cdk-cyclin D complexes, whilst 
p21 and p27 inhibit cdk-cyclin D and cdk-cyclin E complexes. The ultimate 
downstream effector of all the pathways is the tumour suppressor, the 
retinoblastoma protein (pRb). The concerted synergy of the CKIs is to prevent 
phosphorylation of pRb, which is keenly inactivated by cdk-cyclin dependent 
phosphorylation, thereby allowing cell cycle progression, as discussed below. 
Furthermore, other members of the pRb protein family have prominent roles in 
actively maintaining cells in G0, which will also be discussed below. 
 
1.14.1.1 The Rb-E2F pathway 
The tumour suppressor, pRb, is so named because it was identified as the 
primary cause of the rare childhood cancer retinoblastoma. Cloning of RB and the 
subsequent identification of homozygous inactivating mutations of RB supported 
earlier hypotheses that retinoblastoma was caused by two mutations, or two ‘hits’, 
which was then predicted to functionally inactivate a tumour suppressor gene 
(Knudson, 1971; Cavenee et al., 1983; Dunn et al., 1988). Studies to delineate its 
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function have shown that the RB gene product pRb is critically involved in cell 
cycle regulation along with two other family members, p107 and p130, in nearly all 
cell types (Dyson, 1998). pRb, p107 and p130 are collectively termed pocket 
proteins because their similar primary sequences form a bipartite pocket domain 
structure, which is important for  interactions with both cellular proteins and viral 
oncoproteins, thus enabling pRb to exert its cellular function (Figure 1.21). 
Specially, pRb is a 928 amino acid protein that contains three important domains: 
A, B and C (Burkhart and Sage, 2008). The A and B domains form the AB pocket, 
which is critical for interaction with various proteins, including the transcription 
factor E2F (Figure 1.21). The AB pocket is separated by a spacer region, which in 
p107 and p130 contains a cdk-cyclin binding site, though it is absent from pRb 
(Zhu et al., 1995; Munger et al., 2003). The C domain of pRb enhances binding of 
the AB pocket to E2F (~ 10-fold) (Qin et al., 1992). The pocket proteins are also 
able to interact with proteins that contain an L-X-C-X-E domain, such as D-type 
cyclins and HDAC (Figure 1.21) (Giacinti and Giordano, 2006). In contrast, E2F 
proteins do not have any L-X-C-X-E domains, and in this way pRb may interact 
with both E2F proteins and L-X-C-X-E domain-containing proteins as the binding 
sites are distinct from each other (Figure 1.21). Furthermore, the growth 
suppressing activities of pRb require both the E2F interaction and L-X-C-X-E 
domains (Giacinti and Giordano, 2006). 
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Figure 1.21 Domain structure pRb and post-translational modifications. pRb 
has three pocket domains: A, B and C. The pocket domains may interact with a 
variety of proteins important for cell cycle regulation, such as E2F and proteins 
with an L-X-C-X-E domain (Burkhart and Sage, 2008). 
 
Functionally, pRb has been widely studied as a tumour suppressor for its role as a 
central regulator of the cell cycle as it acts an inhibitor of the G1-S-phase transition 
(Knudsen and Knudsen, 2008). The inactivation of pRb by cdk-cyclin complex-
dependent phosphorylation is the molecular switch to drive cell cycle progression 
past the irreversible restriction or R-point, analogous to START in yeast 
(Lundberg et al., 1999). Past this point in G1, cells are inextricably committed to 
replicate their DNA via the engagement of a major transcriptional program in a 
mitogen-independent manner. In its hypophosphorylated state, pRb suppresses 
G1-S transition by binding to the E2F transcription factor, which regulates the 
expression of S-phase genes (Figure 1.22) (Mittnacht, 1998). pRb is thought to 
inhibit E2F-dependent transcription in two ways. Firstly, pRb binds to the 
transactivation domain of E2F therefore inhibiting its transcriptional activity. 
Secondly, pRb promotes the active repression of gene expression by recruiting 
histone deacetylases (HDACs), SWI/SNF chromatin remodelling complexes, 
Polycomb group proteins and methyltransferases (Knudsen and Knudsen, 2008). 
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In response to mitogenic signals, D-type cyclins are rapidly transcribed via the 
action of the Ras-Raf-MAPK signaling pathway (Lundberg and Weinberg, 1999). 
Activated cdk4,6-cyclin D complexes act to phosphorylate pRb on various serine 
and threonine residues, therefore inactivating it and allowing expression of a 
multitude of E2F-responive genes necessary for cell cycle progression, including 
cyclin E and A (Figure 1.22) (Bartek and Lukas, 2001). Microarray analyses 
highlights that E2F targets approximately 150–200 genes (Knudsen and Knudsen, 
2008). E2F1-3  functions by recruiting proteins that promote an open chromatin 
structure, allowing the transcription machinery access to promoters, for example 
the basal transcription factor TFIID and other co-activators, such as histone 
acetyltransferases, p300 and CBP, GCN5 and TIP60 are all recruited to gene 
promoters  (Figure 1.22) (Chen et al., 2009). Activated cdk2-cyclin E complexes in 
late G1 further phosphorylate pRb in cooperation with cdk4,6-cyclin D complexes, 
and in this way the pRb-E2F pathway acts in a feed forward mechanism to 
enhance pRb phosphorylation (Figure 1.22) (Mittnacht, 1998). pRb is maintained 
in a phosphorylated state until late mitosis until it is dephosphorylated by 
members of the type 1 protein phosphatase family (PP1).  
 
Figure 1.22. Role of pRb in the cell cycle. pRb is phosphorylated, and in turn 
inactivated by cdk-cyclin complexes leading to E2F-dependent gene expression 
required for S-phase progression (Knudsen and Knudsen, 2008). 
91 
 
The number of E2F family members is quite extensive, broadening the ways in 
which cell cycle progression is regulated. Furthermore, not all E2Fs are 
transcriptional activators, some act so as to repress transcription (Chen et al., 
2009). To date, there are ten E2F family members: E2F1, E2F2, E2F3a, E2F3b 
(all activators); E2F4, E2F5, E2F6, E2F7a, E2F7b, E2F8 (all repressors). The E2F 
activators contain sequence-specific DNA-binding domains and a dimerisation 
domain, which enables binding with one of three dimerisation partners (DP1-3) 
(Chen et al., 2009). Interaction with the DP proteins allows E2F to bind DNA and 
stabilises the interaction with pocket protein, although they do not determine the 
specificity of the interacting pocket protein (Giacinti and Giordano, 2006; Polager 
and Ginsberg, 2008). Notably, E2F7 and 8 do not dimerise with DP proteins, but 
rather may homodimerise or form E2F7/E2F8 heterodimers. Activator E2Fs also 
contain a cdk-binding domain and NLS near the N-terminus. The C-terminus 
contains a transcriptional transactivation domain, which enables activation of gene 
expression, and pRb-binding domain within this transactivation domain, allowing 
pRb to actively repress E2F-mediated gene expression (Giacinti and Giordano, 
2006; Polager and Ginsberg, 2008). The E2F repressor group proteins also 
contain a DNA-binding domain and pRb-binding domain whilst they contain a NES 
instead of a NLS (for E2F4 and E2F5). E2F6-8 do not contain pRb-binding 
domains, indicating that their repressor function in the cell cycle is independent of 
the pocket proteins. 
 
The various combinations that may exist between the E2F family and the pocket 
proteins (pRb, p107 and p130) show a degree of specificity in the interactions, 
which suggests that the biological functions of the pocket proteins are not wholly 
redundant.  For example, pRb interacts with E2F1-4, although E2F4 mainly 
interacts with p107 and p130 and E2F5 associates predominantly with p130 
(Attwooll et al., 2004; Cobrinink, 2005; Chen et al., 2009). Functionally, the 
plethora of E2Fs, in conjunction with their interacting pocket protein, appear to 
have specific functions within the cell cycle either due to their expression levels or 
their activation, or both. Temporally, in G0, E2F4 and E2F5, whose protein levels 
are unchanged throughout the cell cycle, associate with p107 and p130 and other 
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co-repressors (e.g. histone deacetylases (HDACs), the DNA methyltransferase 
DNMT1 and C-terminal binding protein (CtBP)) to repress E2F-responsive genes. 
Upon mitogenic signalling, cdk4,6-cyclin D phosphorylation of pRb inactivates 
pRb repressor function, therefore promoting the transcription of E2F-responsive 
genes, including E2F1-3, in late G1. The repressor E2Fs, E2F6,7 and 8, which 
function independently of the pocket proteins, mediate the repression of the 
transcription program, including E2F1, therefore acting to antagonise E2F1-3 
activator function (Chen et al., 2009). 
 
Pocket proteins may also control the G1/S-phase transition in an E2F-independent 
manner. Firstly, p107 and p130, but not pRb, may bind cdk4,6-cyclin D and cdk2-
cyclin E complexes (Zhu et al., 1995). In contrast, pRb interacts with the F-box 
protein Skp2, which is part of the SCF ubiquitin ligase complex (see 1.13.3) (Ji et 
al., 2004). This interaction inhibits the ubiquitylation and thus degradation of p27, 
which leads to increased p27 levels and inhibits G1/S-phase progression (Wang et 
al., 2010). pRb also induces PML body formation and suppress Ras signalling, 
two functions which ultimately also lead to inhibition of proliferation in an E2F-
independent manner (Cobrinink, 2005). 
 
1.14.1.2 The Myc pathway 
Acting synergistically with the Rb-E2F pathway to the control the G1/S-phase 
transition is the Myc pathway (Bartek and Lukas, 2001). The c-myc gene product 
is proto-oncogene and transcription factor of the bHLH/LZ protein family, whose 
expression is rapidly induced by mitogenic signalling. Myc may act as both a 
transcriptional activator and repressor depending on its interacting partners, with 
one estimate suggesting that it may regulate up to 15% of all genes (Dominguez-
Sola et al., 2007; Cotterman et al., 2008). Myc promotes the production of 
proteins that promote G1/S-phase including D-type cyclins, cyclin E and Cdc25. 
Moreover, Myc also functions indirectly by sequestering p27 into cdk4-cyclin D 
complexes, enabling its phosphorylation and subsequent UPS-mediated 
degradation (Bartek and Lukas, 2001). Silencing of either the Rb-E2F or Myc 
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pathway is not enough to inhibit cell cycle progression, probably as a result of 
over-lapping gene targets, but inhibition of both pathways prevents S-phase entry. 
 
1.14.1.3 Cdk2-cyclin E is a G1/S-phase convergence point 
The synergistic actions of the Rb-E2F and Myc pathways cooperate to inactivate 
pRb and promote the entry into S-phase. The regulation of the abundance and 
activity of cdk2-cyclin E complexes by these two convergent pathways has been 
suggested to be the rate-limiting step that is essential for S-phase entry (Sherr 
and Roberts, 1999; Nilsson and Hoffmann, 2000). As well as phosphorylating pRb 
and p27, the cdk2-cyclin E complex promotes phosphorylation of p220NPAT, a 
protein involved in the activation of histone gene promoters during DNA 
replication. Furthermore, the Cdc45 protein, which loads DNA polymerase α onto 
replication origins, is activated by cdk2-cyclin E complexes, providing evidence for 
an essential role for cdk2-cyclin E in G1/S-phase control (Zou and Stillman, 1998). 
1.14.2 S-phase 
Whilst a thorough discussion of S-phase is beyond the scope of this thesis, I will 
cover the salient conceptual points important in the context of the cell cycle. The 
basic machinery of DNA replication is highly conserved throughout evolution, with 
higher organisms adapting more elaborate strategies in order to replicate larger 
segments of DNA (Kelly and Brown, 2000). Two problems must therefore be 
overcome in eukaryotes for replicating such a large amount of genetic material. 
First, DNA replication must be initiated at the multiple sites at the correct time in 
the cell cycle and, secondly, these initiation sites must be prevented from firing in 
the newly synthesised daughter chromosomes (Kelly and Brown, 2000). These 
events are regulated extensively within the framework of the cell cycle and 
checkpoint pathways, which arrest cell cycle progression in response to 
replication stress, thereby inhibiting the transmission of damaged DNA to 
daughter cells. 
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Figure 1.23 Model of eukaryotic DNA replication. ORC binds origins of 
replication, which then allows Cdt1 and Cdc6 to load MCM2-7 onto chromatin. 
CDK and DDK govern the loading of the replisome and activation of MCM2-7 
complex (adapted from Sclafani and Holzen, 2007). 
 
DNA replication is initiated at specific DNA sites called origins of replication. 
These sequences are bound by the origin replication complex (ORC) during G1-
phase (Masai et al., 2010). Studies using a range of organisms has highlighted 
that ORCs vary in their ability to recognise specific DNA sequences and in higher 
eukaryotes ORC displays no DNA binding sequence specificity, suggesting that 
other factors such as chromatin structure may influence ORC association 
(Sclafani and Holzen, 2007). The minichromosome maintenance (MCM) complex 
is a heterohexameric assembly of MCM 2,3,4,5,6 and 7 subunits. The MCM 
complex is loaded onto the chromatin-bound ORC by Cdc6 and Cdt1 during late 
mitosis-early G1-phase to form a prereplicative complex (pre-RC) (Figure 1.23) 
(Blow and Gillespie, 2008). Once MCM has loaded onto ORC, origins are said to 
be ‘licensed’. Re-replication from licensed sites is inhibited by blocking MCM 
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loading during S, G2 and M-phases via the action of cdks (Nguyen et al., 2001; 
Blow and Dutta, 2005). In this way, origins are either licensed (L = 1, A = 0) or 
activated (L = 0, A = 1), like binary code (See Figure 1.23). This is accomplished 
in a number of ways. Firstly, cdk-mediated phosphorylation of ORC results in its 
degradation by SCFSkp2 during S-phase (Mendez et al., 2002). Cdc6 is stabilised 
during G1-phase by cdk-dependent phosphorylation, which prevents its 
association with APC/C, however, as APC/C is inactivated during G1, Cdc6 
stabilisation is decreased, thereby inhibiting replication licensing (Duursma and 
Agami, 2005; Mailand and Diffley, 2005). Cdt1 levels are regulated in two ways. 
Firstly, it may be signalled for SCFSkp2-dependent and independent degradation 
after initial phosphorylation by either cdk2 or cdk4 (Blow and Dutta, 2005). 
Secondly, Cdt1 is stabilised by binding to the cell cycle regulated protein geminin, 
which is expressed during S, G2 and early mitosis, therefore inhibiting the loading 
of the MCM complex onto origins (Blow and Dutta, 2005). Interestingly, cells 
contain far more licensed pre-RCs that are eventually fired, i.e. they prepare an 
excess of potential DNA replication start sites and in this way DNA replication 
displays great plasticity (Gilbert, 2004). It has been shown that cells use ‘dormant’ 
origins if the replication machinery is stalled in response to DNA damage (Masai 
et al., 2010). The selection of origins fired during S-phase may be regulated either 
at the pre-RC assembly step or the actual activation step (Masai et al., 2010). 
Furthermore, origins are temporally regulated during S-phase and although the 
long standing dogma of euchromatin being replicated during early S-phase and 
heterochromatin being replicated during late S-phase holds true in some 
instances, recent evidence suggests that the temporal differences in replication 
timing is likely due to three-dimensional chromatin structure and nuclear 
architecture (Hiratani et al., 2009).  
 
Once licensed, i.e. by the loading of MCM2-7 helicase onto ORC by Cdc6 and 
Cdt1, the process of firing them needs to be activated at the appropriate stage. 
The two major protein kinases responsible for this are cdk and Cdc7-Dbf4, which 
activate the MCM helicase. Cdc7-Dbf4 is absent in G1-phase due to degradation 
via APC/CCdh1, which is itself inactivated as cells enter S-phase, therefore allowing 
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Cdc7-Dbf4 levels to rise. MCM complexes are loaded in excess at origins and 
once activated by cdk and Cdc7-Dbf4, are able to interact with Cdc45, a protein 
that loads the replisome (multi-protein replication fork complex) and moves with 
the replication fork and is necessary for fork initiation and elongation (Masai et al., 
2010). Various other proteins, such as the GINS complex, Sld2 and 3, MCM10 
and Dpb11 are involved in facilitating the activation of the MCM2-7 helicase and 
loading the replisome (Figure 1.23) (Diffley and Labib, 2002). 
1.14.3 G2/M-phase 
Once a cell has replicated its genetic material, before it can divide its progression 
is halted until cdk1-cyclin B complexes are activated and several G2/M 
checkpoints must be satisfied. During G2, phosphorylation on Thr168 of cdk1 
allows binding to cyclin B. However, the cdk1-cyclin B complex is inactivated by 
phosphorylation of cdk1 on Thr14/15 by Wee1 and Myt1. At the end of G2 and 
beginning of mitosis, these two residues are dephosphorylated by Cdc25. 
Activated cdk1-cyclin B then phosphorylates Cdc25, activating it and initiating a 
positive feedback loop, whilst also phosphorylating Wee1, thereby inactivating it, 
providing a negative feedback loop (Vermeulen et al., 2003). Phosphorylation by 
cdk1 and Plk1 of Wee1 promotes its degradation after ubiquitylation by SCFβ-TrCP. 
Activated cdk1-cyclin B1 complexes promote chromatin condensation and mitotic 
spindle assembly, whilst phosphorylating a range of other targets, including 
nuclear lamins (inducing nuclear envelope breakdown) and histone H1 (Nigg, 
2001; Yu and Yao, 2008). Activated cdk1-cyclin B and Plk1 also phosphorylate 
Emi1, the APC/C inhibitor, stimulating degradation by via SCFβ-TrCP in prophase 
(Hansen et al., 2004). Cdk1 also phosphorylates APC/C, which promotes 
interaction with Cdc20, and this activated APC/CCdc20 complex targets cyclin A 
destruction during prometaphase (Vodermaier, 2004). After prometaphase, the 
spindle assembly checkpoint (SAC) prevents chromosome segregation until all 
chromosome are aligned correctly (Nasmyth, 2005). A single unattached 
kinetochore is sufficient to inhibit activation of APC/C (Musacchio and Hardwick, 
2002). Once the SAC has been satisfied, anaphase commences via the activity of 
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APC/CCdc20, which targets the Separase inhibitor, Securin, for degradation, 
allowing sister chromatids to be pulled apart (Nasmyth, 2005). APC/CCdc20 also 
targets cdk1-cyclin B complexes for degradation at this stage. Later in mitosis, 
during telophase, Cdh1 is activated in the absence of cdk activity and 
dephosphorylating action of Cdc14p, and forms the APC/CCdh1 complex, which 
targets APC/CCdc20 for degradation and remains active through to G1 in the two 
daughter cells (Nigg, 2001).  
1.15 When the cell cycle goes wrong: cancer 
The cell cycle machinery is a prime target for the progression of cancer as it 
provides the potential to allow unlimited cell divisions and bypasses checkpoint 
controls even in the presence of genomic instability (Hanahan and Weinberg, 
2011). The number of cell cycle-related genes mutated in cancer, the types of 
mutations found, and how they impact on the cell cycle is far too numerous to 
cover here. However, in light of what I have discussed previously, I will simplify 
the discussion to proteins that drive G1/S-phase and G2/M-phase transitions.  
 
Both the pRb-E2F and Myc pathways that govern the G1/S-phase transition are 
targets in cancer (Hanahan and Weinberg, 2000). As the restriction-point in G1 
governs the decision to commit to cell division, there is great selective pressure in 
cancers to bypass this decision point by promoting the pRb-E2F pathway (Bartek 
et al., 1997). The G1/S-phase regulators may be seen as either proto-oncogenes 
(E2F, Myc, cyclins D1, D2 and E, cdk4 and 6, Cdc25) or tumour suppressors 
(p53, pRb, p15, p16, p21, p27) (Bartek et al., 1997; Sherr, 2004). Tumour 
suppressor genes encode proteins that inhibit cell cycle progression and loss-of-
function mutations in these genes may cause the the resulting oncoprotein to 
become non-functional and therefore oncogenic. In contrast, proto-oncogenes 
generally undergo gain-of-function mutations resulting in an oncoprotein that may 
be refractory to normal regulatory mechanisms that governs its activity (Sherr, 
2004). These two groups either drive proliferation by encouraging cell cycle 
proliferation (proto-oncogenes) or through their inability to inhibit the cell cycle 
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(tumour suppressors) (Sherr, 2004). The promotion of oncogenesis by either 
proto-oncogenes or tumour suppressors, or both, proceeds by several distinct 
mechanisms (Bartek et al., 1997). These include gene amplification, chromosomal 
translocations or inversions, activating or inactivating mutations, promoter 
silencing, increased/decreased protein turnover and altered protein-protein 
interactions (Bartek et al., 1997). Whilst pRb function is completely lost in 
retinoblastoma, it is also found to be mutated in a great number of cancer types, 
for example, in 80% of small cell lung cancer cases (Sherr and McCormick, 2002). 
Furthermore, inactivating mutations in p16 are frequently found in cancers, for 
example, in up to 80% of pancreatic cancer cases (Kamb, 1998; Sherr and 
McCormick, 2002). It has been estimated that ~ 90% of all cancers have a 
deregulated pRb-E2F pathway (Hall and Peters, 1996). The pRb-E2F pathway is 
thus particularly susceptible to mutations causing this a shift towards uncontrolled 
proliferation. Moreover, upstream mitogenic signalling mutations in genes such as 
Ras also contribute to increased use of the pRb-E2F pathway by promoting pRb 
phosphorylation (Peeper et al., 1997). 
 
Mutations in G2/M-phase genes are less profound numerically than those that 
control the G1/S-phase transition, presumably because mutations in these genes 
would undermine the bypass of G1/S-phase control, i.e. it is essential that a 
cancer cell retains the ability to divide having gone through G1 and S-phase 
(Bartek et al., 1997). However, Cdc25 is deregulated in cancer and can be 
overexpressed in certain cancer types, leading to unscheduled cdk-cyclin 
activation (Nilsson and Hoffmann, 2000).   
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CHAPTER 2. MATERIALS AND METHODS 
 
2.1 Cell Culture 
2.1.1 Maintenance of human dermal fibroblasts 
Wild type human dermal fibroblasts (HDFs) have previously been isolated from 
neonate and juvenile foreskin and cryopreserved (Bridger et al., 1993). The 2DD 
strain of HDFs used in this study were cultured in Dulbecco’s modified Eagle’s 
medium (DMEM, Invitrogen) supplemented with 10% (v/v) FBS (Sigma) (from now 
on referred to as 10% DMEM) with the addition of 10 units/ml penicillin 
(Invitrogen) and 50 µg/ml streptomycin (Invitrogen) at 37ºC in a humidified 
incubator with 5% CO2. During this study only early passage HDFs (p8-p12) were 
used.  
 
HDFs were grown in 75 cm2 culture flasks (Nunc) with a media change every 2-3 
days. Once the cells had reached approximately 70-80% confluency they were 
subcultured and reseeded at 3 x 105 cells per 75 cm2 culture flask. For 
subculturing, cells were washed once with Versene buffer (137 mM NaCl, 2.7 mM 
KCl, 8 mM Na2HPO4, 1.5 mM KH2PO4, 1.5 mM EDTA pH 7.4) and then detached 
from the culture flask by the addition of Versene buffer plus 10% (v/v) trypsin 
(Sigma) and placed for a maximum of 5 minutes at 37ºC in a humidified incubator 
with 5% CO2 to aid detachment. Subsequently, trypsin was inactivated via the 
addition of 10% DMEM and antibiotics. The cells were transferred to a sterile 30 
ml universal tube and centrifuged at 200 x g for 5 minutes. The media was 
aspirated off and the cells were then thoroughly resuspended and counted using 
a haemocytometer to determine the cell density and thereafter seeded into 75 cm2 
flasks.  
 
HGPS fibroblasts (AG06297) carrying classical G608G mutation in the LMNA 
gene and fibroblasts from young (GM0323; eight year old) and old (GM09588; 
eighty-five year old) healthy individuals were obtained from the Coriell Cell 
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Repository. HDFs from a patient with lethal foetal akinesis harbouring a 
homozygous Y259X mutation in the LMNA gene were obtained as an autopsy 
sample after an informed consent and were a kind gift from Dr. Jos Broers. AD-
EDMD (Emery-Dreyfuss muscular dystrophy) fibroblasts carrying the R453W 
mutation in the LMNA gene, X-EDMD HDFs carrying a mutation in the STA gene, 
and HDFs from patients with Greenberg dysplasia carrying a mutation in the LBR 
gene were a kind gift from Dr. Manfred Wehnert.  
2.1.2 Maintenance of transformed cell lines 
HEK293T and U2OS cells (a kind gift from Eric Schirmer, University of Edinburgh) 
were maintained in 10% DMEM. They were typically split at a ratio of 1:10 and 
routinely passaged every 2-3 days.  
2.1.3 G0 synchronisation by serum-starvation 
Synchronisation of HDFs in the reversible G0 phase (quiescence) of the cell cycle 
has been described previously (Bridger et al., 1993). In order to induce 
quiescence, HDFs were seeded at a density of 3 x 105 cells per 75 cm2 culture 
flask and cultured in 10% DMEM and antibiotics at 37ºC in a humidified incubator 
with 5% CO2. Cells were allowed to proliferate up to approximately 70-80% 
confluency, at which point the media was aspirated from the culture flasks and 
cells were washed once with, and then maintained in, DMEM supplemented with 
0.5% (v/v) FBS and antibiotics for 3-5 days at 37ºC in a humidified incubator with 
5% CO2. G1 arrested cells were confirmed by immunofluorescence staining with 
Ki67 antibody. 
2.1.4 Generation of stable U2OS cell lines 
U2OS cells were transfected with either GFP-pMax (Lonza) or GFP-prelamin A 
using Lipofectamine 2000 (see 2.5.1). After 24 hours, cells were plated in 10 cm 
dishes with the addition of 800 µg/ml G418. Selection in G418-supplemented 
media continued for 7-14 days. Single isogenic clones were then created by 
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cloning in 96-well plates before propagation and use. Levels of GFP-expression 
were assessed by microscopy and western blotting. 
2.1.5 Drug/IR treatment 
Etoposide and hydroxyurea were purchased from Sigma. Etoposide powder was 
dissolved in DMSO to a final stock concentration of 10 mM and kept in the dark at 
4ºC. Unless stated otherwise, cells were treated with 20 µM etoposide for 30 
minutes. Hydroxyurea (HU) was dissolved in MilliQ water to a final stock 
concentration of 0.5 M and discarded after immediate use. HU was used at a final 
concentration 20 mM and was applied to cells overnight (16-20 hours). Bleomycin 
sulphate was purchased from Calbiochem, dissolved in MilliQ water to produce a 
stock concentration of 5 mg/ml and stored in the dark at -20ºC. Bleomycin 
sulphate was applied for 1 hour and used at a final concentration of 20 µg/ml. 
After all treatments, cells were either assayed immediately or at later time points, 
in which case cells were then washed twice with sterile PBS and re-fed with 10% 
DMEM and antibiotics. N-acetyl-L-cysteine (NAC) was purchased from Sigma, 
dissolved in MilliQ water to a stock solution of 0.5 M and applied to cells to final 
concentration of 10 mM. Hydrogen peroxide (H2O2) was purchased from Sigma 
and comes as a stock solution of 8.8 M. In order to treat cells with µM quantities 
of H2O2, the stock solution was diluted in MilliQ water to produce a working stock 
solution of 4 mM before subsequent addition to cells at the concentrations 
indicated in the text. Ionizing radiation treatment was performed with a NDT 320 
irradiator using a Comet MXR-321 X-ray tube (130 kV, 5 mA) at a dose rate of 1.9 
Gy/min. Cells were irradiated before being returned to 37ºC 5% CO2 incubators 
for the time indicated in the text. Caffeine (Sigma) was made fresh by dissolving in 
water at a stock concentration of 0.5 M and added to cells at a final concentration 
of 20 mM for 1 hour prior to irradiation. MG-132 (Calbiochem) was used at a 
concentration of 30 µM and added to culture medium for 6 hours. 
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2.2 Plasmids 
2.2.1 Flag-prelamin A 
Prelamin A cDNA was previously cloned into the mammalian expression vector 
pSVK3 (Amersham Pharmacia Biotech Inc), which has an N-terminal Flag-tag and 
a multiple cloning site downstream from an SV40 early promoter and an ampicillin 
resistance cassette (Östlund et al., 2001). The construct was kindly provided by 
H.J. Worman (Departments of Medicine and of Anatomy and Cell Biology, 
Columbia University College of Physicians and Surgeons, New York, USA). Flag-
prelamin A cysteine mutants (see text for specific details) were kindly provided by 
V.Pekovic (University of Durham). 
2.2.2 GFP-prelamin A and GFP-lamin C 
Prelamin A cDNA was previously cloned by a member of our laboratory into 
pEGFP-C2 (Clontech Inc), which contains a multiple cloning site downstream from 
the cytomegalovirus early promoter and expresses the gene with an N-terminus 
EGFP fusion (Vaughan et al., 2001). Lamin C was previously cloned into the 
pS65T expression vector and was previously obtained from Dr Jos Broers 
(Department of Molecular Cell Biology and Genetics, University of Maastricht, The 
Netherlands).  
2.2.3 HA-tagged 53BP1 
HA-tagged 53BP1 expression constructs were kindly provided by Kuniyoshi 
Iwabuchi (Department of Biochemistry, Kanazawa Medical University, Japan). 
Various cDNA fragments were previously cloned into the mammalian expression 
construct pCMH6K, which contains an N-terminal tag with an influenza virus 
hemagglutinin (HA) epitope (Iwabuchi et al., 2003).  
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2.3 Generation of amplified plasmid DNA 
2.3.1 Transformation of DH5α E.coli 
Expression constructs were used to transform competent DH5α E.coli cells. 
Briefly, 100µl of E.coli cells were thawed on ice for 10 minutes. After which time, 
1-1000 µg of plasmid DNA was added to the cells and mixed carefully using a 
pipette, then left for up to 30 minutes on ice. The cells were then placed at 42ºC 
for 90 seconds, then returned to ice for exactly 2 minutes. Next, 1ml of room 
temperature LB was added to the cells and then incubated at 37ºC for 90 minutes 
with shaking at 225-250 rpm. Cells were then plated onto LB agar containing 100 
µg/ml ampicillin or 30 µg/ml kanamycin (depending of the expression construct) 
and allowed to grow for 16-20 hours at 37ºC. From these plates, clearly isolated 
colonies were chosen and grown in LB with 100 µg/ml ampicillin or 30 µg/ml 
kanamycin for 16 hours with shaking at 225-250 rpm before conducting small 
scale DNA purification of the culture. 
2.3.2. Plasmid purification  
Small and large-scale DNA purification was carried out according to the 
manufacturer’s guidelines (Promega). 
2.4 RNAi  
2.4.1 siRNA sequences  
Knockdown of target proteins was achieved by following standard laboratory 
protocols that had previously been adapted from published protocols (Elbashir et 
al., 2001; Harborth et al., 2001; Pekovic et al., 2007). The negative control and 
LAP2α siRNA sequences were obtained from Ambion, whilst the lamin A/C siRNA 
sequence was obtained from Qiagen. Alternatively, to determine transfected cells, 
these oligos were purchased from the same companies with a 5’-Cy3 tag. Upon 
arrival, siRNA duplexes were resuspended in nuclease-free water to give a final 
working concentration of 20 µM (for Oligofectamine transfection) or 40 µM (for 
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Amaxa transfection), aliquoted and stored at -20˚C until use. The sequences of 
LAP2α and lamin A/C siRNAs have been selected from the open reading frames 
of both LAP2α and lamin A/C mRNAs to obtain 21-nt sense and 21-nt antisense 
strand with symmetric 2-nt 3′-overhangs of identical sequence. The negative 
control siRNA is targeted against a sequence that does not have any significant 
sequence similarity to mouse, rat or human transcript sequences (note: sequence 
details not available from supplier). The LAP2α siRNA sequence is targeted 
against the LAP2α-specific exon 4 of TMPO such that no other isoforms should 
be targeted. The LAP2α and lamin A/C siRNA sequences were as follows:  
LAP2α sense: 5′-GCU AAG AAA GUA CAU ACU U tt-3′ 
LAP2α anti-sense: 5′-AAG UAU GUA CUU UCU UAG C tg-3′ 
Lamin A/C sense: 5′-CUG GAC UUC CAG AAG AAC A tt-3′ 
Lamin A/C anti-sense: 5′-UGU UCU UCU GGA AGU CCA G tt-3′. 
 
2.4.2 Transfection of HDFs with siRNA 
2.4.2.1 Oligofectamine siRNA transfection 
In order to knockdown endogenous LAP2α or lamin A/C, HDFs were either 
synchronised as previously described or used during log-phase growth and then 
transfected with the appropriate siRNA. On the day of transfection, siRNA was 
allowed to thaw to room temperature before use. Following this, 15 µl of 
Oligofectamine (Invitrogen) was mixed gently with 60 µl warmed DMEM (note: 
DMEM was not supplemented with 10% FBS or antibiotics) and incubated for 5-
10 minutes at room temperature. During this time period 15 µl of negative control, 
LAP2α or lamin A/C siRNA was mixed gently with 250 µl of warmed DMEM.  After 
5-10 minutes, the two mixtures were combined by gentle tapping and allowed to 
incubate for 20 minutes at room temperature. Whilst allowing this transfection 
complex to form, synchronised HDFs were washed with Versene buffer and then 
detached with Versene buffer and trypsin as described previously, then 
neutralised with 10% DMEM and no antibiotics. Cells were counted using a 
haemocytometer to determine the cell density and then seeded at a density of 1 x 
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105 into 60mm plates (Nunc) in the presence of 2660 µl 10% DMEM and no 
antibiotics. After the 20 minute incubation period, the siRNA/Oligofectamine 
mixture was added dropwise across the 60mm culture dish resulting in a final 
concentration of 100 nM of the siRNA.  The culture dish was placed at 37ºC in a 
humidified incubator with 5% CO2 and after 24 hours the media was aspirated off 
and replaced with fresh DMEM supplemented with 10% FBS and no antibiotics. 
Cells were then assayed at various times post-transfection. 
 
2.4.2.2 Amaxa siRNA transfection 
As an alternative transfection methodology, HDFs were transfected with siRNA by 
electroporation using the Amaxa Normal Human Dermal Fibroblast Nucleofector 
kit (Lonza). Cells were used at 80-90% confluency and on the day of transfection 
HDFs were washed with Versene buffer before trypsinisation and subsequent 
resuspension in 10% DMEM plus antibiotics. HDFs were then counted and 
aliquoted at 5 x 105 per 15 ml falcon tube before being pelleted at 200 x g for 5 
minutes at room temperature. The media was then completely removed from the 
falcon tube and the pellet was resuspended in 100 µl room temperature 
Nucleofector solution and 5 µg of the appropriate siRNA. The suspension was 
transferred to a cuvette and electroporated using program U-23 as suggested by 
the supplier. The suspension was then supplemented with 1 ml 10% DMEM 
before gentle transfer to a 10 cm plate. The culture dish was placed at 37ºC in a 
humidified incubator with 5% CO2 and after 24 hours the media was aspirated off 
and replaced with fresh 10% DMEM. For immunofluorescence studies, cells were 
trypsinised 24 hours post-transfection and plated onto glass coverslips before 
fixation at the times indicated in the text. 
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2.5 Plasmid transfection 
2.5.1 Lipofectamine 2000 
Plasmid transfection was carried out according to the manufacturer’s instructions 
(Invitrogen). Briefly, cells were plated in 2ml 10% DMEM without antibiotics 24 
hours prior to transfection in 6-well plates so as to be 90-95% confluent the next 
day. On the day of transfection, 250µl of DMEM was mixed with 5 µl of 
Lipofectamine 2000 for 5 minutes at room temperature. During this time 4.0 µg of 
plasmid DNA was diluted in 250 µl of DMEM and the two solutions were then 
mixed gently and incubated for 20 minutes at room temperature. This solution was 
then added to adherent cells for 24 hours, after which time it was replaced with 
fresh 10% DMEM. Plasmid expression was assayed by immunofluorescence or 
western blotting after 48 hours. 
2.5.2 Amaxa nucleofection 
HDFs were transfected with 3 µg plasmid DNA by electroporation using the 
Amaxa Normal Human Dermal Fibroblast Nucleofector kit (Lonza). The 
methodology was the same for siRNA transfection (see 2.4.2.2). 
2.5.3 Genejuice  
U2OS/GFP-lamin A cells were plated to 70-80% confluency in 10 cm dishes 24 
hours before transfection. The following day cells were transfected with HA-
53BP1 constructs using Genejuice (Genejuice:DNA ratio, 3:1) with a total of 6 µg 
DNA per plate. Protein extracts were prepared 24 hours post-transfection for 
GFP-Trap immunoprecipitation. 
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2.6 Flow Cytometry 
2.6.1 Estimation of S-Phase Fraction 
In order to estimate S-phase fraction the Click-iT EdU flow cytometry assay kit 
was obtained from Invitrogen. HDFs were synchronised as described above and 
transfected with negative control, LAP2α or lamin A/C siRNA. The media was 
changed after 24 hours with fresh DMEM supplemented with 10% FBS and no 
antibiotics. After 42 hours EdU (5-ethynyl-2’-deoxyuridine), an analogue of bromo-
deoxyuridine (BrdU), was added to the culture dishes to a final concentration of 50 
µM for 1 hour. The cells were washed, detached and neutralized with fresh 10% 
DMEM and subsequently centrifuged in 15 ml falcon tubes at 200 x g for 5 
minutes. Cells were then washed once with 3 ml ice-cold 1% bovine serum 
albumin (BSA) in phosphate-buffered saline (PBS) and pelleted by centrifugation 
at 500 x g for 5 minutes (these centrifugation parameters are used for the rest of 
this flow cytometry protocol). The supernatant was removed and the pellet 
resuspended in 100 µl 1% BSA in PBS. An equal volume of 4% 
paraformaldehyde in PBS was added to fix the cells and the mixture was 
incubated for 15 minutes at room temperature, protected from light. Cells were 
then washed once with 3 ml 1% BSA in PBS, pelleted, the supernatant removed 
and the cells resuspended in 100 µl of 1% BSA in PBS. At this point samples 
were kept for up to one week at 4˚C or processed immediately. The cells were 
then permeabilised with 100 µl of Triton X-100-based permeabilisation reagent 
and mixed thoroughly. The cells were washed with 3 ml 1% BSA in PBS, pelleted 
and the supernatant removed. The Click-iT reaction cocktail was prepared and 0.5 
ml added to the cells, which were then incubated for 30minutes at room 
temperature, protected from light. The cells were washed with 3 ml 1% BSA in 
PBS, pelleted, the supernatant removed and the cells were resuspended in 0.5 ml 
1% BSA in PBS. The cells were then mixed thoroughly with 5 µl of 20 mg/ml 
Ribonuclease A. Finally, 2 µl of CellCycle 488-red (7-amino-actinomycin D) was 
added to the cells, mixed well and incubated at room temperature for 30 minutes 
protected from light. Samples were kept on ice before cell cycle analysis on a 
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Becton Dickinson FACSCalibur flow cytometry. For the detection of EdU, with 
Alexa Fluor 488 azide, a 488nm excitation with green emission filter was used. 
The fluorescent signal generated by the Alexa Fluor 488 azide was detected with 
logarithmic amplification. For the detection of the Click-iT EdU CellCycle 488-red, 
a red emission filter was used and the fluorescent signal generated by the 
CellCycle stain was detected with linear amplification. A minimum of 5,000 cells 
were analysed per sample and the percentage of cells in each phase of the cell 
cycle was determined using FlowJo software. 
2.6.2 Estimation of ROS Levels 
Intracellular ROS levels were estimated using the cell permeant indicator 5-(and-
6)-chloromethyl-2',7'-dichlorodihydrofluorescein diacetate, acetyl ester (CM-
H2DCFDA) (Molecular Probes). The dye is non-fluorescent until the removal of 
acetate groups by intracellular esterases and oxidation occurs within the cell. CM-
H2DCFDA was resuspended in 86 µl of DMSO to produce a 1 mM stock solution. 
Cells were washed twice with PBS before CM-H2DCFDA was added to serum-
free phenol-free low glucose DMEM (Invitrogen) at a final concentration of 5 µM 
and subsequently added to the cells for 1 hour at 37ºC. Cells were washed once 
with PBS before being scraped into 0.5 ml PBS. Intracellular ROS levels were 
then analysed using FACSCalibur flow cytometer with appropriate settings 
(excitation 485-95nm; emission 520-25nm). Data were collected as histograms 
from 10,000 single-cell events and median fluorescence intensity of FL1 peaks 
was analysed using FlowJo software. To measure the rate of intracellular ROS 
production, cells were treated with 100µM H2O2 during the last 20-30min of 
incubation with carboxy-H2DCFDA in serum-free phenol-free DMEM. To measure 
the rate of intracellular ROS elimination, H2O2-treated cells were allowed to 
recover for 1h in phenol-free serum-free medium containing carboxy-H2DCFDA. 
For anti-oxidant treatments, cells were incubated with 10 mM NAC for 1h in 
serum-free phenol-free low glucose DMEM containing 5 µM CM-H2DCFDA. As a 
background control, cells were incubated in phenol-free serum-free DMEM 
without CM-H2DCFDA. 
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2.7 Protein extraction 
2.7.1 Preparation of whole cell extracts 
Cells grown on plates were washed twice with ice-cold PBS before being scraped 
into the same buffer and centrifuged at 1000 x g for 5 minutes at 4ºC. Cell pellets 
were then lysed in ice-cold hypotonic buffer (10 mM Tris pH 7.4, 10 mM KCl, 3 
mM MgCl2, 0.1% Triton X-100), containing freshly added complete protease  and 
phosphatase inhibitor (Thermo) and 500 units/ml RNase-free DNase I 
(Sigma/Roche) for 10-15 minutes on ice. An appropriate volume of 2X/5X sample 
buffer was added to the extract and then boiled for 5 minutes at 95ºC before 
loading onto SDS-PAGE gels or freezing. Alternatively, washed and pelleted cells 
were lysed directly into 2X sample buffer and boiled for 5 minutes at 95ºC. 
Extracts were then drawn through a 23G needle to reduce viscosity or sonicated 
(3 x 5 seconds followed by 30 seconds intervals; 10 µm amplitude) before loading 
onto SDS-PAGE gels or freezing. 
2.7.2 Preparation of nuclear extracts 
Cells were pelleted as above before lysis in ice-cold hypotonic buffer containing 
freshly added complete protease and phosphatase inhibitor for 10 minutes on ice. 
Extracts were then subjected to homogenization with 10 rotating strokes of a tight 
fitting pestle in a Dounce homogenizer. Nuclei were then collected by 
centrifugation at 4000 rpm for 5 minutes at 4ºC. Nuclei were then resuspended in 
hypotonic buffer containing freshly added complete protease and phosphatase 
inhibitor and 500 units/ml RNase-free DNase I for 10 minutes on ice. An 
appropriate volume of 2X/5X sample buffer was added to the extracts before 
boiling for 5 minutes at 95ºC. Samples were then frozen or loaded onto SDS-
PAGE gels. 
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2.7.3 Biochemical fractionation 
Biochemical fractionation of cells was carried out according to standard laboratory 
protocols (Pekovic et al., 2007). All steps were carried out on ice and all buffers 
were ice-cold and supplemented with freshly added complete protease and 
phosphatase inhibitor. Furthermore, 40 mM NEM was added to all buffers to 
prevent protein oxidation during the fractionation. Typically, 10 x 10cm plates of 
70-80% confluent cells were washed once in ice-cold PBS before being scraped 
and aliquoted into 5 x 15ml falcon tubes and collected by centrifugation at 1000 x 
g for 5 minutes at 4ºC. Cell pellets were then resuspended in 200µl CSK buffer 
(10 mM PIPES pH 6.8, 10 mM KCl, 300 mM sucrose, 3 mM MgCl2, 1 mM EGTA 
pH 8.0), transferred to 5 x 1.5ml micro-centrifuge tubes and collected by 
centrifugation. This and all subsequent centrifugation steps were carried out at 
4000 rpm for 5 minutes at 4ºC unless stated otherwise. Supernatants were 
discarded and one pellet, named P1, which represents the whole cell extract, was 
snap frozen in liquid nitrogen before use later in the procedure. The remaining 
four cell pellets were subsequently resuspended in 200µl CSK/T buffer (CSK 
buffer supplemented with 0.5% Triton X-100) for 5 minutes before centrifugation. 
The four supernatants were collected into a tube labelled S2 and snap frozen 
whilst one pellet was labelled P2 and also snap frozen. The remaining three cell 
pellets were resuspended in RSB buffer (42.5 mM Tris-HCl pH 8.3, 8.5 mM NaCl, 
2.6 mM MgCl2), centrifuged and supernatants discarded. The three cell pellets 
were then resuspended in 200µl RSB-Magik buffer (RSB buffer containing 1% 
(v/v) Tween 20 and 0.5% (v/v) sodium deoxycholate) for 5 minutes and 
centrifuged. The three supernatants were collected and in tube labelled S3 and 
snap frozen with one cell pellet labelled P3. The remaining two cell pellets were 
resuspended in 200µl extraction buffer (10 mM PIPES pH 8.3, 250 mM 
ammonium sulphate, 300 mM sucrose, 3 mM MgCl2, 1 mM EGTA pH 8.0), 
centrifuged and the supernatants discarded. The two pellets were then 
resuspended in room temperature digestion buffer containing 500 U/ml RNase-
free DNase I (Sigma/Roche) for 20 minutes at room temperature before 
subsequent centrifugation. The two supernatants were pooled in a tube labeled 
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S4 and snap frozen with one pellet labeled P4. The remaining pellet was 
resuspended in extraction buffer for 5 minutes before centrifugation for 10 
minutes. The last supernatant, labeled S5, and last pellet, P5 were then snap 
frozen (Figure 2.1).  All pellets were then thawed and resuspended in 200µl 
hypotonic buffer (see 2.7.1) for 15 minutes on ice before addition of 50µl 5X 
sample buffer, boiled for 5 minutes, then frozen.  For P1, the extract was passed 
through a 23G needle to reduce viscosity. All supernatants were thawed and an 
appropriate volume of 5X sample buffer (e.g. 200µl to S2 and 50µl to S5) was 
added to the extracts before boiling for 5 minutes and freezing. For western blot 
analysis, an equal volume of sample was loaded from each fraction.   
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Figure 2.1. Schematic of biochemical fractionation procedure. 
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2.8 Western Blotting 
2.8.1 Gel electrophoresis and immunoblotting 
Samples were separated by one-dimensional SDS-PAGE, which was carried out 
according to standard protocols (Markiewicz et al., 2002). Sample protein was 
loaded as well as 10 µl of prestained protein ladder (Fermentas) to ensure correct 
separation of proteins, correct electrotransfer and for determining the molecular 
weight of detected proteins. Proteins were separated on various percentage gels 
run at 100V in tank buffer (25 mM Tris [pH 8.3], 192 mM Glycine, 0.1% SDS) until 
the bromophenol blue in the sample buffer had run out of the gel. Proteins were 
then electrophoretically transferred to a nitrocellulose membrane (0.2mm, 
Whatman) in transfer buffer (25 mM Tris-Cl [pH 9.2], 200 mM glycine, 0.1% SDS, 
20% methanol) using the Mini Transblot system (Bio-Rad), which was run at 
100V, 250 mA for 1.5 hours or 30V, 90 mA overnight at 4ºC. 
2.8.2 Membrane blocking and antibody incubations 
Post-transfer, membranes were rinsed once in blot rinse buffer (BRB, 10 mM Tris-
HCl [pH 7.4], 150 mM NaCl, 1 mM EDTA) for 5 minutes with constant agitation. 
Membranes were then blocked in 5% (wt./vol.) nonfat dry milk or BSA in BRB-T 
(10 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1 mM EDTA, 0.1% Tween-20) for either 
1 hour at room temperature or overnight at 4˚C, both with constant agitation. 
Primary antibodies were diluted in their appropriate incubation buffer and applied 
to the membrane overnight at 4˚C. After primary antibody incubation, membranes 
were washed three times for 10 minutes each with BRB-T at room temperature 
with constant agitation. Membranes were then incubated with the appropriate 
secondary antibody diluted with 5% (wt./vol.) nonfat dry milk or 5% BSA in BRB-T 
at a concentration of [1:2000] for 1 hour at room temperature with constant 
agitation. The secondary antibodies used were donkey anti-mouse IgG 
conjugated to horseradish peroxidase (HRP) or donkey anti-rabbit IgG conjugated 
to HRP (both Stratech). Membranes were then washed three times for 10 minutes 
each with BRB-T at room temperature with constant agitation. 
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2.8.3 Protein detection 
Immunological detection of proteins on the membranes was performed with the 
Enhanced Chemiluminescence kit (ECL; GE Healthcare). ECL reagents were 
mixed and added to the membranes, which were then exposed to Hyperfilm ECL 
films (GE Healthcare). The bands were visualised using a Compact X4 Automatic 
X-ray Film Processor (Xograph Imaging Systems Ltd). 
2.8.4 Quantification of bands 
The signals obtained for the protein bands were quantified by densitometry using 
one of two methods. Firstly, the autoradiogram was scanned into Adobe 
Photoshop using a ScanJet 6300C (Hewlett Packard) and the resulting image was 
saved and then processed using the ImageJ software. Alternatively, the 
densitometry was performed using Image Gauge analysis software (FujiFilm). 
Background signal was always subtracted from the signal obtained for each band. 
2.8.5 Stripping of blots 
The Re-Blot Plus kit was purchased from Millipore. The antibody stripping solution 
was prepared according to the manufacturer’s instructions and applied to the 
membrane with gentle mixing for 15 minutes at room temperature. The membrane 
was then washed twice for 5 minutes with 5% (wt./vol.) nonfat dry milk or 5% BSA 
in BRB-T before re-probing with the desired antibody.  
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2.9 Immunoprecipitation 
2.9.1 Immunoprecipitation of endogenous lamin A/C complexes 
Proliferating wild type HDFs grown in 10 cm plates were first cross-linked in vivo 
using DSP (Dithiobis[succinimidyl propionate]) (Pierce), essentially as described 
(Fujita et al., 2002). Briefly, HDFs were washed twice with room temperature PBS 
pH 8.0 before adding 10 ml PBS per 10 cm plate with DSP added to a final 
concentration of 1 mM. Plates were swirled for 15 minutes at room temperature 
before the addition of 1 M Tris-HCl pH 7.5 to a final concentration of 25 mM for 15 
minutes at room temperature to quench the reaction. Plates were then washed in 
ice-cold PBS, pelleted and lysed in NP-40 buffer (50 mM Tris-HCl pH 7.5, 150 mM 
NaCl, 1% NP-40, 100 mM EDTA) containing freshly added complete protease and 
phosphatase inhibitor (Thermo) for 20 minutes on ice. Extracts were then 
sonicated for 3 x 10 seconds (amplitude 10 µm) with 30 second intervals. Lysates 
were then cleared by centrifugation at 12,0000 rpm for 10 minutes and added to 
pre-equilibrated Dynabeads Protein G (Invitrogen) with pre-bound lamin A/C (sc-
7292, Santa Cruz) or unspecific IgG overnight at 4ºC. Beads were then washed 
four times with NP-40 buffer before addition of 2X sample buffer and boiled for 10 
minutes at 95ºC before loading onto SDS-PAGE gels. 
2.9.2 Immunoprecipitation of GFP-lamin A complexes 
For 293T and U2OS immunoprecipitations, cells washed and scraped into ice-
cold PBS before centrifugation at 1000 x g for 5 minutes. Cell pellets were then 
lysed in NP-40 buffer (see above) for 20 minutes on ice before centrifugation at 
12,000 rpm for 10 minutes. Clarified extracts were then added to pre-equilibrated 
GFP-Trap M beads (Chromotek) overnight at 4ºC. Beads were washed and 
bound proteins eluted as for HDFs. 
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2.10 Immunocytochemistry and confocal microscopy 
2.10.1 Fixation and permeabilisation  
Cells grown on glass coverslips were washed once with PBS and fixed for 15 
minutes at room temperature with 4% formaldehyde (AnalaR) in PBS. Coverslips 
were then washed three times for 5 minutes each with PBS. Cells were then 
permeabilised with 0.5% Triton X-100 (Sigma) in PBS for 5 minutes at 4°C. Again, 
coverslips were washed three times for 5 minutes each with PBS. In order to 
ensure specificity of antibody binding, cells were incubated with blocking buffer 
(1% NCS (v/v) in PBS) for 45-60 minutes at room temperature.  
2.10.2 Primary and secondary antibodies 
Blocking buffer was aspirated off and coverslips were incubated with primary 
antibodies in a moist chamber for 1 hour at room temperature or overnight at 4ºC. 
Primary antibodies were diluted in 1% NCS in PBS; those used and their dilutions 
can be seen in Table 2. Following primary antibody incubation, cells were washed 
five times in five changes of PBS. Secondary antibodies were applied for 1 hour at 
room temperature in a moist chamber protected from light. The secondary 
antibodies used were a combination of donkey anti-mouse IgG or donkey anti-
rabbit IgG (both Stratech) each conjugated to either tetramethylrhodamine B 
isothiocyanate (TRITC) or fluorescein isothiocyanate (FITC) and diluted 1:100 in 
1% NCS in PBS. Coverslips were washed five times in five changes of PBS 
before a final wash in distilled water. Coverslips were mounted on to glass slides 
in 30% (v/v) glycerol containing 12% (v/v) Mowiol (Sigma), 2mg/ml 4,6-
diamindino-2-phenylindole (DAPI) and 2.5% (v/v) 1,4-diazobicyclo-[2.2.2]-octane 
(DABCO; Sigma).  
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2.10.3 Estimation of S-phase fraction and phase by EdU labelling 
HDFs were synchronised in G0 as described above and transfected with negative 
control, LAP2α or lamin A/C siRNA on coverslips. In order to visualise replication 
factories, 23 hours post-transfection, and every three hours thereafter, HDFs were 
labelled for 1 hour with EdU (5-ethynyl-2’-deoxyuridine) to a final concentration of 
10 µM for 1 hour. After the 1 hour labelling period, HDFs were washed with PBS, 
fixed and permeabilised as described above. To detect EdU incorporation, 
coverslips were incubated with 50 µl Click-iT reaction cocktail for 30 minutes at 
room temperature according to the manufacturer’s instructions (Invitrogen). 
Coverslips were then mounted onto glass slides with DNA visualised using DAPI 
as described above. 
2.10.4 Confocal microscopy 
Micrographs of immunostained cells were taken with a confocal imaging system 
(LSM510 Meta; Carl Zeiss MicroImaging Inc) with LSM510 image browser 
software equipped with a 40x / 1.3 oil-immersion lens and photomultiplier tube. A 
dynamic range adjustment was used to optimize the signal for the fluorophores, 
and images were collected in multichannel mode. Images were imported into 
ImageJ, where they were merged and scale bars added before subsequent 
collation using Adobe Photoshop 7.0.  
2.10.5 ImageJ manipulation of micrographs  
For fluorescence signal profiles, fluorescence output along defined paths was 
determined using the ‘Plot Profile’ macro in the ImageJ software package. 
Alternatively, fluorescence signal intensity of defined regions was measured using 
the polygon selection tool in ImageJ. Non-specific background fluorescence was 
subtracted from results. Data was then exported into Excel for statistical analysis. 
Nuclear outlines were produced using the ‘Threshold’ and ‘Find Edges’ functions 
in ImageJ.   
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2.11 In situ nuclear matrix preparation 
The sequential treatment of HDFs on coverslips with detergents, nucleases and 
salt was essentially as described (Pekovic et al., 2007). All buffers contained 
freshly added protease inhibitor cocktail (Sigma). HDFs were grown for 48-72 
hours on coverslips before treatment with IR (3 Gy) and allowed to recover for 1 
hour. Cells were then washed twice with ice-cold PBS before the addition of 
CSK/T (see 2.7.3) for 10 minutes at 4ºC. Cells were then incubated in extraction 
buffer (see 2.7.3) for 5 minutes at 4ºC. To digest DNA, coverslips were then 
incubated in digestion buffer with the addition of 500 U/ml DNase I (Sigma) for 30 
minutes at room temperature. Cells were then incubated in extraction buffer to 
terminate the digestion for 5 minutes at 4ºC. HDFs were fixed at various times 
during the extraction procedure (i.e. unextracted, CSK/T and after the last 
extraction buffer step) and processed for immunofluorescence as described 
above. 
2.12 Senescence-associated β-galactosidase assay 
The Senescence β-Galactosidase Staining Kit was purchased from Cell Signaling 
to histochemically detect β-galactosidase activity in cells at pH 6 (Dimri et al., 
1997). Cells were washed once with PBS and fixed with a mixture of 2% 
formaldehyde and 0.2% glutaraldehyde in PBS for 15 minutes at room 
temperature. Cells were washed twice with PBS and then stained overnight at 
37ºC with 40 mM citric acid/sodium phosphate [pH 6.0], 150 mM NaCl, 2 mM 
MgCl2, 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide and 1 mg 5-
bromo-4chloro-3-indolyl-βD-galactopyranoside (X-gal). Cells were then checked 
under the microscope for the development of blue colour and, for long-term 
storage, the staining solution was removed and cells were overlaid with 70% 
glycerol and stored at 4ºC. 
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2.13 Clonogenic assay 
The colony formation assay was performed exactly as described (Franken et al., 
2006). U2OS cells were transfected twice in 24 hours with siRNA and then 
harvested by trypsinisation after 48 hours from the initial transfection. Cells were 
counted and then plated by serial dilution into 60mm culture dishes. The initial 
seeding density (100-1000) was dependent upon the severity of the treatment as 
judged by preliminary experiments. Cells were allowed to adhere for 
approximately 24 hours and then treated with the indicated dose of IR. Cells were 
returned to the incubator for 12 days. After this time dishes were washed once 
with PBS before staining with a solution of 6% glutaraldehyde (vol/vol) and 0.5% 
crystal violet (wt.vol) in dH2O for 30 minutes at room temperature. Dishes were 
then rinsed and the number of colonies formed counted. The surviving fraction at 
each IR dose was calculated based on the plating efficiency of the untreated 
plates.  
2.14 Laser micro-irradiation 
To induce localised tracts of double-strand breaks, a protocol was adapted from 
established methods (Lukas et al., 2003). Cells were grown in a 2-well Lab-tek II 
chamber slide system and pre-sensitised by incubation with 10µM BrdU (Sigma) 
in phenol-free 10% DMEM (Invitrogen) for 24 hours prior to laser irradiation. Cells 
were then mounted on the stage of a Zeiss Axiovert 200 microscope integrated 
with the PALM microbeam workstation (P.A.L.M. Laser Technologies, Bernried, 
Germany). Cells were visualized under visible light and nuclei were targeted using 
the supplied software. The irradiation was carried out with a pulsed nitrogen laser, 
set at 50% power output, which was coupled to the bright field path of the 
microscope and focussed through a LD 40x NA 0.55 Zeiss objective to produce a 
beam width of approximately 1 µm. Some 50-150 cells were irradiated within 5 
minutes with each cell exposed to the laser for less than 500-ms, before being 
immediately returned to a 37ºC 5% CO2 incubator. Cells were then fixed at the 
times indicated in the text and processed for immunofluorescence as outlined 
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above. Three independent experiments were performed to confirm the validity of 
the observations with non-irradiated cells acting as an internal control for the 
effect of the induced DNA damage and the antibodies used in the experiment. 
2.15 Statistical analysis 
Graphs were produced in Excel (Microsoft) and the standard deviation calculated 
using the same software. To determine any statistical significance between the 
results a two-tailed Student t test was carried out using Excel.  
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Table 1. Antibodies used in this study.  
(IF = immunofluorescence; IB = immunoblotting; m = monoclonal; p = polyclonal) 
Antibody Name Target Antibody Type Dilution Source 
IF IB  
Jol2 
 
Lamin A/C 
 
Mouse (m) 
 
1:200 
 
1:200 
5% Milk 
Dyer et al., (1997) 
Jol4  Lamin A Mouse (m) Undiluted 1:10 Dyer et al., (1997) 
636 Lamin A/C Mouse (m) 1:5000 
 
 
 
Santa  Cruz 
RαLA Lamin A  Rabbit (p) 1:5000 
 
1:2000 
5% milk 
Sigma 
133A2 Lamin A Mouse (m) 1:500 
 
 Immuquest 
RαLC Lamin C Rabbit (p) 1:2000 
 
 Immuquest 
LAP15 
 
LAP2α 
 
Mouse (m) 1:10 
 
1:100 
5% milk 
Dechat et al., (1998) 
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IQ175 LAP2α Rabbit (p) 1:2000 1:2000    
5% milk 
Immuquest 
AC-40 β-actin Mouse (m)  
 
1:2000 
5% milk 
Sigma 
JBW301 
 
Phospho-histone 
H2AX (Ser139) 
Mouse (m) 1:500 
 
1:1000 
5% milk 
Upstate 
2577 Phospho-histone 
H2AX (Ser139) 
Rabbit (p) 1:100  Cell Signalling 
Phospho-Chk2 (Thr68) Phosphothreonine 68 Rabbit (p) 1:100 
 
1:1000 
5% milk 
Cell Signalling 
NB100-304 Total 53BP1 Rabbit (p) 1:500 
 
1:2000 
5% milk 
Novus Biologicals 
Ki67 Ki67 Rabbit (p) 1:200 
 
 Dako 
WA3 β-tubulin Mouse (m)  1:1000 
5% milk 
Kind gift from  
Dr.  Karakesisoglou  
(University of Durham) 
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H-92 Rad51 Rabbit (p) 1:50 1:200 
5% milk 
Santa Cruz 
F-7 HA-tag Mouse (m)  1:200 
5% milk 
Santa Cruz 
Anti-GFP GFP-tag Mouse (m)  1:5000 
5% milk 
Roche 
ATM/ATR substrate 
motif  
Phospho-SQ/TQ Rabbit (p)  1:500 
5% BSA 
Cell Signalling 
H2A Histone H2A Rabbit (p)  1:1000 
5% BSA 
Cell Signalling 
2D9A12 p16INK4a Mouse (m)  1:1000 
5% milk 
Abcam 
PC-10 PCNA Mouse (m)  1:5000 
5% milk 
Abcam 
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CHAPTER 3:                                                                
LAMIN A MODULATES THE CELLULAR RESPONSE TO 
OXIDATIVE STRESS 
3.1 Introduction 
3.1.1 Overview 
Aging affects nearly all metazoans, thus how and why organisms age has been, 
and will continue to be, widely and extensively researched throughout the world 
(Kenyon, 2005; Kirkwood, 2005). In the UK, 16% of the population were aged 65 
and over in 2009, with this estimated to rise to 23% by 2034 
(www.statistics.gov.uk). Furthermore, the number of people aged over 85 was ~ 
660,000 in 1984 and whilst the number reached 1.4 million in 2009, it is estimated 
that by 2034 this number will have reached 3.5 million people, accounting for 5% 
of the population. Importantly, age is a major risk factor associated with a number 
of medical conditions, most notably, cancer, cardiovascular disease, type II 
diabetes, pulmonary disease, stroke, dementia and arthropathies. Therefore, 
understanding the fundamental biological pathways that govern aging is essential 
for improved medical care necessary to provide healthcare for our aging 
population.  
3.1.5 The role of A-type lamins in senescence and aging 
Progeroid syndromes are diseases characterised by premature aging of one 
(unimodal) or many, but not all (segmental), tissue types. Our understandings of 
the pathways that cause premature aging provide evidence that these pathways 
may underlie the normal aging process. A-type lamins were first linked to the 
aging process by the finding that Hutchinson-Gilford progeria syndrome (HGPS), 
was caused by a point mutation in LMNA, leading to the production of a truncated 
lamin A protein called progerin (De Sandre-Giovannoli et al., 2003; Eriksson et al., 
2003). Three further premature aging diseases that may arise from mutations in 
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LMNA, atypical Werner’s syndrome (aWS), mandibuloacral dysplasia (MAD) and 
restrictive dermopathy (RD) are phenotypically similar to HGPS patients, yet 
display slightly milder symptoms (Broers et al., 2006). These diseases are part of 
a wider set of diseases, termed laminopathies, which arise from mutations of 
LMNA. Laminopathies collectively affect mesenchymal tissues and exhibit 
phenotypes that may be found in normally aged tissues, which has led A-type 
lamins to be labelled ‘guardians of the soma’ (Hutchison and Worman, 2004). 
Moreover, a range of laminopathy mouse models have reduced longevity, whilst 
RNAi of Ce-lamin in C.elegans leads to a decrease in lifespan (Haithcock et al., 
2005; Stewart et al., 2007).  
 
At the cellular level, the link between lamin A/C and senescence has been 
provided by insights from HGPS patient cells (Kudlow et al., 2007). HGPS cells 
exhibit reduced proliferative capacity in vitro, and therefore undergo senescence 
earlier than from healthy donors (Goldman et al., 2004; Liu et al., 2011). 
Importantly, normal human cells, from both young and old individuals, expressed 
a basal level of progerin by sporadically activating the same cryptic splice site 
found in HGPS cells (Scaffidi and Misteli, 2006). Coupled to this, human 
fibroblasts from old patients exhibited increased nuclear abnormalities, which is 
correlated with reduced nucleoplasmic lamin A/C levels and reduced levels of 
HP1γ and H3K9 methylation (Scaffidi and Misteli, 2006). Furthermore, progerin 
expression was found in skin tissues from healthy aged individuals (McClintock et 
al., 2007). In contrast to this, one study has found decreased expression of lamin 
A in different cell types of old mice (Duque et al., 2006).   
3.1.6 Current aims 
Various studies suggest that a number of mechanisms could be at work by which 
prelamin A may influence cellular senescence. However, no study so far has 
addressed the role, if any, that mature lamin A plays in cellular senescence. 
Therefore, in this chapter I explore the role of mature lamin A in cellular 
senescence with further exploration of its role in the oxidative stress response.  
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3.2. Senescence-associated hyper-oxidation of cysteine residues 
in the lamin A tail 
Human dermal fibroblasts (HDFs) that have been aged in vitro to reach replicative 
senescence exhibit a range of dysmorphic nuclear shapes that are reminiscent of 
those observed in fibroblasts from patients with Hutchinson-Gilford Progeria 
Syndrome (HGPS) (Supplementary Figure 1a-c) (Goldman et al., 2004). To 
assess if altered protein levels of lamin A/C and lamin B2 contributed to this 
cellular phenotype, cellular extracts were prepared from wild type HDFs at 
different population doublings. Immunoblotting revealed that total protein levels of 
lamin A/C and lamin B2 were unchanged during cellular aging, ruling out the 
possibility that the increased dysmorphic nuclear shapes observed in senescent 
cells were due to altered protein levels (Supplementary Figure 1d). Previous 
studies have shown that oxidative damage during cellular aging can lead to 
protein unfolding (Friguet, 2006) and that protein thiols are prime targets of 
oxidative modifications (Eaton, 2006). I therefore investigated whether lamin A/C 
could be a target of oxidative thiol damage in during the aging of HDFs in vitro, 
which might account for the accumulation of dysmorphic nuclei. To assess the 
potential contribution of thiols, multiple sequence alignments of lamins A, C, B1 
and B2 revealed that lamin A contains three unique cysteine residues (C570, 
C588 and C591) in its specific C-terminal tail domain and shares a single cysteine 
residue with lamin C in the common IgG domain (C522), whilst none of these 
cysteine residues are present in lamins B1 or B2 (Figure 3.1a). Importantly, three 
cysteines (C522, C588 and C591) are conserved throughout the mammalian 
phylogeny (Figure 3.1b). 
 
Cysteine residues in proteins can form disulfide bonds under oxidizing conditions, 
which can be detected on non-reducing SDS-PAGE as slower-migrating protein 
species, for inter-molecular complexes, or faster-migrating protein species for 
intra-molecular disulfide bonds (Benham et al., 2000). To investigate the 
availability of cysteine residues to form disulfide bonds in lamins A/C, cell extracts 
from HDFs at increasing population doublings (p12, p24 and p40) were resolved 
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on non-reducing or reducing SDS-PAGE and probed with anti-lamin A (Jol4) and 
anti-lamin C (RαLC) antibodies. Under non-reducing conditions lamin A was 
weakly detected as a monomer in young (p12) HDFs but exhibited two band shifts 
to the positions of the slower-migrating lamin A homodimer and faster-migrating 
protein species (Figure 3.2a). Under reducing conditions, lamin A was detected 
only as a monomer across all three population doublings confirming that both the 
slower- and faster-migrating bands of lamin A in young (p12) HDFs were disulfide-
dependent (Figure 3.2a). A progressive decline in the amounts of both inter- and 
intra-molecular disulfide species with increasing population doublings was 
coupled to the accumulation of lamin A monomers at p40 (Figure 3.2a). In 
contrast to lamin A, lamin C migrated as a monomer across all three population 
doublings under both non-reducing and reducing conditions (Figure 3.2b). These 
findings suggest that the cysteine residues in the lamin A tail promote both inter 
and intra-disulfide bond formation (Figure 3.2c). Note the inter-molecular bonds 
could form with other lamin A polypeptides or with other lamin A binding proteins 
(e.g. LAP2α). Lastly, as HDFs age in vitro, cysteine residues in lamin A become 
progressively less available for forming disulfide bonds. 
 
Protein thiols can undergo different degrees of oxidation, which can be either 
reversible (sulfenic acid) or irreversible (sulfinic and sulfonic acids) (Poole et al., 
2004) (Supplementary Figure 2). To investigate if cysteine residues in lamin A 
become irreversibly oxidized in senescent HDFs, and therefore explain why they 
become progressively less available for forming disulfide bonds as HDFs age, 
MALDI-TOF/TOF peptide mass fingerprinting in conjunction with reductive thiol-
trapping alkylation was used. Three cysteine-containing peptides of lamin A were 
identified in the Mascot database: αα516-27, which contains C522, and αα585-97 
and αα583-97 (the latter having one missed cleavage site at R585), both 
containing C588 and C591 (Figure 3.2d). In young (p12) HDFs, the observed and 
predicted masses of each peptide corresponded to the mass difference of either 
one (αα516-27) or two (αα583-97 & αα585-97) alkylation adducts, indicating an 
absence of reduction-resistant oxidative modifications (Figure 3.2d). In contrast, in 
senescence (p40) HDFs, the observed and predicted peptide masses differed by 
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32Da (αα516-27) or 48Da + a mass of one alkylation adduct (αα583-97 & αα585-
97) (Figure 3.2d). The observed peptide modifications were resistant to DTT 
reduction and corresponded to those expected for irreversible oxidation to sulfinic 
(SO2H) and sulfonic (SO3H) acids respectively. Together, this data shows that 
lamin A cysteines are targets of irreversible oxidative modifications in senescent 
(p40) HDFs, which most likely explains the observed decrease in disulfide bond 
formation under oxidizing conditions shown previously. 
 
HDFs from old individuals also display increased dysmorphic nuclei similar to 
senescent HDFs from young individuals (Scaffidi and Misteli, 2006). Therefore, to 
interrogate the ability of lamin A cysteine residues to form disulfide bonds in HDFs 
from old individuals, cell extracts were resolved on non-reducing or reducing SDS-
PAGE and probed with anti-lamin A (Jol4) antibody as described previously. 
Under non-reducing conditions, HDFs from an old individual (aged 84) displayed a 
reduction in both the slower-migrating lamin A homodimer and faster-migrating 
protein species (Figure 3.3a). Quantification of band intensities revealed 
reductions of ~70% and ~50%, respectively, for inter- and intra-disulfide bond 
formation (Figure 3.3b). Under reducing conditions, lamin A migrated as a 
monomer, confirming that both the slower- and faster-migrating bands of lamin A 
in HDFs were disulfide-dependent (Figure 3.3a) In sum, this extends the previous 
findings and suggests that reduced lamin A disulfide bond formation may occur in 
vivo during the normal aging of healthy individuals. 
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Figure 3.1. Conserved cysteine residues in the lamin A C-terminal. (a) 
Multiple sequence alignment of the C-terminal regions from human A- and B-type 
lamins. Cysteine residues are labelled as follows: a single cysteine common to the 
IgG domain of lamins A and C (purple), three lamin A specific cysteines (red) and 
a CAAX-box associated cysteine (green). (b) A-type lamin C-terminal sequence 
alignment of various mammalian species with labelling as in (a). 
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Figure 3.2. Hyper-oxidation of lamin A tail thiol residues in senescent 
fibroblasts. (a,b) Protein extracts from p12-40 HDFs were subjected to non-
reducing or reducing SDS-PAGE and immunoblotted against Jol4 (a) to detect 
lamin A or RαLC (b) to detect lamin C. Thick arrow, lamin A (72kDa); thin arrow, 
lamin A intra-molecular disulfide (~67kDa). *, lamin A inter-molecular disulfide 
(~144kDa). (c) Cartoon showing redox-dependent formation of lamin A intra- and 
inter-molecular disulfides (S-S). Note the inter-molecular bonds could form with 
other lamin A polypeptides or with other lamin A binding proteins (e.g. LAP2α). 
SH, cysteine sulfhydryl group. (d) MALDI-TOF/TOF peptide mass fingerprinting of 
lamin A peptides isolated from p12 and p40 HDF in the presence of NEM. Three 
lamin A cysteine-containing peptides αα516-27 (C522), αα583-97 and αα585-97 
(C588 and C591) were identified in Mascot database (C570-containing peptide 
was not detected and could not be analysed). The mass differences (in daltons) 
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between observed and predicted peptide mass peaks, the amino acid sequence 
of modified peptides and their corresponding modifications are listed. SO2H = 
sulfinic acid, SO3H = sulfonic acid. 
 
 
Figure 3.3. Age-dependent modifications to lamin A cysteine residues 
inhibit disulfide bond formation. (a) HDF protein extracts from young and old 
individuals were subjected to either non-reducing or reducing SDS-PAGE and 
immunoblotted with anti-lamin A (Jol4) antibody. Representative blots were 
selected from two repeat experiments using two young and three old donors. 
Thick arrow, lamin A; *, lamin A inter-molecular dimers; thin arrow, lamin A intra-
molecular disulfides. (b) Optical densitometry of non-reducing blots was 
performed to determine the relative proportion of inter-molecular dimers and intra-
molecular disulfides in protein extracts from young and old donors and the values 
obtained for protein bands were normalised to those of the corresponding 
monomeric lamin A. 
 
 
 
 
 
 
132 
 
 
3.3 Temporary cell cycle arrest of HDF in response to mild 
oxidative stress is correlated with disulfide bond formation in 
lamin A.    
HDFs enter a state of stress induced premature senescence (SIPS) following 
exposure to high levels of oxidative stress, whilst exposure to mild oxidative 
stresses elicits a protective stress response leading to temporary growth arrest 
(Davies, 1999). Furthermore, it has been proposed that the formation of disulfide 
bonds may act as part of a protective response to mild oxidative stress (Eaton, 
2006). Hydrogen peroxide (H2O2) is the most widely used pro-oxidant as it is 
produced physiologically and serves as an essential second messenger in redox 
signalling (Toussaint et al., 2000). Since I have shown that lamin A forms disulfide 
bonds in young HDFs but not in senescent HDFs, I investigated whether lamin A 
forms disulfide bonds in vivo in response to oxidative stress. Based on the prior 
data and the above hypotheses of Davis et al. and Eaton, I anticipated that mild 
oxidative stress would cause a temporary cell cycle arrest and the formation of 
lamin A disulfide bonds, whereas excessive oxidative stress would cause entry 
into a senescent state and inhibit the formation of lamin A disulfide bonds.  
 
Firstly, I assessed the proliferation of HDFs in the presence of either low or high 
levels of oxidative stress. Young (p12) HDFs were treated in vivo with either 
150µM or 350µM H2O2 alone, or following anti-oxidant pre-treatment with N-acetyl 
cysteine (NAC) (Figure 3.4a). The viability of HDFs was not affected by any of the 
treatments (not shown). After the treatments, HDFs were either cultured for 72h or 
were reseeded and cultured for an additional 24h, before being assessed for 
cellular morphology, expression of proliferation markers, expression of 
senescence-associated β-galactosidase (SA β-gal) activity and nuclear 
morphology. In response to 150µM H2O2 alone, HDFs entered a state of growth 
arrest, demonstrated by reduced expression of the proliferation marker Ki67 
(<30%) (Figure 3.4b). The growth arrest was readily reversible following 
reseeding in the absence of H2O2, as assessed by the spindle-shaped cell 
morphology (Figure 3.4a) and a high Ki67+ index (>70%, Figure 3.4b). Treatment 
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of HDFs with 150µM H202 did not affect nuclear morphology (Figure 3.4e) or 
induce expression of SA β-gal (Figure 3.4d). In contrast, in response to 350µM 
H2O2, HDFs entered a state of stress induced premature senescence as shown 
by a flattened cell morphology (Figure 3.4a), greatly reduced Ki67 labelling 
(<20%, Figure 3.6c) and high SA β-gal activity (>50%, Figure 3.4d). Notably, none 
of these phenotypes was reversed by re-seeding in the absence of H2O2. 
Premature entry into a senescent state was correlated with greatly increased 
numbers of abnormally shaped nuclei (Figure 3.4e). Pre-treatment of HDFs with 
the free radical scavenger N-acetyl cysteine (NAC) prevented both the transient 
effects of 150µM H2O2 and the senescence inducing effects of 350µM H2O2 
(Figure 3.4a-e).  
 
To analyse the ability of lamin A to form disulfide bonds in response to oxidative 
stress, young (p12) HDFs were treated with either 150µM or 350µM H2O2 in vivo. 
Cell extracts were prepared in the presence of the alkylating agent N-
ethylmaleimide (NEM) and resolved on non-reducing or reducing SDS-PAGE. In 
untreated cells, both faster and slower migrating forms of lamin A were weak but 
detectable with an anti-lamin A (Jol4) antibody (Figure 3.4f). The detection of the 
faster and slower migrating bands increased significantly after treatment with 
150µM H2O2, suggesting enhanced intra- and inter-disulfide bond formation in 
response to mild oxidative stress (Figure 3.4f). Neither species was detected in 
the presence of 350µM H202, suggesting that thiol residues were unavailable for 
disulfide bond formation (Figure 3.4f). Under reducing conditions, lamin A was 
detected as a monomer after each H2O2 treatment confirming that the slower and 
faster migrating species were disulfide-dependent (Figure 3.4f). Importantly, 
following NAC pre-treatment there was no increase in  the level of disulfide bonds 
formation in the presence of 150µM H2O2, neither was there any elimination of 
disulfides following 350µM H2O2 (Supplementary Figure 3). Taken together, these 
findings show that in response to mild oxidative stresses HDFs enter a state of 
temporary cell cycle arrest, which is correlated with disulfide bond formation in 
lamin A. Moreover, in the absence of effective ROS scavenging, high levels of 
oxidative stress promote stress induced premature senescence and this is 
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correlated with the appearance of dysmorphic nuclei and absence of disulfide 
bond formation in lamin A. 
3.4 HDF are hypersensitive to ROS stimulation in the absence of 
lamin A. 
Whilst the data presented thus far has determined a correlation between 
senescence and oxidation of lamin A cysteine residues preventing intra- and inter-
disulfide bond formation, senescence is also correlated with the appearance of 
dysmorphic nuclei. One interpretation of this may be the presence of non-
functional lamin A in the nuclear lamina. Thus, to determine the role of lamin A in 
cellular senescence, I investigated the cellular response to mild oxidative stress in 
HDFs harbouring a homozygous mutation Y259X in the LMNA gene, which are 
null for expression of lamins A/C (Muchir et al., 2003). I hypothesized that in the 
absence of lamin A, these HDFs would be more sensitive to mild oxidative 
stresses and therefore have an increased likelihood of undergoing stress induced 
premature senescence instead of temporary growth arrest. Wild-type and Y259X 
HDFs were either left untreated or treated in vivo with 150µM H2O2 and analysed 
for their proliferative capacity, SA β-gal activity and nuclear morphology. As 
observed previously, Y259X HDFs showed a reduced Ki67 proliferative index and 
an increased percentage of dysmorphic nuclei and SA β-gal activity when 
compared to wild type HDFs (Figure 3.4g-i) (Pekovic et al., 2007). In response to 
150µM H2O2, wild-type HDFs entered a growth arrest as shown by a ~2.5 fold 
reduction in expression of Ki67, but re-entered the cell cycle following reseeding 
as shown by re-expression of Ki67 (Figure 3.4g). Treatment of wild type HDFs 
with 150µM H2O2 did not induce either SA β-gal activity or the appearance of 
dysmorphic nuclei (Figure 3.4h,i). In contrast, treatment of Y259X HDFs with 
150µM H2O2 led to a ~2 fold reduction in Ki67 expression that was not reversible 
following re-seeding (Figure 3.4g), and caused them to enter stress induced 
premature senescence as shown by a >2 fold increase in both SA β-gal activity 
and the percentage of dysmorphic nuclei (Figure 3.4h,i). Taken together, these 
results suggest that lamin A is essential for cellular resilience to oxidative stress. 
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Figure 3.4. The effects of mild and SIPS-inducing oxidative stress on lamin 
A disulfide bridge formation, nuclear morphology and growth. (a-e) HDFs 
were treated with 150 or 2x 350µM H2O2 alone or after pre-incubation with 10mM 
NAC. (a) Phase contrast images were taken within one week of H2O2 treatments 
(left and middle panels), or following additional reseeding for 24h (right panels). 
Bar, 20µm. (b) The fraction of Ki67 +ve nuclei determined before reseeding. (c) 
The fractions of Ki67 +ve nuclei, (d) SA β-gal +ve HDFs and (e) dysmorphic 
nuclei determined after reseeding. (f) Protein extracts from 150, 250 or 2x 350µM 
H2O2-treated HDFs were prepared with 40mM NEM, resolved on non-
reducing/reducing SDS-PAGE and probed with JoL2. Thick arrow, lamin A 
(72kDa); arrowhead, lamin C (65kDa); thin arrow, lamin A intra-molecular disulfide 
(~67kDa); *, lamin A inter-molecular dimer (~144kDa). (g-i) Wild-type and lamin 
A/C -/- HDFs (Y259X) were left untreated or treated with 150µM H2O2 and the 
fractions of Ki67 +ve nuclei (g), SA β-gal +ve cells (h) and dysmorphic nuclei (i) 
determined before or after reseeding. Fractions were calculated by scoring 300 
cells from random fields on triplicate coverslips in three independent experiments. 
Means ± S.D. are shown. *, p<0.05 relative to 150µM H2O2-treated HDFs without 
NAC (c-e) or untreated lamin A/C -/- HDFs (g-i).  
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3.5 Loss of conserved C-terminal lamin A cysteine residues 
abrogates lamin A function and promotes cellular senescence. 
As the data has implicated lamin A in the cellular response to oxidative stress, 
which is correlated with intra- and inter-disulfide bond formation in lamin A, I 
sought to assess whether the redox-dependent disulfide bond formation in lamin 
A is associated with an adaptive response to oxidative stress. To this end, I used 
a panel of cysteine-to-alanine Flag-tagged lamin A constructs including the single 
mutants C522A, C588A, C591A, a double mutant C588/591A and a triple mutant 
C522/588/591A. Wild-type and mutant constructs were then expressed in young 
(p12) HDFs. Cell extracts were prepared in the presence of NEM and were 
resolved on either non-reducing or reducing SDS-PAGE and immunoblotted with 
anti-Flag or anti-lamin A (Jol4) antibodies. Under non-reducing conditions, Flag-wt 
lamin A was detected as a monomer as well as the slower and faster-migrating 
protein bands, indicating the formation of both intra- and inter-molecular disulfide 
bonds (Figure 3.5a). Mutants C588A and C591A also formed intra and inter-
molecular disulfide bonds (Figure 3.5a). In contrast, whilst mutant C522A readily 
formed inter-molecular disulfides, intra-molecular disulfides were undetectable 
(Figure 3.5a). Furthermore, disulfide bond formation was nearly undetectable in 
the double mutant (C588/591A) and completely undetectable in the triple mutant 
(C522/588/591A) (Figure 3.5a). As expected, Flag-lamin A proteins migrated as 
monomers under reducing conditions (Figure 3.5b). The level of over-expression 
of lamin A was then investigated by immunoblotting with an anti-lamin A (Jol4) 
antibody. The results indicated that on average there was a ~2 fold increase in the 
level of lamin A following transfection, suggesting an approximate 1:1 ratio of 
endogenous compared to Flag-lamin A (Figure 3.5c). This panel of lamin A 
constructs were therefore used to determine which cysteine residues in lamin A 
were important for cellular resilience to ROS and in determining whether disulfide 
bond formation is a component of an adaptive cellular response to oxidative 
stress. 
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Figure 3.5. Cysteine-to-alanine mutations differentially affect lamin A 
disulfide formation. (a-b) HDF were transfected with Flag-wt or one of five 
different Flag-cys-ala lamin A constructs. Protein extracts prepared in the 
presence of NEM were resolved on non-reducing (a) or reducing (b) SDS-PAGE 
and probed with anti-Flag M2 antibodies. Lanes contain untransfected control (-), 
wild type lamin A (WT), C522A, C588A, C591A single lamin A mutants, 
C588/591A double lamin A mutant or C522/588/591A triple lamin A mutants. 
Arrowhead, lamin A monomer; arrow intra-molecular disulfide species; *, inter-
molecular disulfides species. (c) HDF were transfected with the same constructs 
and probed with anti-lamin A (133A2) or anti-β-actin antibodies. The graph shows 
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the fold expression of cys-ala lamin A protein relative to endogenous lamin A in 
untransfected control and normalized to β-actin following optical densitometry. 
 
 
In order to investigate the effects of the lamin A mutants on nuclear morphology 
and cellular proliferation, young HDFs (p12) were transfected with either Flag-wild 
type (Flag-wt) lamin A or one of the cysteine-to-alanine lamin A mutants. As 
expected, Flag-wt lamin A localised both to the nuclear envelope and to the 
nucleoplasm and >85% of transfected HDFs showed normal nuclear morphology 
(Figure 3.6a,b). Each of Flag-C522A, C588A and C591A lamin A also localised 
strongly to the nuclear envelope and transfected HDFs displayed normal nuclear 
morphology (Figure 3.6a,b). Flag-C588/591A lamin A also localised to the nucleus 
but displayed elevated (~20% of transfected cells) levels of nuclei containing 
aggregates of Flag-tagged proteins (Figure 3.6a,b). In contrast, expression of 
Flag-C522/588/591A lamin A resulted in gross disorganisation within nuclei and 
~45% of transfected HDFs displayed dysmorphic nuclear shapes (Figure 3.6a,b). 
A range of assays were then utilised to assess the affect of each mutant on 
proliferation and senescence. Firstly, the Ki67 index, a marker of actively dividing 
cells, and proliferation rates of HDFs did not differ significantly following 
transfection with Flag-wt, C522A, C588A or C591A lamin A (Figure 3.6c,d). 
Transfection with Flag-C588/591A lamin A did not significantly affect the 
proliferation index but did significantly impair the growth rate of HDFs (Figure 
3.6c,d). Finally, transfection with Flag-C522/588/591A lamin A significantly 
reduced the proliferation index (to <40%) and halved the growth rate of HDF when 
compared Flag-wt lamin A and the single mutants (Figure 3.6c,d). I then 
investigated the possible emergence of a senescent phenotype to account for the 
reduced Ki67 and growth rates, either by expression of SA β-gal or by cell 
morphology. Consistent with the above findings, only HDFs expressing Flag-
C522/588/591A lamin A were able to induce cellular senescence in a significant 
fraction (>25%) (Figure 3.6e). Furthermore, only HDFs expressing Flag-
C522/588/591A lamin A exhibited a flattened enlarged cellular morphology, 
indicative of entry into senescence (Figure 3.6f) (Dimri et al., 1995). Taken 
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together, this data suggests two important results. Firstly, the ability of lamin A to 
form intra- and inter-molecular disulfide bonds is not directly linked to entry into a 
senescent state, since neither the expression of Flag-C522A lamin A (which is 
unable for form intra-molecular disulfide bonds) nor Flag-C588/591A lamin A 
(which is unable for form any disulfide bonds) were able to induce a senescent 
phenotype, although the Flag-C588/591A lamin A mutant does impair growth 
rates. Secondly, the loss of all three C-terminal cysteine residues generates a 
phenotype that is remarkably similar to a lamin A null phenotype suggesting a 
complete abrogation of lamin A function (compare Figures 3.4 and 3.6). 
 
 
 
 
 
 
 
 
Figure 3.6. A triple lamin A mutant C522/588/591A impairs cellular fitness 
which induces premature senescence. (a) HDFs (p12) were transfected with 
Flag-wt (WT) or one of C522A, C588A, C591A, C588/591A or C522/588/591A 
lamin A constructs and immunostained with anti-Flag M5 antibody and DAPI. 
Micrographs are displayed as two-colour merged images (Flag, red; DAPI, blue). 
Scale bar = 10µm. The fraction of Flag +ve cells showing dysmorphic nuclei (b) or 
Ki67 ve+ cells (c) for each construct used is shown. Fractions were calculated by 
counting 300 cells from triplicate coverslips in three independent experiments. (d) 
Growth curves of cells transfected with WT, or each of the cys-ala lamin A 
mutants. (e) The fractions of SA β-gal +ve transfected HDFs were calculated by 
counting 300 cells in triplicate wells in three independent experiments. (f) Phase 
contrast images of Flag-wt, Flag-C522A C588A, C591A, C588/591A or 
C522/588/591A mutant lamin A transfected HDFs. Scale bars = 20µm. Means ± 
S.D. are shown. *, p<0.05 relative to Flag-wt HDFs. 
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3.6 Abrogation of lamin A function by C522/588/591A causes 
ROS intolerance in HDFs 
To further investigate the finding that the lamin A mutant C522/588/591A 
abrogates lamin A function, I compared ROS generation in a broad spectrum of 
cell types with various LMNA backgrounds. These included HDFs expressing 
either Flag-wt lamin A or Flag-C522/588/591A lamin A, HDFs functionally null for 
lamin A/C (Y259X), HDFs from a HGPS patient harbouring the classical G608G 
mutation and HDFs expressing a mutant lamin A/C (R453W) that causes 
Autosomal dominant Emery Dreifuss Muscular Dystrophy (AD-EDMD). HDFs 
were treated with mild levels of oxidative stress (150µM H2O2) and the levels of 
ROS before or after treatment were determined using a ROS-sensitive fluorescent 
dye (Figure 3.7e). Representative cytograms from wild type, Y259X, G608G and 
R453W HDFs are shown (Figure 3.7a-d). In HDFs expressing Flag-
C522/588/591A lamin A, basal levels of ROS were ~3 fold higher when compared 
to HDFs expressing Flag-wt lamin A (Figure 3.7e). The presence of single lamin A 
mutants did not affect basal levels of ROS (e.g. C522A, Supplementary Figure 4). 
Upon stimulation with 150µM H2O2, ROS levels increased by ~2 fold in HDFs 
expressing Flag-wt lamin A, whereas in HDFs expressing Flag-C522/588/591A 
lamin A, ROS levels became saturated (Figure 3.7e). These data suggest that in 
the presence of Flag-C522/588/591A lamin A, ROS homeostasis is disturbed and 
HDFs become hypersensitive to oxidative stress. Similarly, the basal levels of 
ROS were ~2.5 fold higher in Y259X HDFs, compared to those expressing Flag-
wt lamin A, and increased still further upon stimulation with H2O2 (Figure 3.7e). In 
contrast, whilst HDFs expressing progerin or R453W displayed basal levels of 
ROS that were ~1.5 fold higher than controls, upon stimulation with H2O2 ROS 
levels were only slightly elevated and did not exceed the levels observed following 
H2O2 stimulation in the controls (Figure 3.7e). Importantly, pre-treatment of HDFs 
with the ROS scavenger NAC abrogated the effects of H2O2 stimulation in all 
cases (Figure 3.7e). I also investigated ROS levels in HDFs from patients with X-
linked EDMD, which are null for the inner nuclear membrane protein emerin and 
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from patients with Greenberg Dysplasia, which are null for the inter nuclear 
membrane protein Lamin B receptor (LBR). I found that both basal levels and 
stimulated levels of ROS were identical to controls (Supplementary Figure 5 and 
data not shown). Taken together, these data suggest that hypersensitivity to 
oxidative stress is a phenotype that occurs specifically due to the loss of 
conserved cysteine residues in the lamin A tail or absence of lamin A, rather than 
the general NE defects or with disease associated mutations in the LMNA tail 
domain. To confirm this finding, I also investigated the cellular responses to mild 
oxidative stress in HDFs from HGPS and AD-EDMD, harbouring G608G and 
R453W mutations, respectively. As for wild type HDFs, both the G608G and 
R453W HDFs entered a reversible cell cycle arrest following stimulation with 
150µM H202 (Figure 3.7f) and this treatment did not significantly increase the 
fraction of cells expressing SA β-gal (Figure 3.7g) or the percentage of 
dysmorphic nuclei (Figure 3.7h). Therefore, these data confirm that the presence 
of functional lamin A is required for resilience to cellular ROS and that elimination 
of the conserved cysteine residues in the lamin A tail abrogates lamin A function.  
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Figure 3.7. Absence of lamin A or presence of lamin A C522/588/591A 
cysteine mutant impairs ROS homeostasis in cells. (a-d) Basal intracellular 
ROS levels were determined by measuring relative DCF fluorescence in HDFs, 
Y259X, HGPS (G608G) and AD-EDMD (R453W) cells under basal conditions, 
following 200µM H2O2 stimulation for 30min, or after antioxidant treatment with 
10mM NAC. Representative cytograms are shown. (e) Data from (a-d) with the 
addition of HDFs transfected with Flag-wt or C522/588/591A lamin A (Flag-Cys). 
DCF fluorescence is expressed as % relative to Flag-wt HDFs or control HDFs 
(not shown) which is set at 100%. The increase or decrease in DCF fluorescence 
following H2O2 or NAC treatments, respectively is expressed as % relative to the 
basal level for each culture. Means ± S.D. are shown. *, p<0.05 compared to 
Flag-wt HDFs or control HDFs. (f-h) Patient HDFs expressing progerin or AD-
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EDMD mutation R453W were left untreated or treated with 150µM H2O2 and the 
fractions of Ki67 +ve cells (f), SA β-gal +ve cells (g) and dysmorphic nuclei (h) 
determined before and after reseeding. Fractions were calculated by scoring 300 
cells from random fields on triplicate coverslips in three independent experiments. 
Means ± S.D. are shown. NS = not significant when comparing untreated cells 
with 150µM H2O2-treated cells after reseeding for each culture. 
 
 
Since HDFs expressing Flag-C522/588/591A lamin A appear to be hypersensitive 
to oxidative stress, I predicted that the deleterious effects of this mutant on cell 
proliferation arose as a direct result of the increased cellular accumulation of 
ROS. To test this hypothesis, I investigated both nuclear morphology and cell 
proliferation in conditions that either increase or decrease cellular ROS. I 
assessed nuclear morphology and SA β-gal activity following stimulation with 
150µM H2O2. As expected, there was no significant increase in dysmorphic nuclei 
or SA β-gal expression (<5%) in H2O2-treated HDFs expressing Flag-wt lamin A 
(Figure 3.8a,b). In contrast, H2O2-treated HDFs expressing Flag-C522/588/591A 
lamin A showed increases of 23% and 14% in dysmorphic nuclei and SA β-gal 
expression, which were effectively prevented by NAC pre-treatment (Figure 
3.8a,b). Importantly, direct treatment of these fibroblasts with NAC (in the absence 
of H2O2) reduced basal levels of dysmorphic nuclei and SA β-gal activity to levels 
similar to those observed in HDFs expressing Flag-wt lamin A (Figure 3.8a,b). 
These results suggest that the induction of dysmorphic nuclei and stress induced 
premature senescence in HDFs expressing Flag-C522/588/591A lamin A results 
from higher levels of ROS accumulating in these cells, since they could be 
prevented by exogenous treatments with anti-oxidants.  
 
Oxygen tension is another factor that can modulate cellular ROS levels (Parrinello 
et al., 2003), and under standard culture conditions oxygen tension is relatively 
high (20.6%). Cells were therefore cultured under low (5%) oxygen tension to 
investigate whether this would ameliorate the deleterious effects of expressing 
Flag-C522/588/591A lamin A. A comparison between basal ROS levels in HDFs 
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expressing Flag-wt lamin A and Flag-C522/588/591A lamin A revealed that, as 
previously observed, under standard culture conditions, basal ROS levels were 
significantly higher in HDFs expressing Flag-C522/588/591A lamin A mutant 
compared to Flag-wt lamin A (Figure 3.8c). In contrast, basal ROS levels in HDFs 
expressing the mutant were reduced by ~2.5 fold in 5% oxygen as compared to 
20.6% oxygen (Figure 3.8c). Similar reductions in cellular ROS were also 
observed following pre-treatment with NAC (Figure 3.7). Since ROS are major 
inducers of DNA damage, which is known to result in senescent arrest 
(Gorbunova et al., 2002), I examined whether increased ROS levels in HDFs 
expressing Flag-C522/588/591A lamin A were accompanied with the formation of 
DNA damage foci. When grown under standard oxygen tension, the fraction of 
cells displaying DNA damage foci was ~3 fold greater in HDFs expressing Flag-
C522/588/591A lamin A compared to HDFs expressing Flag-wt lamin A (Figure 
3.8d). As expected, the fraction of HDFs displaying DNA damage foci declined 
significantly when they were grown under low oxygen tension (Figure 3.8d). 
Similarly, the levels of both dysmorphic nuclei and SA β-gal activity were also 
significantly decreased in HDFs expressing Flag-C522/588/591A lamin A in 5% 
oxygen as compared to 20.6% oxygen conditions (Figure 3.8e,f). In sum, these 
data suggests that HDFs expressing C522/588/591A lamin A have reduced 
tolerance to oxidative stress, leading to a number of deleterious cellular effects 
including accumulation of ROS, ROS-induced DNA damage and premature entry 
into senescence. Moreover, deleterious cellular effects can be ameliorated either 
by application of exogenous ROS scavengers or by growth under low oxygen 
tension. This data strongly suggests that loss of the conserved cysteine residues 
in the lamin A tail reduces cellular fitness by rendering fibroblasts hypersensitive 
to ROS.  
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Figure 3.8. HDFs expressing C522/588/591A lamin A mutant show 
intolerance to mild oxidative stress. (a-b) HDFs expressing Flag-wt or 
C522/588/591A lamin A were left untreated or treated with 150µM H2O2 in the 
presence or absence of 10mM NAC. Alternatively, transfected cultures were 
treated with 10mM NAC in the absence of H2O2 stimulation. (a) The fraction of 
Flag +ve dysmorphic nuclei or (b) SA β-gal +ve cells were determined 72h after 
H2O2 stress. Fractions were calculated by scoring 300 cells on triplicate coverslips 
in three independent experiments. (c-f) Transfected HDFs were assessed under 
standard (20.6%) or low (5%) oxygen tension for basal ROS levels (c) and for 
fractions of Flag +ve nuclei showing either γ-H2AX DNA damage foci (d), 
dysmorphic nuclei (e), or SA β-gal +ve cells (f). Fractions were scored by counting 
300 nuclei on triplicate coverslips from three independent experiments. Means ± 
S.D. are shown. *, p<0.05 relative to untreated Flag-C522/588/591A lamin A 
HDFs (a-b), or Flag-wt lamin A HDFs at 21% O2 (c-f). **, p<0.05 relative to 
untreated Flag-C522/588/591A lamin A HDFs (a-b), or Flag- C522/588/591A 
HDFs at 21% O2 (c-f). 
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3.7 Mild oxidative stress stimulates over-expression of AP-1 
genes in the presence of Flag-C522/588/591A lamin A or absence 
of   lamin A 
The previous data shows that the absence of lamin A or the presence of a lamin 
mutant lacking conserved C-terminal cysteine residues causes ROS intolerance. 
To begin to understand the mechanism behind ROS intolerance, I investigated 
whether expression of transcription factors that can activate anti-oxidant enzymes 
or expression of the genes encoding the anti-oxidant enzymes themselves is 
impaired in HDFs null or expressing various forms of LMNA. To assess this, 
qPCR was used to quantify the expression of these genes in the presence or 
absence of mild oxidative stress (150µM H2O2) in HDFs expressing Flag-wt lamin 
A or Flag-C522/588/591A lamin A, and also in  HGPS HDFs harbouring the 
classical G608G mutation and in lamin A null (Y259X) HDFs. The expression 
levels of all the genes assessed were similar in HDFs expressing Flag-wt lamin A 
and HGPS HDFs (Figure 3.9). In contrast, in HDFs expressing Flag-
C522/588/591A lamin A or HDFs null for lamin A (Y259X), genes in the AP-1 and 
NF-κB family, c-fos and p65, were both significantly up-regulated following mild 
oxidative stress, although levels of expression of Sp1 were similar to controls 
(Figure 3.9). The likely down-stream targets of AP-1 and NF-κB, including 
manganese superoxide dismutase (MnSOD), catalase (CAT) and glutathione S-
transferase (GST) were also all significantly up-regulated following mild oxidative 
stress in both HDFs expressing Flag-C522/588/591A lamin A and HDFs null for 
lamin A (Y259X), suggesting that the anti-oxidant defence pathways were 
activated (Figure 3.9). Interestingly, the level of activation of c-fos, which exhibited 
a ~6 fold activation following oxidative stress, has previously been reported only in 
response to chronic (500µM H2O2) oxidative stress (Chaum et al., 2009). Taken 
together, whilst these data do not reveal the mechanism behind ROS intolerance 
they do confirm our hypothesis that loss of lamin A function does lead to 
hypersensitivity to and intolerance of ROS.  
 
150 
 
 
 
Figure 3.9. C522/588/591A lamin A mutant induces expression of many 
stress-responsive genes. HDFs expressing Flag-wt lamin A and Flag-
C522/588/591A lamin A as well as patient HDFs expressing progerin or that are 
null for lamin A/C (Y259X) were cultured in the presence (stress) or absence 
(basal) of 150 µM H2O2 . Total RNA was isolated and cDNA samples subjected 
to real-time qPCR using primers specific for detoxification enzymes (MnSOD and 
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CAT), glutathione enzyme (GST) and transcription factors NF-κB (p65), AP-1 (c-
Fos) and Sp1. PCR reactions for each sample were performed in triplicates in two 
independent experiments. Values for each sample were normalised to β-actin. 
Data were presented as fold change of the ratio between stress-induced and 
basal levels of gene expression relative to HDFs expressing Flag-wt lamin A, 
which is set at 1. (Figure kindly provided by Dr Ewa Markiewicz, University of 
Durham) 
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3.8 Discussion 
3.8.1 The oxidation status of lamin A cysteine residues influences cellular 
redox homeostasis and the onset of cellular senescence 
In this chapter, I propose a novel function for lamin A in the maintenance of 
cellular redox homeostasis. Lamin A is a target of irreversible oxidative 
modifications on cysteine residues during cellular aging, which is associated with 
decreased redox-dependent disulfide bond formation and alterations in nuclear 
morphology. Furthermore, I have also shown that in response to mild oxidative 
stress, HDFs require the presence of functional lamin A to correctly activate an 
adaptive stress response that is characterized by temporary growth arrest and 
lamin A disulfide bond formation. In order to investigate the role of conserved 
cysteine residues on lamin A function, I utilised various cysteine-to-alanine lamin 
A mutants including C522A, which has limited ability to form intra-disulfides, and 
C522/588/591A, which is unable to form both intra- and inter-disulfide bonds. 
Expression of Flag-C522/588/591A lamin A in HDFs leads to nuclear 
disorganisation and high levels of cellular ROS, resulting in ROS-induced DNA 
damage and the onset of stress induced premature senescence. The increased 
ROS levels in HDFs expressing Flag-C522/588/591A lamin A appear to result 
from greatly impaired ROS homeostasis since growth under standard oxygen 
tension appears to result in high ROS levels. Whether this is a direct 
consequence of mutating three cysteine residues or a dominant negative effect of 
impairing lamin filament assembly will need future clarification based on in vitro 
structural studies of lamin filament assembly. Interestingly, other disease-causing 
LMNA mutations that disrupt nuclear morphology such as those causing HGPS 
(G608G) and AD-EDMD (R453W) also lead to increased cellular ROS levels, but 
in contrast to Flag-C522/588/591A lamin A, these mutations do not sensitize 
HDFs to additional low levels of ROS stimulation. Importantly, mutating the 
common cysteine residue in the Ig fold domain of the lamin A/C tail (C522A) has 
no affect on ROS stimulation, nuclear morphology or adaptive responses to mild 
oxidative stress. Lowering of ROS levels in HDFs expressing Flag-cys by either 
153 
 
 
exogenous treatments with ROS scavengers or growth under low oxygen tension 
are both able to significantly rescue dysmorphic nuclear morphology, DNA 
damage and the entry into senescence. Taken together, these findings strongly 
suggest that lamin A is an essential component of an adaptive cellular response 
to mild oxidative stress. Furthermore, these findings suggest an essential 
component of the adaptive response is the ability to form inter-disulfide bonds via 
the lamin A tail domain.  
 
Protein oxidative damage is known to result in either a loss-of-function or a toxic 
gain-of-function (Linke and Jakob 2003). The data presented here implies that 
oxidative damage during cellular aging to cysteine residues in the lamin A tail lead 
to a loss-of-function, because the phenotype and cellular responses of HDFs 
expressing Flag-C522/588/591A lamin A are identical to those of HDFs that are 
functionally null for lamin A (Y259X). In either case, the dominant phenotype is 
elevated basal levels of ROS (when cells are grown under high oxygen tension) 
and hyper-sensitivity to mild oxidative stress. Therefore, I propose that lamin A 
mediates the transient cell cycle arrest that typifies an adaptive response to mild 
oxidative stress. Moreover, this adaptive response is intimately connected to 
disulfide bond formation in the lamin A tail.  
 
Disulfide bond formation has been proposed to serve a protective function (Linke 
and Jakob, 2003) and therefore the simplest explanation for the elevated ROS 
phenotype observed in HDFs expressing Flag-C522/588/591A lamin A is that it 
leads to the formation of unstable lamin A dimers. However, this seems unlikely 
since the mutant is stably expressed in HDFs and is dominant over its 
endogenous wild type counterpart. The dominant effect of Flag-C522/588/591A 
lamin A is presumably because lamin A is an obligate homo-dimer (Stuurman et 
al., 1998), and therefore the Flag-C522/588/591A lamin A would become paired 
with the endogenous wild type lamin A, which would prevent formation of inter-
disulfide bonds in response to oxidative stress. Therefore, an alternative 
hypothesis is that inter-disulfide bond formation gives rise to conformational 
changes in the lamin A tail that may modify its binding to cell cycle response 
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proteins and this is what mediates the adaptive ROS response. If this hypothesis 
is correct then inter-molecular disulfide bond formation most likely involves 
sequestration of cell cycle response proteins to the nuclear lamina since HDFs 
expressing Flag-C522/588/591A lamin A have an equivalent phenotype to HDFs 
null for lamin A (Y259X). 
3.8.2 Lamin A as a mediator of an adaptive response to oxidative stress 
Previous studies have shown that oxidative stress leads to cysteine oxidation of 
many proteins including lamins A/C (Eaton et al., 2003). Whilst cellular 
senescence has been associated with widespread ROS-related damage that is 
not targeted to specific proteins, proteins that are highly abundant and contain 
reactive thiols are the most strongly favoured ROS targets. Such abundant thiol 
proteins act as redox regulators in cells and only when their thiols become fully 
oxidized, so do other less abundant thiol proteins become susceptible to ROS 
(Winterbourn and Hampton 2008). A-type lamins are expressed in all 
mesenchymal tissues and are highly abundant nuclear proteins, interfacing 
chromatin and both the nuclear interior and periphery (Hutchison and Worman 
2004). Moreover, A-type lamins bind to and regulate a number of proteins that are 
pivotal to the processes of cell proliferation and cellular senescence (Dechat et 
al., 2010). Firstly, lamin A has been implicated in p53-dependent DNA damage 
response pathway (Liu et al., 2005; Varela et al., 2005). This is important because 
ROS-mediated DNA damage has been implicated in both cellular senescence and 
organismal aging (Campisi and D’Adda di Fagagna, 2007; Sahin and DePinho, 
2010). Furthermore, ROS may also cause telomere damage, which may induce 
cellular senescence independently of telomere length (Passos et al., 2007). As 
lamin A is involved in the maintenance of telomeres (Gonzalez-Suarez et al., 
2009), this provides another link between lamin A and its role in cellular 
senescence and also as part of an adaptive response to oxidative stress. 
Additionally, lamin A also regulates cellular proliferation via the pRb-E2F pathway 
(Markiewicz et al., 2002, Johnson et al., 2004, van Berlo et al., 2005). More 
recently, lamin A has also been implicated in regulating proliferation via the AP1 
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pathway (Ivorra et al., 2006; Gonzalez et al., 2008). Previous studies from our 
laboratory, as well as data presented in Chapter 4, have shown that depletion of 
lamin A in HDFs by RNAi leads to impaired cell cycle progression and premature 
cell cycle arrest (Pekovic et al., 2007). Thus, I propose that lamin A mediates an 
adaptive response to oxidative stress because it is a highly abundant protein that 
is ideally positioned both within the nuclear periphery and interior to enable it to 
regulate various proliferative and senescent pathways, which ultimately make it a 
target for age-related oxidative damage.  
 
It remains to be determined whether lamin A-interacting proteins are also 
oxidatively modified during cellular aging. Of note, multiple sequence alignments 
of the lamin A nucleoplasmic binding partner, LAP2α, revealed that it contains 
nine unique cysteine residues in its C-terminal region and shares only one 
cysteine residues with two other LAP2 family members, LAP2β and LAP2γ 
(Supplementary Figure 6). Future work should therefore seek to determine the 
role of LAP2α cysteine residues in cellular aging and the implication this has for 
nucleoplasmic lamin A functions in senescence pathways. 
 
Interestingly, in parallel to these findings, a recent study has implicated B-type 
lamins in the cellular response to oxidative stress (Malhas et al., 2009). It was 
previously shown that B-type lamins sequester the transcription factor Oct-1 at the 
nuclear envelope (Imai et al., 1997). Furthermore, Oct-1 has been shown to 
regulate genes involved in the oxidative stress response (Tantin et al., 2009). 
Based on these findings, Malhas et al. showed that Lmnb1-/- MEFs exhibited 
elevated ROS levels and were more susceptible to oxidative stress, with free Oct-
1 occupying gene promoters of genes involved in the oxidative stress response, 
causing their deregulation (Malhas et al., 2009). It therefore seems likely that both 
A- and B-type lamins contribute to the cellular response to oxidative stress, but via 
distinct mechanisms. Future work will determine if the known transcription factors 
that are sequestered at the nuclear envelope in an A-type lamin dependent 
manner may influence the response to oxidative stress analogously to the lamin 
B1-Oct-1 relationship.  
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3.8.3 Possible synergy between oxidative thiol damage to lamin A and the 
accumulation of prelamin A and progerin during normal aging 
Cellular aging of HDFs is associated with loss of nucleoplasmic A-type lamins and 
the appearance of lamin A disease-linked variants such as progerin and prelamin 
A (Scafidi and Misteli 2006, Ukekawa et al., 2007). Interestingly, activation of the 
same cryptic splice site found in HGPS patients (harbouring a G608G mutation, 
which produces the mutant protein termed progerin) has been detected at low 
levels in human skin cells and tissues from both young and old individuals 
(Scaffidi and Misteli 2006). Furthermore, progerin has been detected in a subset 
of dermal fibroblasts and terminally differentiated keratinocytes in skin biopsies 
from old individuals (McClintock et al., 2007). Thus, it is has been suggested that 
the presence of low levels of progerin, in concert with other age-dependent 
mechanisms, may be required for the observed adverse effects on nuclear 
morphology and cellular proliferation in aged cells (Kudlow et al., 2007). In this 
context, the current findings suggest that, in addition to progerin and prelamin A 
representing important determinants of age-related changes in cells, oxidative 
damage to lamin A thiols may also have an important influence on cellular aging. 
Oxidative damage to lamin A thiols may act synergistically with relatively low 
levels of progerin that could amplify its dominant-negative effects, and in 
combination, contribute towards a state of cellular senescence. Therefore, in sum, 
these findings support the concept that lamin A is an important determinant of 
normal aging. 
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CHAPTER 4:                                                                
LAP2α-LAMIN A/C COMPLEXES GOVERN CELL CYCLE 
PROGRESSION IN HUMAN DERMAL FIBROBLASTS 
 
4.1 Introduction 
4.1.1 Overview 
The eukaryotic cell cycle is elegantly controlled by highly evolved mechanisms 
that co-operate to ensure the accurate transmission of DNA from mother cell to 
daughter cells. Exquisite regulation of the cell cycle is essential for organismal 
development and, subsequently, organismal longevity. Importantly, the cell cycle 
machinery is a prime target for mutations that contribute to many cancers, which 
may lead to chronic proliferation of cells, a fundamental trait of all cancers 
(Hanahan and Weinberg, 2011). Therefore, understanding the fundamental 
processes that operate to control normal cellular proliferation is of basic, as well 
as clinical, scientific interest.  
4.1.2 The role of LAP2α-lamin A/C complexes in G1/S-phase transition 
There is evidence to suggest that nucleoplasmic LAP2α-lamin A/C complexes 
regulate the G1/S-phase transition via interaction with pRb (Markiewicz et al., 
2002). Previous studies showed that the active hypophosphorylated pRb is tightly 
bound to the nuclear matrix during G1 and resists extraction with DNase 
(Mittnacht and Weinberg, 1991). Hyperphosphorylated pRb bound weakly to the 
nuclear matrix, suggesting that phosphorylation of pRb disrupts the interaction 
with the nuclear matrix as cells traverse the G1/S-phase transition (Mittnacht and 
Weinberg, 1991). Further work demonstrated that this inactive form of pRb bound 
to lamin A via the pocket C domain of pRb and was only bound in G1-phase, when 
pRb is active in its hypophosphorylated state (Mancini et al., 1994). Importantly, 
using cells which contained a mutated RB gene, pRb was readily solubilised in 
G1-phase cells, suggesting that tethering to the nuclear matrix was important for 
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the tumour suppressor functions of pRb (Mancini et al., 1994). More recent work 
has dissected these pRb-lamin A/C complexes (Dechat et al., 2000; Markiewicz et 
al., 2002; Dorner et al., 2006). The lamin A/C-interacting partner LAP2α is found 
within the nucleoplasm and interacts with lamin A/C (amino acids 319-572) via its 
C-terminal domain (amino acids 615-693) (Dechat et al., 2000). LAP2α is also 
able to interact with the pocket C domain of pRb via its own C-terminal region 
(amino acids 415-615) (Markiewicz et al., 2002; Dorner et al., 2006). This region 
is downstream of the lamin A/C-interacting domain, thus enabling a trimeric pRb-
LAP2α-lamin A/C complex to form (Markiewicz et al., 2002; Dorner et al., 2006). 
Lamin A/C also interacts with the pocket C domain of pRb via residues 247-355 in 
the α-helical rod domain (Ozaki et al., 1994). Overexpression of a domain 
negative lamin B1 mutant sequesters endogenous lamin A/C, LAP2α and pRb 
into nucleoplasmic aggregates, underlining the interactions between these three 
proteins (Markiewicz et al., 2002). Importantly, this suggests that LAP2α-lamin 
A/C complexes may govern the G1/S-phase transition by promoting pRb nuclear 
anchorage (Markiewicz et al., 2002). Moreover, LAP2α resides at E2F-dependent 
promoters, suggesting that the pRb-LAP2α-lamin A/C complex may interact at 
promoters to inhibit E2F-dependent transcription of S-phase genes (Dorner et al., 
2006). Indeed, whilst overexpression of LAP2α in both Hela and mouse 3T3 cells 
inhibited G1/S-phase progression, RNAi of endogenous LAP2α in Hela cells 
enhanced proliferation and also inhibited the ability to exit the cell cycle in 
response to low serum conditions (Dorner et al., 2006). Furthermore, over-
expression of LAP2α inhibited E2F transcriptional activity in mouse 3T3 cells, 
underlining its negative effect on cell cycle progression (Dorner et al., 2006). 
However, loss of LAP2α, and indeed lamin A/C, in normal human fibroblasts 
(HDFs) by RNAi elicits a different cellular response than mouse and transformed 
human cells (Pekovic et al., 2007). HDFs depleted of either LAP2α or lamin A/C 
lead to cell cycle arrest by 72 hours post-transfection, as assessed by Ki67 
staining (Pekovic et al., 2007). The differences between the two studies probably 
reflect fundamental differences in the cell types used (Dorner et al., 2006; Pekovic 
et al., 2007). 
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4.1.3 Current aims 
Previous studies have implicated LAP2α-lamin A/C complexes in the regulation of 
cell cycle progression with HDFs depleted of either protein undergoing cell cycle 
arrest. However, the underlying causes of this have yet to be established. In this 
chapter, I explore in more detail the cell cycle alterations associated with loss of 
either LAP2α or lamin A/C in HDFs.  
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4.2 Depletion of LAP2α or lamin A/C causes altered cell cycle 
progression in HDFs 
The nuclear lamins have been implicated in cell cycle progression by a number of 
studies (Dechat et al., 2010). Both A- and B-type lamins have been suggested to 
have roles in S-phase progression, however, seemingly contradictory data has 
underpinned the necessity for a more thorough exploration of A-type lamins in 
DNA replication (Kennedy et al., 2000; Izumi et al., 2000). Previous work from our 
laboratory has shown that depleting LAP2α or lamin A/C by RNAi leads to an 
initial accumulation of G2/M-phase cells after 48 hours, before entering a G1-
phase arrest after 72 hours, as analysed by single parameter FACS (Pekovic et 
al., 2007). It was therefore hypothesized that the accumulation of cells transiently 
in G2/M-phase after 48 hours may be due to accelerated passage through S-
phase, as has been shown previously for Lap2α-/- MEFs (Dorner et al., 2006).  
Experimentally, to circumvent differences in cell cycle phase upon RNAi, HDFs 
were serum-starved for 5-7 days. HDFs were then stimulated with 10% DMEM to 
allow re-entry into the cell cycle and transfected with siRNA (Figure 4.1a) (Kill et 
al., 1991). Depletion of LAP2α or lamin A/C in HDFs by RNAi is first detectable at 
the protein level by 48 hours and is most prominent by 72 hours with ~ 70% 
knockdown of LAP2α or lamin A/C protein levels compared to control cells (Figure 
4.1d-f). Note that LAP2α protein levels are initially at 0% as LAP2α protein levels 
are down-regulated in quiescent cells and are then up-regulated in response to 
mitogenic stimuli (Supplementary Figure 7) (Markiewicz et al., 2002; Pekovic et 
al., 2007). In order to estimate S-phase fraction, HDFs were labelled after 42 
hours post-transfection with EdU (an analogue of BrdU) for 1 hour. Fixed cells 
were then processed and analysed by FACS using a dual parameter EdU/DNA 
analysis to obtain the percentage of cells in each phase of the cell cycle. Bivariate 
histograms were produced from at least three different samples to calculate the 
mean percentage of cells in each phase of the cell cycle (Figure 4.1b,c).  
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HDFs transfected with non-targeting control siRNA were predominantly in G1-
phase (~68%) after 43 hours, with ~18% of cells in G2/M-phase and a minority of 
cells in S-phase (~13%) (Figure 4.1b,c). In contrast, HDFs depleted of LAP2α or 
lamin A/C showed a statistically significantly reduced percentage of cells in G1-
phase, ~33% for LAP2α and ~27% for lamin A/C (Figure 4.1b,c). The percentage 
of cells in S-phase in LAP2α or lamin A/C depleted HDFs was also dramatically 
increased compared to control cultures, with ~29% for LAP2α and ~25% for lamin 
A/C. Lastly, analysis of the cytograms revealed a significantly increased 
percentage of cells in G2/M-phase for both LAP2α and lamin A/C depleted HDFs, 
with ~30% for LAP2α and ~38% for lamin A/C compared to control HDFs (~18%) 
(Figure 4.1b,c). Together, this data suggests that loss of LAP2α and lamin A/C 
causes altered cell cycle progression as cells passage from quiescence back into 
the cell cycle.  
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Figure 4.1. Loss of LAP2α or lamin A/C leads to delayed cell cycle 
progression. (a) Schematic diagram showing the experimental methodology. (b) 
HDFs were transfected with control, LAP2α or lamin A/C siRNA and then labelled 
with EdU (10µм for 1h) 42h post-transfection before subsequent fixation and 
analysis by flow cytometry. Representative cytograms are shown. (c) Data from 
cytograms was analysed using FlowJo software and the mean percentage values 
(n = 3-5) + S.D. for each cell cycle phase were calculated. * p<0.05 relative to G1-, 
S-, or G2-phase for siCon.  (d) HDFs transfected with siRNA were harvested after 
24, 48 or 72h and protein extracts were subjected to reducing SDS-PAGE and 
then immunoblotted with anti-lamin A/C, LAP2α or β-actin antibodies. (e-f) The 
level of LAP2α or lamin A/C protein remaining in protein extracts as a function of 
time (siCon vs. siLAP2α and siCon vs. siLMNA) was assessed using optical 
densitometry and expressed as a percentage of the control siRNA, which was set 
a value of 100%. 
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4.3 Depletion of LAP2α or lamin A/C delays G1/S-phase 
progression in HDFs 
Based on the findings that loss of either LAP2α or lamin A/C caused altered cell 
cycle progression, it was unclear how loss of LAP2α or lamin A/C leads to an 
increased percentage of cells in both S and G2/M-phases. I therefore sought to 
investigate whether loss of LAP2α or lamin A/C causes alterations in either G1/S-
phase progression, S-phase duration, or both. Studies in Lap2α-/- and Lmna-/- 
MEFs hinted that loss of either protein may lead to either accelerated entry into S-
phase or accelerated passage through S-phase, although these two are not 
mutually exclusive (Johnson et al., 2004; Dorner et al., 2006). To assess these 
hypotheses directly, it was necessary to estimate the S-phase fraction in LAP2α 
or lamin A/C depleted HDFs both before and after the 42 hours timepoint 
previously used for bivariate FACS analysis. To this end, HDFs depleted of 
LAP2α or lamin A/C were labelled with EdU (for 1 hour) every 3 hours ranging 
from 23 to 65 hours post-transfection before fixation and processing (Figure 4.2a). 
The HDFs used in this study exhibit four types of replication patterns when 
stained with an anti-PCNA antibody (Kill et al., 1991) or, as in this study, labelled 
with EdU and then detected using an Alexa Fluor 488-conjugated azide that 
reacts with a side-chain of EdU (Diermeier-Daucher et al., 2009). At the initiation 
of S-phase, a small number of dim foci are evident and are termed Type I foci. 
The Type II pattern is granular in appearance and is observed uniformly across 
the nucleus. Type III nuclei exhibit a punctate pattern with the perinuclear region 
enriched. The Type IV pattern displayed fewer bright foci and is the last pattern 
observed (Figure 4.2b).  
 
Initially, the mean percentage of EdU+ cells, i.e. those in S-phase, was analysed 
over a timecourse from non-targeting control, LAP2α or lamin A/C depleted HDFs. 
Control HDFs progressed from G0 (0 hours) through G1-phase and had entered S-
phase by 24 hours, as indicated by the Edu+ cells (Figure 4.2 ‘siCon’). Control 
HDFs then showed a decrease in EdU+ cells after 27 hours, suggesting 
165 
 
 
procession through to G2/M-phase (Figure 4.2c ‘siCon’). After ~ 51 hours post-
transfection, control HDFs showed an increase in EdU+ cells, indicating that a 
second round of replication was initiated (Figure 4.2c ‘siCon’). The peak of the 
second round of replication did not reach the levels of the first round of replication, 
suggesting that the culture had lost synchrony. In contrast to control HDFs, 
LAP2α or lamin A/C depleted HDFs exhibited a significantly altered EdU+ and 
hence S-phase distribution over the time-course investigated (Figure 4.2c,d 
‘siLAP2α’ and ‘siLMNA’). Importantly, the progression into S-phase was delayed 
for LAP2α or lamin A/C depleted HDFs compared to control HDFs, with the EdU+ 
cells peaking around 39-42 hours (Figure 4.2c,d ‘siLAP2α’ and ‘siLMNA’). The 
percentage of cells in S-phase in LAP2α or lamin A/C depleted HDFs then 
declined to ~15-20% and showed no distinct increase at later time points, 
indicating that the second round of DNA replication was inhibited or delayed 
beyond the extent of the times investigated (Figure 4.2c,d). Together, these 
findings suggest that loss of either LAP2α or lamin A/C in HDFs delays the first 
G1/S-phase progression after cell cycle re-entry from G0. 
 
To explore these findings in more detail, HDFs were then assessed for the S-
phase type after 42 hours, as this timepoint was used for flow cytometry analysis 
previously. Based on the flow cytometry data, I predicted that EdU+ cells in HDFs 
depleted of either LAP2α or lamin A/C would be in mid-to-late S-phase, whereas 
control HDFs would show increased early S-phase cells. Indeed, control HDFs 
typically displayed the Type I (~15%) and II (~64%) patterns, with a minority 
exhibiting Type III (~12%) and Type IV (~9%) patterns, indicating that the EdU+ 
cells were mainly in early-mid S-phase (Figure 4.2e). In contrast, LAP2α or lamin 
A/C depleted HDFs showed an over-representation of Type III and IV S-phase 
patterns (p-values for pattern types observed in siLAP2α or siLMNA vs. siCon is 
shown in Figure 4.2e). LAP2α depleted HDFs displayed ~7% Type I, ~48% Type 
II, 29% Type III and ~16% Type IV patterns (Figure 4.2e). Similarly, lamin A/C 
depleted HDFs exhibited 10% Type I, 53% Type II, 22% Type III and 15% Type IV 
patterns (Figure 4.2e). The increased percentage of LAP2α or lamin A/C depleted 
HDFs showing Type III and IV S-phase patterns indicates that these cells are in 
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mid to late S-phase by 42 hours. Therefore, in combination with the prior flow 
cytometry data, this data suggests that, upon re-stimulation from quiescence (G0), 
control HDFs proceed through the first S-phase by 24 hours, progress into G2/M 
and then G1-phase before initiating another round of DNA replication by ~ 51 
hours. In contrast, HDFs depleted of LAP2α or lamin A/C progress through the 
first G1/S-phase more slowly than control HDFs. Together, these findings suggest 
that LAP2α and lamin A/C are required for efficient G1/S-phase progression. 
 
Analysis of the EdU+ data suggested that S-phase duration was unchanged 
between control HDFs and LAP2α or lamin A/C depleted HDFs, i.e. the rate of 
decline from the maximum to the minimum percentage of EdU+ cells was similar 
in these cultures (Figure 4.2c,d). To underline this, I investigated PCNA, an 
adaptor protein that acts to dramatically enhance the processivity of DNA 
polymerase δ during chain elongation in DNA synthesis by acting as a loading 
clamp and encircling DNA (Bowman et al., 2004). Immunoblotting of protein 
extracts from LAP2α or lamin A/C depleted HDFs revealed that total PCNA levels 
were unchanged after 48 and 72 hours post-transfection (Figure 4.2f). This 
suggests that loss of LAP2α or lamin A/C does not affect total PCNA protein 
levels. In sum, this data suggests that depletion of LAP2α or lamin A/C leads to 
delayed G1/S-phase progression in HDFs. 
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Figure 4.2. Loss of LAP2α or lamin A/C causes delayed G1/S-phase 
progression. (a) Schematic diagram showing the experimental methodology. (b) 
HDFs grown in culture exhibit four distinct patterns of S-phase staining (I-IV). 
These patterns can be visualised by labelling HDFs with EdU (10 M) for 1 hour. 
EdU was detected using an Alexa Fluor 488-conjugated azide that reacts with a 
side-chain of EdU. (c,d) HDFs were transfected with control, LAP2α or lamin A/C 
siRNA and then labelled with EdU (10µM for 1h) at various times post-transfection 
before subsequent fixation and analysis by microscopy. The mean percentage of 
EdU+ cells was calculated from at least 300 cells and the experiment was 
repeated twice. Error bars represent ± S.D. (e) S-phase patterns were analysed 
42h post-transfection according to (b). At least 500 EdU positive cells were scored 
and the experiment was repeated twice. p-values are relative to siCon patterns. (f) 
HDFs transfected with siRNA were harvested after 48 or 72h and protein extracts 
were subjected to reducing SDS-PAGE and then immunoblotted with anti-PCNA 
or β-actin antibodies.  
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4.4 Depletion of LAP2α or lamin A/C causes transient cell cycle 
arrest in HDFs 
Previous work within our laboratory has shown that HDFs undergo cell cycle 
arrest in response to either LAP2α or lamin A/C knockdown by RNAi (Pekovic et 
al., 2007). To re-affirm this, HDFs were synchronised by serum-starvation, 
transfected with siRNA and then processed for indirect immunofluorescence after 
72 hours. Cells were stained the with prototypic cell cycle related nuclear protein 
Ki67, which is expressed in proliferating cells in all phases of the active cell cycle 
(G1, S, G2, M phases) but is absent when cells enter into a quiescent or 
senescent state (G0 phase) (Scholzen and Gerdes, 2000). Control HDFs typically 
showed between 3 and 10 prominent foci of positive Ki67 staining, whilst HDFs 
depleted of LAP2α or lamin A/C showed very weak staining or the complete 
absence of any Ki67 staining, indicating exit from the cell cycle (Figure 4.3a). The 
number of Ki67+ cells were quantified and results revealed that HDFs transfected 
with LAP2α or lamin A/C siRNA (~40%) had a significantly lower Ki67+ index than 
control HDFs (~75%) (Figure 4.3b). The similar cellular phenotype exhibited by 
depleting HDFs of either LAP2α or lamin A/C may arise because the two proteins 
exist in a complex within the nucleoplasm (Markiewicz et al., 2002). Indeed, 
Lap2alpha-/- MEFs display a loss of nucleoplasmic lamin A/C, suggesting that it is 
involved in targeting lamin A/C within the nucleoplasm (Naetar et al., 2008). 
Therefore, to investigate this in HDFs, co-staining of HDFs depleted of LAP2α 
with anti-LAP2α and lamin A/C antibodies showed a distinct loss of nucleoplasmic 
lamin A/C but not nuclear envelope lamin A/C in LAP2α-depleted HDFs (Figure 
4.3c). This further corroborates the finding that LAP2α may target a pool of lamin 
A/C to the nucleoplasm and may explain why depletion of either protein gives rise 
to similar phenotypes, as shown here (Figure 4.3c).   
 
As I have shown previously, HDFs depleted of LAP2α or lamin A/C show delayed 
progression through G1/S-phase before eventual cell cycle exit by 72 hours. To 
confirm these findings, cellular proliferation curves revealed that whilst control 
HDFs divided regularly (every ~24 hours by day 4 post-transfection), HDFs 
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depleted of LAP2α or lamin A/C displayed a significantly reduced proliferative rate 
(Figure 4.3d). Therefore, together, these results suggest that loss of 
nucleoplasmic LAP2α or lamin A/C leads to reduced Ki67 positive cells, which 
causes reduced rates of cellular proliferation. 
 
Following depletion of LAP2α or lamin A/C, HDFs arrest in G1 phase with a 2N 
content after 72 hours (Pekovic et al., 2007). This finding, together with the data 
presented thus far, led me to investigate whether loss of LAP2α or lamin A/C 
caused cellular senescence. Cellular senescence is governed by two major 
pathways, the p53 and pRb pathways (Campisi, 2005). The pRb pathway is 
activated by the cell cycle inhibitor p16INK4A, which is one of two major splice 
products from the CDKN2A gene, the other being p14ARF (Lowe and Sherr, 
2003). As well as targeting CDK4 directly, thereby inhibiting S-phase progression, 
p16INK4A directly activates pRb and induces repressive irreversible chromatin 
formation at E2F loci (Campisi, 2005). Therefore, to assess the nature of the cell 
cycle arrest, protein extracts were prepared from HDFs depleted of LAP2α or 
lamin A/C after 120 hours post-transfection. Immunoblotting with an anti-p16INK4A 
antibody showed no differences in p16INK4A levels, suggesting that the pRb-
dependent senescence pathway was not activated (Figure 4.3e). To confirm this 
finding using an independent assay, HDFs depleted of LAP2α or lamin A/C were 
fixed after 120 hours post-transfection and stained with a senescence-associated 
β-galactosidase kit, which is a known to be a robust marker of senescent cells 
(Dimri et al., 1995). Results indicated that depletion of LAP2α or lamin A/C in 
HDFs did not induce cells to enter senescence (Figure 4.3f). As a positive control, 
HDFs were treated with H2O2 to promote stress-induced premature senescence 
(SIPS) (Figure 4.3f). Taken together, this data suggests that depletion of LAP2α 
or lamin A/C in HDFs induces a transient cell cycle arrest rather than a permanent 
cell cycle arrest and entry into senescence. 
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Figure 4.3. Loss of nucleoplasmic LAP2α—lamin A/C complexes leads to 
transient cell cycle arrest in HDFs. (a) G0-synchronised HDFs were transfected 
with the indicated siRNAs, fixed after 72h and processed for immunofluorescence 
with anti-Ki67 and LAP2α antibodies. (b) The percentage of Ki67 negative cells 
from (a) were scored after 72h (* p<0.05 siLAP2α vs. siCon; + p<0.05 siLMNA vs. 
siCon). Data represents the mean from duplicate coverslips in three independent 
experiments. (c) HDFs transfected with LAP2α siRNA were fixed after 72h and 
processed for immunofluorescence with anti-LAP2α and lamin A/C antibodies. 
Knockdown of LAP2α causes a loss of nucleoplasmic lamin A/C in the transfected 
cell. The graph shows the lamin A/C fluorescence signal across each nucleus as 
indicated by the white lines and arrows. (d) G0-synchronised HDFs were 
transfected with the indicated siRNAs and after 24h counted and seeded in 
triplicate wells. Cells were then counted every 24h for the next 4 days (* p<0.05 
siLAP2α vs. siCon; + p<0.05 siLMNA vs. siCon). (e) HDFs transfected with siRNA 
were harvested after 120h and protein extracts were subjected to reducing SDS-
PAGE and then immunoblotted with anti-p16INK4A or anti-β-tubulin antibodies. (f) 
HDFs transfected with the indicated siRNA were fixed and stained for 
senescence-associated β-galactosidase activity 120h post-transfection. As a 
positive control, untransfected HDFs were treated twice with 350µм H2O2 within a 
week, a treatment that has previously been shown to cause stress-induced 
premature senescence (SIPS). Data represents the mean from three independent 
experiments.  
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4.5 Cell cycle arrest in LAP2α or lamin A/C depleted HDFs is 
correlated with high levels of ROS, but not increased double 
strand breaks 
Why should loss of LAP2α or lamin A/C lead to a G1 arrest by 72 hours? One 
hypothesis is that loss of nucleoplasmic LAP2α or lamin A/C might cause 
endogenous DNA damage, therefore activating DNA damage checkpoint 
pathways that act to arrest cells in order to repair the damage (Jackson and 
Bartek, 2009). One of the most toxic DNA lesions encountered cells are double 
strand breaks (DSBs), the presence of which activates DNA damage signalling 
kinases ATM and ATR leading to the phosphorylation of the tail of the histone 
variant H2AX adjacent to the site of DNA damage (Ciccia and Elledge, 2010).  
The generation of γ-H2AX facilitates the focal assembly of DNA repair factors 
including 53BP1 and MDC1, and also promotes the phosphorylation and 
activation of Chk1 and Chk2, two protein kinases involved in the DNA damage 
checkpoint response (Polo and Jackson, 2011). Therefore, to test this hypothesis, 
HDFs depleted of LAP2α or lamin A/C were fixed after 24, 48 and 72 hours post-
transfection and immunostained with an anti-γ-H2AX antibody (Figure 4.4a). 
Results indicated that depletion of either LAP2α or lamin A/C in HDFs did not 
induce substantial endogenous DNA damage (Figure 4.4a and data not shown). 
The radiomimetic chemotherapeutic drug bleomycin is a potent inducer of DSBs 
and acts as a positive control for the immunostaining. To confirm this, protein 
extracts were prepared 24, 48 and 72 hours post-transfection and immunoblotting 
with an anti-γ-H2AX antibody confirmed the absence of endogenous DNA 
damage in HDFs depleted of LAP2α or lamin A/C (Figure 4.4b). The huge 
increase in γ-H2AX and the presence of the ubiquitylated species of γ-H2AX in 
extracts from bleomcyin-treated cells serve as a positive control in the 
immunoblotting experiments (Huen et al., 2007; Kolas et al., 2007; Mailand et al., 
2007).  
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Another ATM phosphorylation target along with H2AX is the checkpoint protein 
Chk2 (Chaturvedi et al., 1999; Matsuoka et al., 2000). Chk2 is phosphorylated on 
seven SQ/TQ motifs, including threonine 68, in response to a variety of DNA 
damage, some of which are ATM-independent (Matsuoka et al., 2000; Melchionna 
et al., 2000). Therefore, HDFs depleted of LAP2α or lamin A/C were fixed after 
24, 48 and 72 hours post-transfection and immunostained with an anti-phospho-
Chk2(Thr68) antibody (Figure 4.4c and data not shown). Results revealed that 
depletion of either LAP2α or lamin A/C in HDFs did not induce substantial 
phosphorylation of Chk2 on threonine 68 (Figure 4.4c and data not shown). As a 
positive control, HDFs were treated with hydroxyurea (HU), which inhibits DNA 
synthesis by inhibiting ribonucleotide reductase, and leads to Chk2 
phosphorylation on threonine 68 (Matsuoka et al., 2000; Platt, 2008). To 
corroborate the immunostaining data, protein extracts were prepared 24, 48 and 
72 hours post-transfection and immunoblotting with an anti-Chk2(Thr68) antibody 
confirmed the absence of phosphorylated Chk2 on threonine 68 in HDFs depleted 
of LAP2α or lamin A/C (Figure 4.4d). Together, this data suggests that acute loss 
of LAP2α or lamin A/C in HDFs does not induce DSBs, and therefore rules out the 
possibility that DSBs are the underlying cause of the cell cycle arrest observed 
after 72 hours in HDFs depleted of LAP2α or lamin A/C. 
 
Based on the previous findings that lamin A is involved in the oxidative stress 
response, I hypothesised that depletion of LAP2α or lamin A/C in HDFs might 
induce oxidative stress, which may contribute to the cell cycle alterations (Chapter 
3). HDFs were synchronised in G0 by serum-starvation then transfected with 
siRNA in the presence of 10% serum. After 72 hours cells were then labelled with 
the fluorescent dye DCF-DA either in the presence or absence of the ROS 
scavenger N-acetyl cysteine (NAC) and analysed by FACS. Representative 
cytograms are shown (Figure 4.5a). Basal levels of DCF-DA in HDFs depleted of 
either LAP2α or lamin A/C were ~ 2-fold higher than in control HDFs, indicating 
that intracellular ROS levels are elevated in the absence of either LAP2α or lamin 
A/C (Figure 4.5b). Interestingly, treatment with NAC effectively reduced ROS 
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levels in HDFs depleted of LAP2α or lamin A/C, although they were still higher 
than control HDFs, by 76% and 65% respectively (Figure 4.5b). This reduction in 
ROS levels with NAC treatment was proportionate to the initial ROS levels, as 
indicated by the similar negative percentage change values from basal to NAC 
(Figure 4.5c). Together, this data reveals that LAP2α or lamin A/C depletion in 
HDFs causes increased intracellular ROS levels, which is readily reduced to near 
control levels with NAC treatment.  
 
To correlate these findings with the observed cellular proliferation defects in HDFs 
depleted of LAP2α or lamin A/C, I next examined whether long-term anti-oxidant 
(NAC) treatment of these cells would ameliorate these proliferative defects. HDFs 
were transfected with control, LAP2α or lamin A/C siRNA and then treated for 1 
hour with various concentrations of NAC at 24 hours post-transfection. These 
treatments were repeated twice more before fixation and immunostaining with 
anti-Ki67 antibody (Figure 4.6a,b). Quantification of Ki67+ cells revealed that long-
term acute NAC treatment caused a dose-dependent inhibition of cellular 
proliferation in control HDFs, with a significantly reduced percentage of Ki67+ 
cells after treatment with 10 mM compared to 0.1 mM (Figure 4.6c). As shown 
previously, LAP2α or lamin A/C depleted cells have a reduced percentage of 
Ki67+ cells. Treatment of these cells with NAC caused a further smaller reduction 
(~10% for each) in the percentage Ki67+ cells (Figure 4.6c). This data suggests 
that the proliferative defects associated with loss of LAP2α or lamin A/C in HDFs 
cannot be rescued by reducing ROS levels by application of anti-oxidants.  
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Figure 4.4. Acute loss of nucleoplasmic LAP2α—lamin A/C complexes is not 
associated with activation of a DNA damage response. (a) HDFs transfected 
with the indicated siRNAs were fixed after 48h and processed for 
immunofluorescence before staining with anti-γ-H2AX (Ser139) antibody. As a 
positive control, untransfected HDFs were treated with the bleomycin (20 µg/ml) 
for 1h. (b) HDFs transfected with the indicated siRNA were harvested after 24, 48 
or 72h and protein extracts were subjected to reducing SDS-PAGE and then 
immunoblotted with anti-γ-H2AX (Ser139) antibody. Bleomycin was used as a 
positive control as in (a) and the presence of the ubiquitylated form of γ-H2AX 
confirms activation of the DNA damage response in these HDFs (Huen et al., 
2007). (c) HDFs transfected with the indicated siRNAs were fixed after 48h and 
processed for immunofluorescence before staining with anti-phospho-Chk2 
(Thr68) antibody. As a control, untransfected HDFs were treated with the 20µм 
hydroxyurea for 16h. (d) HDFs transfected with the indicated siRNA were 
harvested after 24, 48 or 72h and protein extracts were subjected to reducing 
SDS-PAGE and then immunoblotted with anti-phospho-Chk2 (Thr68) antibody. 
Hydroxyurea was used as a positive control as in (c).  
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Figure 4.5. HDFs depleted of LAP2α or lamin A/C exhibit high levels of 
intracellular ROS that can be rescued with NAC treatment. (a) HDFs were 
synchronised in G0 by serum-starvation before transfection with siRNAs against 
control, LAP2α or lamin A/C. After 72 hrs cultures were incubated with 5 µм DCF-
DA for 1 hr in the presence or absence of the ROS scavenger NAC. HDFs were 
then analysed by flow cytometry and the resulting histograms of a typical 
experiment (n = 3) are shown. (b) Basal levels (±NAC) of intracellular ROS of the 
above siRNA-transfected HDFs were determined using the FlowJo software and 
data is expressed as a percentage of control HDFs (-NAC), which are arbitrarily 
set a value of 100%. (c) The negative percentage change of basal ROS levels to 
+NAC ROS levels was calculated for the siRNA-transfected HDFs. 
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Figure 4.6. Long-term NAC treatment fails to rescue growth defects 
associated with loss of LAP2α or lamin A/C in HDFs. (a,b) HDFs were 
transfected with siRNAs against control, LAP2α or lamin A/C. After 24 hrs post-
transfection, cells were treated with various concentrations of NAC for 1 hour 
before replacing with fresh medium. This was repeated every 24 hours for a total 
of 3 treatments. After 96 hours, cells were fixed and processed for 
immunofluorescence with anti-Ki67, LAP2α or lamin A/C antibodies and counter-
stained with DAPI. Untransfected cells provide an internal control. Scale, 10µm. 
(c) Quantification of data obtained from immunofluorescence, n= 3, + S.D. * 
p<0.05 siCon (0.1mM NAC) vs. siCon (10mM NAC); + p<0.05 siLAP2α or siLMNA 
vs. siCon for corresponding NAC treatment.  
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4.6 Discussion 
4.6.1 LAP2α and lamin A/C are required for normal cell cycle progression in 
HDFs 
LAP2α-lamin A/C complexes have been proposed to govern the G1/S-phase 
transition via interaction with pRb (Dorner et al., 2007). Furthermore, A- and B-
type lamins have been reported to be involved in S-phase itself, although the 
exact mechanism remains elusive (Broers et al., 2006). In the present work, I 
have shown that, in response to re-stimulation from G0 (or quiescence), HDFs 
depleted of either LAP2α or lamin A/C undergo delayed G1/S-phase progression. 
This was evidenced by bivariate cell cycle analysis, which showed that HDFs 
depleted of either LAP2α or lamin A/C displayed a greater proportion of cells in S- 
and G2/M-phases, with a concomitant decrease in G1 cells. This suggested that 
cells were progressing through G1 to S-phase from quiescence at different rates, 
either faster or slower, in HDFs depleted of either LAP2α or lamin A/C compared 
to control HDFs. A time-course assessment of the percentage of cells in S-phase, 
and which phase of S-phase they were in, revealed that HDFs depleted of either 
LAP2α or lamin A/C accumulated in S-phase more slowly than control HDFs. This 
finding does not suggest that S-phase progressed more slowly per se, but rather 
the entry into S-phase appears delayed. Therefore, at 42 hours, whilst control 
HDFs have passed through the first S-phase, HDFs depleted of LAP2α or lamin 
A/C are still in late S-phase as assessed by the replication patterns and flow 
cytometry. Together, the data suggests that disruption to nucleoplasmic LAP2α or 
lamin A/C complexes inhibits G1/S-phase progression upon transition from G0-G1-
S-phase. This finding is in keeping with previous reports that have utilised HGPS 
or Y259X HDFs, which both show reduced proliferation rates and reduced 
phosphorylated pRb levels (Muchir et al., 2003; Goldman et al., 2004; Dechat et 
al., 2007; Pekovic et al., 2007; Vos et al., 2010). However, these results in human 
somatic cells are in stark contrast to previous studies using Lmna-/- and 
Lap2αlpha-/- MEFs (Johnson et al., 2004; van Berlo et al., 2005; Naetar et al., 
2008). These studies have shown that Lmna-/- and Lap2αlpha-/- MEFs behave in a 
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similar manner to Rb-/- MEFs, which exhibit increased proliferative rates owing to 
a higher percentage of cells in S-phase (Johnson et al., 2004; van Berlo et al., 
2005; Naetar et al., 2008). As LAP2α-lamin A/C complexes interact with active 
hypophosphorylated pRb, and as pRb levels are lost in Lmna-/- MEFs and are 
deregulated in Lap2αlpha-/- MEFs, loss of pRb repressor function in these three 
genetic backgrounds leads to uncontrolled G1/S-phase transition due to free E2F, 
which activates gene transcription necessary for S-phase progression. This 
simple mechanism may be the dominant pathway in mouse cells but may not be 
applicable to human cells. It is possible that during the process of transformation 
these immortalised mouse cell lines have undergone changes that effect the 
regulation of the cell cycle and its checkpoints. Indeed, in primary Zmpste24-/- 
mouse adult fibroblasts, there is a p53-dependent entry into senescence. Mouse 
cells are dependent on the p53 pathway for cellular senescence, rather than the 
pRb pathway, as found in human cells (Campisi, 2005). Therefore, inherent 
differences between mouse and human cells, as well as embryonic and adult 
cells, may account for the difference observed here and previously that loss of 
nucleoplasmic LAP2α-lamin A/C complexes promote G1/S-phase transition in 
mouse cells, but inhibits this transition in human cells (Pekovic et al., 2007). This 
conclusion would suggest that the nucleoplasmic pRb-LAP2α-lamin A/C complex 
has more precise or previously unrecognised functions than first thought in human 
somatic cells. In support of this, in human fibroblasts depleted of LAP2α or lamin 
A/C, total and phosphorylated pRb levels are reduced, but not completely absent, 
and the localisation of a specific phosphorylated pRb isoform (Ser795) is 
dramatically altered (Pekovic et al., 2007). In light of these findings and the data 
presented here, it is possible that LAP2α-lamin A/C complexes provide specificity 
in nuclear localisation of specific phosphorylated pRb isoforms, which are 
necessary for optimal G1/S-phase progression. Therefore, in HDFs depleted of 
LAP2α or lamin A/C, spatiotemporal regulation of pRb localisation and 
phosphorylation is deregulated, inhibiting G1/S-phase progression. Future work 
should seek to clarify these hypotheses.  
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The data presented here does not argue for a delay in S-phase duration in 
response to LAP2α or lamin A/C depletion in HDFs, though it was no tested 
directly. Conflicting reports have suggested that A-type lamins promote initiation 
or the elongation phase of DNA synthesis (Broers et al., 2006). No differences 
were observed in the levels of the elongation factor PCNA in the data presented 
here, although its activity may be affected by lamin A/C, and possibly LAP2α, loss 
in HDFs. Future work using aphidicolin to block cells at G1/S-phase followed by 
release will allow a more detailed examination of the effect of either LAP2α or 
lamin A/C loss on the progression through S-phase in HDFs. Further work also 
needs to clarify the exact role of lamin A/C in DNA replication. Recently, a 
mammalian in vitro DNA replication assay has been developed based on the 
pEPI-1 plasmid (Rizwani and Chellappan, 2009). Using this system, it will be 
possible to determine if lamin A/C and mutants found in laminopathy patients 
affect DNA replication initiation or elongation, if either.  
4.6.2 LAP2α and lamin A/C prevent cell cycle arrest in HDFs 
Previous work in our laboratory has shown that HDFs depleted of either LAP2α or 
lamin A/C undergo cell cycle exit after 72 hours post-transfection (Pekovic et al., 
2007). Indeed, the present work corroborated this finding. Therefore, to explore 
the downstream consequences of LAP2α or lamin A/C loss in HDFs I assessed 
whether these cells might be induced into premature senescence. Prior studies 
have shown that in the presence of unprocessed prelamin A, in both HGPS and 
RD, cells undergo premature entry into senescence when grown in vitro, therefore 
providing a link between lamin status and permanent cell cycle exit or senescence 
(Mounkes et al., 2003; Liu et al., 2006; Hernandez et al., 2010). More importantly, 
complete loss of A-type lamins in LMNAY259X/Y259X human fibroblasts is associated 
with premature entry into senescence (Chapter 3; Pekovic et al., 2007). However, 
in contrast to this, transient knockdown of lamin A/C or its nucleoplasmic binding 
partner, LAP2α, did not induce cellular senescence in these cells 5 days post-
transfection, as assessed by SA β-gal positivity and p16INK4A expression, a known 
marker of senescent cells (Campisi, 2005). The results in this chapter therefore do 
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not confirm the hypothesis that loss of LAP2α-lamin A/C complexes induces 
senescence. How can the apparent discrepancies between these results and the 
findings using Y259X cells in Chapter 3 be explained?  Firstly, as can be seen in 
Figure 4.1, knockdown of lamin A/C or LAP2α in HDFs is never complete, as has 
been recognised previously (Pekovic et al., 2007). Moreover, this phenomenon is 
not specific to the siRNA used as others have reported the inability of HDFs to 
efficiently respond to RNAi of LMNA (Vos et al., 2010). A-type lamins incorporated 
into the nuclear lamina exhibit a slow turnover rate, as demonstrated by FRAP 
studies using GFP-tagged lamin A and C (Broers et al., 1999). In contrast, the 
turnover of nucleoplasmic A-type lamins was much faster. In the present work, 
depletion of lamin A/C was most evident within the nucleoplasm. This suggests 
that the altered cell cycle effects demonstrated in this chapter may be due to loss 
of nucleoplasmic lamin A/C pools, rather than lamin A/C at the nuclear envelope, 
which were not down-regulated as effectively, probably due to their slow turnover. 
Importantly, the inability to effectively downregulate lamin A/C completely in HDFs 
distinguishes the lamin A/C-depleted cells from the Y259X cells, where absolutely 
no lamin A/C protein is present. The most obvious comparison to make between 
the two cellular backgrounds (i.e. lamin A/C-depleted HDFs vs. Y259X cells) is 
nuclear shape. Whilst Y259X exhibit gross changes in nuclear architecture and 
shape, I could not observe appreciable differences in nuclear shape in lamin A/C-
depleted HDFs, most likely due to residual lamin A/C protein (data not shown). 
Therefore, this may help explain why I could not observe an increase in SA β-gal 
activity in lamin A/C or LAP2α depleted HDFs, as knockdown was never 
complete. Secondly, as this assay was carried out on day 5 post-RNAi 
transfection, future work might examine potential senescent phenotypes using this 
assay at later timepoints. Indeed, this should be extended to the preparation of 
protein extracts. Prior studies have shown that p16INK4A expression levels 
increase notably both in vitro and in vivo between 1 and 4 weeks in response to 
UV, oxidative stress, IR and telomere dysfunction (Piepkorn, 2000; Jacobs and 
De Lange, 2004; Stockl et al., 2006). This delayed induction of p16INK4A is in stark 
contrast to the rapid induction of p21Cip, the transcriptional target of activated p53, 
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in response to cellular aging in vitro (Stein et al., 1999). In this study, induction of 
p21Cip preceded the induction of p16INK4A, with p21Cip expression abruptly 
downregulated once most cells were positive for SA β-gal activity (Stein et al., 
1999). Underlining this, a more recent study has shown that the expression of 
these two CKIs do not overlap in individual cells (Herbig et al., 2004). Therefore, 
there are two important avenues to explore in the future to clarify whether 
depletion of the LAP2α or lamin A/C in HDFs leads to senescence. Firstly, 
examination of p16INK4A expression levels 5 days post-transfection should be 
extended beyond this timepoint to between 2-4 weeks post-transfection, with 
repeated transfections. Secondly, other regulators of the G1 checkpoint need to 
be examined, such as p21Cip protein expression, p27 protein levels, cdk2 
phosphorylation and Cdc25A protein levels (Bartek and Lukas, 2001). In sum, I 
suggest that the inability to detect the activation of a senescence programme in 
HDFs depleted of LAP2α or lamin A/C may be due to a combination of incomplete 
downregulation of these proteins and the temporal assessment of the entry into 
senescence. 
 
In light of these suggestions, one potential problem with using later timepoints for 
both the SA β-gal assay and preparing protein extracts is that the non-transfected 
cells or cells that have not undergone cell cycle arrest are able to proliferate and 
become the dominant cell type in the culture. This might be overcome by the 
production of stable inducible RNAi HDF cell lines. One problem with producing 
stable inducible knockdown cell lines in HDFs is the finite replicative potential of 
HDFs, which would age in culture as stable clones were isolated. Therefore this 
methodology would not represent a good model for studying potential induced 
senescent pathways or provide a renewable source of cells. Instead, it would be 
possible to produce stable inducible knockdown HDFs using a human fibroblast 
cell line that have been immortalised with a retrovirus containing the hTERT gene 
flanked by Cre-recombinase excision sites (Rubio et al., 2002). Importantly, after 
stable inducible knockdown cells have been created, the hTERT gene may be 
excised by expression of Cre recombinase, therefore rendering the proliferative 
potential of the fibroblasts as finite, rather than infinite in the presence of hTERT 
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expression. Once hTERT has been excised it would thus be possible to induce 
stable knockdown of LAP2α or lamins A/C in HDFs and use these cell lines for 
more in-depth studies of complete loss of either in senescence pathways.  
4.6.3 Reducing ROS levels associated with loss of LAP2α or lamin A/C 
cannot ameliorate proliferative defects 
In order to explain the observed cell cycle exit by 72 of either LAP2α or lamin A/C 
depleted HDFs, I explored the possibility that accumulation of endogenous levels 
of DNA damage in these cells might lead to G1 arrest. Notably, I could not detect 
increases in two ATM targets, γ-H2AX and phospho-Chk2. This was surprising as 
lamin null HDFs, Y259X cells, display significantly increased levels of endogenous 
γ-H2AX (Chapter 5). However, based on my previous argument, I would suggest 
that the incomplete knockdown of either LAP2α or lamin A/C may be one reason 
why no increase in γ-H2AX and phospho-Chk2 was observed. Alternatively, as 
the activation of these two targets is in response to double strand breaks (DSBs), 
other forms of DNA damage may contribute to the G1 arrest. Alternative DNA 
damage assays, such as the comet and 8-oxo-dG assays, which detect single 
strand breaks and oxidative DNA damage, could be used to further interrogate 
whether these forms of DNA damage contribute to the G1-arrest in response to 
loss of lamin A/C or LAP2α. Furthermore, other pathways to explore that are 
activated in response to DNA damage are the ATR-Chk1 pathway and the 
p38MAPK-MK2 pathway (Reinhardt and Yaffe, 2009; Ciccia and Elledge, 2010). 
The ATR-Chk1 pathways is primarily activated in response to single-strand breaks 
and replication stress, whilst the p38MAPK-MK2 pathways is a general stress 
pathway that is activated by UV, IR, osmotic stress, heat shock, cytokines and 
ROS (Reinhardt and Yaffe, 2009).  
  
As A-type lamins are involved in multiple signalling pathways, the observed cell 
cycle arrest by 72 hours in response to loss of nucleoplasmic LAP2α and lamin 
A/C appears to be independent of endogenous DNA damage but could be caused 
by defects in other associated pathways (Pekovic and Hutchison, 2009). Based 
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on the results presented in Chapter 3, one such pathway I explored was the 
oxidative stress response. As I found for Y259X cells, HDFs depleted of lamin A/C 
and its nucleoplasmic binding partner, LAP2α, exhibited ROS levels that were ~ 2-
fold higher than control HDFs. Importantly, these levels could be effectively 
rescued by treatment with the ROS scavenger, NAC. However, long-term acute 
treatment of LAP2α or lamin A/C depleted HDFs with NAC could not rescue the 
proliferative defects associated with the down-regulation of either of these 
proteins. These results suggest that high ROS levels caused by loss of either 
LAP2α or lamin A/C is not the primary causes of cell cycle arrest. In the context of 
laminopathies, these results indicate two important conclusions. Firstly, in 
laminopathies with associated high levels of ROS, patients may be treated with 
NAC to reduce cellular and systemic ROS levels. For example, it was shown that 
patient blood samples exhibited high levels of ROS in amyotrophic quadricipital 
syndrome with cardiac impairment due to mutations in lamin A/C (Charniot et al. 
2007). NAC has also been shown to exert protective effects in fibroblasts from 
patients with Alzheimer’s disease, which exhibit high levels of ROS (Moreira et al., 
2007). Exploiting NAC to treat laminopathy patients may therefore be a promising 
avenue to ameliorate some disease phenotypes. Future work should seek to 
exploit the range of laminopathy mouse models that have been created and 
empirically determine the effects of anti-oxidants such as NAC on the disease 
phenotype (Stewart et al., 2007). 
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CHAPTER 5:  
THE ROLE OF A-TYPE LAMINS IN THE DNA DAMAGE 
RESPONSE 
5.1 Introduction 
5.1.1 Overview 
The genomic integrity of mammalian cells is constantly challenged by 
endogenous insults of metabolic by-products such as reactive oxygen species 
(ROS), as well as environmental factors such as chemical agents and ultraviolet 
(UV) radiation (Ciccia and Elledge, 2010). Limits to the fidelity of DNA metabolism 
including replication, recombination, and repair also promote genomic instability. 
Thus, DNA integrity is threatened from multiple sides, with one estimate 
calculating that each cell may encounter up to 105 lesions per cell per day 
(Hoeijmakers, 2009). To combat this, the DNA damage response (DDR) 
represents a complex set of spatiotemporal events that are essential for cellular 
fate in response to genomic insults (Jackson and Bartek, 2009). This vital signal 
transduction pathway acts as a cellular defence mechanism for the preservation 
of genomic integrity. 
 
The DNA repair pathway employed by the cell is dictated by the type of genomic 
insult, which creates different types of DNA damage (Sancar et al., 2004). 
Damaged DNA is sensed and amplified to expedite a series of sequential events 
that cooperate to form an integrated network of cellular responses collectively 
known as the DNA damage response (Figure 5.1). Within the DDR signalling 
hierarchy, DNA damage sensors transmit the signal to transducers and effectors 
via mediator proteins. The effector proteins are responsible for impacting on 
various cellular pathways such as DNA repair, transcriptional response, DNA 
damage checkpoints and apoptosis, to either repair the DNA or eliminate cells 
where the damage is beyond repair (Figure 5.1) (Zhou and Elledge, 2000; 
Jackson and Bartek, 2009). When repair pathways are engaged, it is essential 
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that these pathways signal to the cell cycle machinery to prevent cell cycle 
progression in the presence of DNA damage so that the damage is not replicated 
and inherited by the daughter cell. Thus, failure to cope correctly with DNA 
damage may cause accumulation of genomic rearrangements that promote 
tumorigenesis (Bartkova et al., 2006; Di Micco et al., 2006; Halazonetis et al., 
2008). Indeed, mutations in genes involved in the DNA damage response often 
lead to cancer predisposition (e.g. BRCA1 mutations lead to breast and ovarian 
cancer) and premature aging, therefore highlighting the importance of this 
signalling pathway as both an anti-oncogenic barrier and essential component of 
the normal aging process (Halazonetis et al., 2008). 
 
Figure 5.1. The DNA damage response in mammalian cells. The hierarchical 
nature of the of this signal transduction pathway, via sensors, mediators and then 
transducers and effectors, is responsible for impacting major biological outputs 
that together form the DNA damage response. For simplicity, the pathways are 
shown in a linear manner, however, in reality there is extensive crosstalk between 
them. DNA damage sensors include the MRN complex, Rad9-Hus1-Rad1 and 
Rad17. The ATM and ATR kinases, and their downstream targets Chk1 and 
Chk2, act as transducers and effectors of the DNA damage signal, respectively. 
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Mediator proteins such as MDC1, 53BP1, BRCA1 and TopBP1 enhance the 
signal and facilitate an effective DDR and a range of cellular responses (Jackson 
and Bartek, 2009). 
 
5.1.2 Lamins and the DDR 
Defects in prelamin A processing, either in Zmpste24-/- MEFs and HGPS cells 
have been linked to activation of the DDR (Liu et al., 2005; Varela et al., 2005). 
These cells exhibit increased levels of DNA damage, impaired DNA repair 
pathways and sensitivity to a range of genotoxic stresses (Liu et al., 2005). One 
protein important component of the DDR, 53BP1, was shown to exhibit delayed 
recruitment to sites of DNA damage in HGPS cells, suggesting that the presence 
of unprocessed prelamin A inhibits the upstream signaling events necessary for 
the recruitment of 53BP1 (Liu et al., 2005). Further to this, a recent study has 
shown that Lmna-/- MEFs display reduced 53BP1 protein levels (Gonzalez-Suarez 
et al., 2009). Therefore, as a modulator of 53BP1 levels, A-type lamins have been 
implicated in the DDR. 
5.1.3 Current aims 
Previous studies have implicated A-type lamins in the DDR. However, this role 
has been in the context of unprocessed mutant lamin A. In this chapter, I explore 
the hypothesis that mature wild type lamin A/C has a role in DNA repair pathways 
and ultimately genomic maintenance.  
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5.2 53BP1 co-fractionates with A-type lamins in HDFs 
Previous studies have shown that in the presence of unprocessed lamin A, 
recruitment of 53BP1 to sites of DNA damage is delayed (Liu et al., 2005). 
Furthermore, a range of GFP-tagged lamin A mutants expressed in HeLa cells 
have been shown to inhibit 53BP1 foci formation in response to DNA damage 
(Manju et al., 2006). I therefore postulated that 53BP1 might interact with wild type 
lamin A/C and if so share some biochemical properties. One characteristic of A-
type lamins is their resistance to extraction with detergents and high salts. To 
investigate if a pool of 53BP1 also co-existed within these A-type lamin fractions, I 
performed sequential extraction and immunoblotting of proliferating early passage 
human dermal fibroblasts (HDFs; Ki67 index ~ 70%, data not shown). As 
expected, lamin A/C and lamin B2 were strongly resistant to all extraction steps; 
however, 53BP1 existed as three distinct pools. The first pool was readily 
extracted with Triton X-100 (CSK/T), the second pool was extracted with DNase I 
and the third was completely resistant to extraction (Figure 5.2a). As a control, 
blots were probed with anti-histone H2A antibodies. As expected H2A was 
completely soluble following DNase I treatment (Figure 5.2a, see DNase I S4/P4 
lanes). In response to DNA damage, 53BP1 becomes chromatin bound via 
interaction with methylated lysine 20 of histone H4 (Iwabuchi et al., 2003; Botuyan 
et al., 2006; Pei et al., 2011).  Following treatment of HDFs with 3 Gy ionizing 
radiation (IR) 53BP1 was completely soluble following DNase I treatment (Figure 
5.2b). Furthermore, the level of lamin A/C levels in the S4 fraction also increased, 
suggesting that a pool, predominantly lamin A, becomes chromatin bound in 
response to DNA damage (Figure 5.2b). In contrast to this, lamin B1 did not show 
any differences in extraction properties between untreated and IR (Figure 5.2a,b). 
To further investigate the status of 53BP1 and A-type lamins in response to DNA 
damage, HDFs were extracted in situ and processed for immunofluorescence 
(Pekovic et al., 2007). As a positive control, cells were stained with NuMA, a 
component of the nuclease- and salt-resistant nuclear matrix (Figure 5.2e). 
Consistent with previous studies, in untreated cells, 53BP1 typically showed a 
diffuse nucleoplasmic signal with occasional accumulation in 1-5 large foci and an 
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absence from nucleoli (Figure 5.2c) (Schultz et al., 2000; Lukas et al., 2011). After 
extraction with nucleases and salt, 53BP1 still existed as a diffuse signal 
throughout the nucleoplasm (Figure 5.2c). This suggests that, in untreated cells, 
53BP1 is largely insoluble in human fibroblasts and is anchored within the nucleus 
independently of chromatin.  Lamins A/C were also resistant to extraction in 
untreated HDFs, as shown previously (Pekovic et al., 2007). In response to DNA 
damage, 53BP1 relocalised to ionizing radiation induced foci (IRIF), which were 
resistant to detergent extraction. However, these foci were fully extracted after 
treatment with DNase I, reaffirming the finding that in HDFs 53BP1 is chromatin 
bound after DNA damage (Figure 5.2d). In contrast, lamin A/C did not re-localise 
to IRIFs 1 hour post-IR and remained largely resistant to all extraction steps 
(Figure 5.2d). Together, this data suggests that DNA damage causes 53BP1 to 
relocalise from a nuclear matrix-bound pool to sites of DNA damage in HDFs, 
whilst lamin A/C localisation and solubility properties remain largely unchanged. 
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Figure 5.2. 53BP1 cofractionates with lamin A/C in HDFs. (a-b) Proliferating 
HDFs were biochemically fractionated with a sequence of detergent, nuclease 
and salt extraction, either with (a) or without IR (b). Protein extracts were 
subjected to reducing SDS-PAGE and immunoblotted with the indicated 
antibodies. (c-d) HDFs were extracted in situ, with or without IR treatment, before 
being processed for immunofluorescence with lamin A and 53BP1 antibodies. (e) 
A positive control for retention of nuclear matrix proteins using anti-NuMA and 
anti-lamin A antibodies. Scale bars, 10 µm. 
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5.3 A-type lamins promote genome stability and mediate 53BP1 
protein levels 
A previous report had shown that immortalised Lmna-/- MEFs have reduced 
53BP1 protein levels (Gonzalez-Suarez et al., 2009). To corroborate these 
findings in primary human cells, I performed immunoblotting and 
immunofluorescence on human fibroblasts harbouring a homozygous Y259X 
mutation in the LMNA gene, which renders these cells lamin A/C-null (Muchir et 
al., 2003). 53BP1 protein levels were absent from Y259X fibroblasts but readily 
detectable in normal fibroblasts using both methods (Figure 5.3a). This effect 
appeared specific to 53BP1 as another DNA damage response protein, Rad51, 
was expressed at wild type levels (Figure 5.3a). Moreover, the phosphorylated 
form of H2AX was present at much higher levels in Y259X fibroblasts when 
compared to controls (Figure 5.3b) and was accumulated in multiple DNA damage 
foci (Figure 5.3c). 
 
In order to confirm the lamin A/C-dependency of maintaining 53BP1 protein 
levels, wild type HDFs were depleted of lamin A/C using siRNA. Following siRNA 
depletion of lamin A/C in HDFs there was a substantial decrease (~75%) in 
53BP1 protein levels (Figure 5.3d). This effect was not specific to HDFs as U2OS 
cells depleted of A-type lamins also showed substantially decreased levels of total 
53BP1, with densitometry revealing a decrease of ~65% in 53BP1 protein levels 
(Figure 5.4a). A previous study showed that loss of pRb protein levels are 
significantly reduced in Lmna-/- MEFs (Johnson et al., 2004). Furthermore, 
treatment of Lmna-/- MEFs with a proteasome inhibitor effectively rescued pRb 
protein levels, suggesting that the reduced pRb protein levels were due to 
degradation by the proteasome (Johnson et al.., 2004). Taking inspiration from 
this, HDFs and Y259X cells were treated with the proteasome inhibitor MG-132. 
Proteasome inhibition rescued the protein levels of 53BP1 in Y259X HDFs, with 
densitometry showing a ~3 fold increase in 53BP1 levels in Y259X cells (Figure 
5.3e). Furthermore, proteasome inhibition also rescued 53BP1 protein levels in 
HDFs depleted of lamin A/C by siRNA, with densitometry revealing that the initial 
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levels were ~50% lower in lamin A/C-depleted HDFs without proteasome 
inhibition but were similar to control HDFs after proteasome inhibition (Figure 
5.4b). However, despite this, when assessed by confocal microscopy, the nuclear 
localisation of 53BP1 was not restored following proteasome inhibition (Figure 
5.3f). Notably, 53BP1 foci were absent in HDFs after proteasome inhibition, which 
is in keeping with previous reports showing that blocking ubiquitylation events by 
proteasome inhibition prevents 53BP1 accumulation in foci (Mailand et al., 2007) 
(Figure 3.5f). Taken together, this data suggests two important findings. Firstly, 
that lamin A/C is required for the correct localisation of 53BP1 within the nucleus. 
Secondly, it suggests that cytoplasmic 53BP1 is degraded by the proteasome in 
the absence of lamin A/C.  
 
Previous data from our laboratory has shown that Y259X HDFs have a low 
proliferative index and undergo premature senescence (Pekovic et al., 2007). To 
discount against any cell cycle effects on 53BP1 protein levels, I prepared 
extracts from proliferating, quiescent and stress-induced prematurely senescent 
wild type HDFs. Immunoblotting revealed that total lamin A/C and 53BP1 protein 
levels did not change in these three different proliferative conditions, suggesting 
that the loss of 53BP1 is not cell cycle specific, but dependent on lamin A/C status 
(Figure 5.4c). Together, this data suggests that, in the absence of lamin A/C, 
HDFs exhibit increased genomic instability which is correlated with loss of 53BP1 
protein levels, a known mediator of the DDR (Wang et al., 2002). 
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Figure 5.3. A-type lamins promote 53BP1 stability and nuclear localisation. 
(a-b) Whole cell extracts from wild type and Y259X HDFs were analysed by 
immunoblotting with the indicated antibodies. (c) Wild type and Y259X HDFs were 
fixed, processed for immunofluorescence and co-stained with DAPI and anti-γ-
H2AX antibody. (d) HDFs were transfected with control (Con) or lamin A/C 
(LMNA) siRNA and whole cell extracts prepared after 72 hours and analysed by 
immunoblotting with the indicated antibodies. (e) Wild type or Y259X HDFs were 
treated with MG-132 (30 µм) for 6 hours before protein extracts were prepared. 
Total levels of 53BP1 were assessed by immunoblotting. Boxed values represent 
53BP1 protein levels as assessed by densitometry. (f) Immunofluorescence 
analysis of cells from (e) using DAPI and anti-53BP1 antibody. Scale bars, 10 µm. 
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Figure 5.4. Depletion of A-type lamins promotes 53BP1 protein instability.  
(a) U2OS cells were transfected with control (Con) or lamin A/C (LMNA) siRNA for 
72 hours before whole cell extracts were prepared and 53BP1 levels assessed by 
immunoblotting. Boxed values represent 53BP1 protein levels as assessed by 
densitometry. (b) HDFs transfected as in (a) were treated with MG-132 (30 µм) for 
6 hours before whole cell extracts were assessed by immunoblotting for 53BP1 
levels. Boxed values represent 53BP1 protein levels as assessed by 
densitometry. (c) Cell extracts were prepared from proliferating HDFs, quiescent 
HDFs and HDFs induced to undergo stress-induced premature senescence and 
protein levels were assessed by immunoblotting with the indicated antibodies. 
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5.4 53BP1 interacts with A-type lamins via its C-terminal domain, 
which is lost upon DNA damage 
Based on the above findings and previous reports (Gonzalez-Suarez et al., 2009), 
I sought to determine if the loss of 53BP1 protein levels in the absence of lamin 
A/C reflected an underlying interaction between lamin A/C and 53BP1. Attempts 
to immunoprecipitate 53BP1 from endogenous lamin A/C complexes using high 
salt conditions (500 mM NaCl) were unsuccessful (data not shown). Therefore, I 
first crosslinked proteins in vivo using the reversible protein crosslinker dithiobis 
(succinimidyl propionate) (DSP), followed by lysis in a low salt buffer (150 mM) 
and sonication (Fujita et al., 2002; MacKay et al., 2009). Immunoprecipitation of 
endogenous lamin A/C from HDFs using these conditions showed that 53BP1 
was present in lamin A/C immunoprecipitates, but absent from control IgG 
immunoprecipitates (Figure 5.5a). Importantly, this interaction was clearly 
decreased following DNA damage. To determine whether 53BP1 preferentially 
binds lamin A or lamin C, I co-transfected HEK293T cells (which do not express 
endogenous lamin A/C) with GFP-tagged lamin A or C together with HA-53BP1. 
Cell extracts were prepared and subjected to immunoprecipitation with GFP-Trap 
beads. Immunoblotting revealed that HA-53BP1 bound equally to lamin A and C 
(Figure 5.5b). To confirm these findings, Y259X cells were transfected with GFP-
lamin A or GFP-lamin C and the distribution of 53BP1 was investigated by 
confocal microscopy. Expression of GFP-lamin A and GFP-lamin C both resulted 
in nuclear localisation of 53BP1, whereas expression of GFP alone did not (Figure 
5.6).  
 
To further study the interaction between 53BP1 and lamin A, stable U2OS cell 
lines expressing GFP or GFP-lamin A were created. As expected, GFP-lamin A 
localised both at the nuclear envelope and within the nucleoplasm (Figure 5.7a,b). 
Importantly, endogenous protein levels of 53BP1 were unchanged in U2OS/GFP-
lamin A cells. Microscopy revealed that large nucleoplasmic foci of 53BP1 in 
undamaged cells were largely non-coincident with nucleoplasmic lamin A foci 
(Figure 5.7c). Lamin A fluorescence signal was typically greater at the nuclear 
198 
 
 
envelope with a lower fluorescence intensity but uniform distribution within the 
nucleoplasm, whilst 53BP1 showed a similar uniform distribution in the 
nucleoplasm with the exception of large foci and absence from nucleoli.  
 
In order to map the lamin A interacting domain of 53BP1, I used a panel of HA-
53BP1 constructs and expressed them in U2OS/GFP-lamin A cells. GFP-lamin A 
complexes were obtained by immunoprecipitation and the bound proteins 
analysed by immunoblotting. Results revealed that HA-53BP1 constructs 
containing the Tudor domain interacted strongly with lamin A (represented by + in 
Figure 5.5d), whilst the HA-53BP1 BRCT domain interacted weakly with lamin A 
(represented by +/- in Figure 5.5d). Underlining this, densitometry revealed that 
the HA-53BP1 BRCT signal was only ~20% that of the HA-53BP1 ΔBRCT signal. 
Therefore, these results strongly suggest that lamin A and C interact with a region 
surrounding the 53BP1 Tudor domain.  
 
Previous reports have shown that a large number of proteins become 
phosphorylated upon DNA damage (Matsuoka et al., 2007; Stokes et al., 2007). 
However, DNA damage-dependent phosphorylation of 53BP1 is independent of 
its IRIF localisation (Ward et al., 2003). As I have shown that the interaction 
between lamin A and 53BP1 was decreased by DNA damage, I asked whether 
phosphorylation events in toto were important for this dissociation following DNA 
damage. I therefore treated U2OS/GFP-lamin A cells with the PIKK-inhibitor, 
caffeine, for 1 hour prior to IR treatment. Immunoprecipitation of GFP-lamin A 
complexes showed that endogenous 53BP1 dissociated with GFP-lamin A in 
response to IR (Figure 5.5e). However, blocking phosphorylation events via 
caffeine prevented this dissociation following DNA damage, with densitometry 
revealing that the levels of 53BP1 in caffeine/IR treated GFP-lamin A 
immunoprecipitates were ~70% of the untreated levels (Figure 5.5e). Together, 
this data reveals that 53BP1 interacts with A-type lamins via an area surrounding 
its Tudor domain and this interaction decreases via phosphorylation events in a 
DNA damage-dependent manner. 
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Figure 5.5. A-type lamins interact with the 53BP1 C-terminus, which is lost 
upon DNA damage in a phosphorylation-dependent manner. (a) HDFs were 
crosslinked in vivo before cell extracts were prepared and added to antibody-
bound Dynabeads. Bound complexes were analysed by immunoblotting with anti-
lamin A/C (Jol2) and anti-53BP1 antibodies. (b) HEK293T cells were co-
transfected with full length HA-53BP1 and either GFP-lamin C or GFP-lamin A 
and cell extracts were subjected to immunoprecipitation with GFP-Trap beads. 
Bound complexes were analysed by immunoblotting with anti-HA and anti-GFP 
antibodies. (c) U2OS/GFP-lamin A cells were transfected with HA-53BP1 
constructs for 24 hours before extracts were prepared and subjected to 
immunoprecipitation with GFP-Trap beads. Bound complexes were analysed by 
immunoblotting with anti-HA and anti-GFP antibodies. (d) HA-53BP1 constructs 
used for interaction studies, fragments that form at IRIFs are indicated (Iwabuchi 
et al., 2003). (e) U2OS/GFP-lamin A cells were pre-treated with caffeine (20 mм) 
for 1 hour before IR. Extracts were prepared and subjected to 
immunoprecipitation with GFP-Trap beads followed by immunoblotting. Bound 
endogenous 53BP1 was assessed using anti-53BP1 antibody. 
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Figure 5.6. Reintroduction of lamin A and C in Y259X cells restores 53BP1 
nuclear localization. Y259X cells were transfected with either GFP, GFP-lamin C 
or GFP-lamin A, fixed after 48 hours and immunostained with anti-53BP1 
antibody. Outline indicates area occupied by DAPI signal. Scale bar, 10 µm. 
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Figure 5.7. Generation of a U2OS/GFP-lamin A stable cell line. (a) Whole cell 
extracts prepared and total levels of lamin A and 53BP1 were assessed by 
immunoblotting with anti-lamin A/C (Jol2) and 53BP1 antibodies. (b) Micrographs 
of U2OS/GFP and U2OS/GFP-lamin A cells. (c) U2OS/GFP and U2OS/GFP-
lamin A cells were fixed, processed for immunofluorescence and stained with anti-
53BP1 antibody. Graph shows the fluorescence intensity from GFP and 53BP1 
signals from the indicated cell. Scale bars, 10 µm. 
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5.5 Lamin A/C-deficient cells display DNA repair defects and 
reduced cellular fitness in response to DNA damage  
As I have shown that A-type lamins interact with 53BP1, a component of the DNA 
damage response, I investigated what affect loss of A-type lamins would have on 
the DNA repair process. I used residual γ-H2AX foci as a readout to assess DNA 
repair efficiency (Figure 5.8a-d). Cells were treated with a relatively small dose of 
IR (3 Gy) as it has been shown that cells depleted of 53BP1 display a defective 
DNA damage response in response to 3 Gy rather than higher doses (10 Gy) 
(Wang et al., 2002). Even without IR, Y259X cells exhibited increased numbers of 
γ-H2AX foci compared to wild type HDFs, indicating increased levels of genomic 
instability even in the absence of genotoxic stress, as noted previously (Figure 
5.8e). After IR, which predominantly induces double strand breaks, wild type 
HDFs were able to effectively repair most DNA damage as γ-H2AX foci numbers 
over 24 hours. Note that DSB repair was biphasic in nature, with an initial larger 
fast component, which has been shown to typically represent repair of 
euchromatin, and a smaller slow component, which represents the repair of 
heterochromatin (Figure 5.8e) (Goodarzi et al., 2010). In contrast, although Y259X 
cells were able to induce a similar number of γ-H2AX foci after 0.5 hours 
compared to wild type HDFs, they exhibited a significant inability to repair late 
kinetic DSBs (Figure 5.8e). Together, this data suggests that A-type lamins help 
promote DNA repair in response to genotoxic stress in human fibroblasts. 
 
Double strand breaks generated by IR are scattered randomly throughout the 
genome. Therefore, to circumvent problems in assaying DNA repair in real time, 
advances have been made to compartmentalise DSBs using a technique known 
as laser micro-irradiation (Lukas et al., 2003; 2005). This technique utilises an old 
finding that incorporation of halogenated thymidine analogs (BrdU, IdU) 
presensitises DNA to light within the UV-A spectrum, which generates a 
photochemical reaction to induce DNA damage (Limoli and Ward, 1993). Wild 
type HDFs and Y259X cells were presensitised by addition of BrdU for 24 hours 
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before being subject to laser micro-irradiation. Immunostaining revealed reduced 
γ-H2AX induction in the laser stripes of Y259X cells, with densitometry of the laser 
stripe revealing that the signal intensity was ~ 50% that of wild type HDFs 0.5 
after laser-irradiation (Figure 5.8f). This suggests that phosphorylation of H2AX in 
these laser stripes is inhibited in the absence of A-type lamins. Notably, this is in 
direct contrast to the IR data which shows that induction of H2AX phosphorylation 
is comparable in both Y259X and HDFs (Figure 5.8e,f). 
 
To complement these studies using a different cell line widely used to study the 
DNA damage response (U2OS cells, derived from an osteosarcoma), I assessed 
the ability of cells depleted of lamin A/C by RNAi to effectively repair DNA 
damage. Control or lamin A/C-depleted U2OS ells were treated cells with IR (5 
Gy) and whole cell extracts prepared after various time points thereafter. U2OS 
cells treated with control siRNA exhibited a transient spike in γ-H2AX levels 
(histone H2A served as a histone loading control), which decreased over time, 
suggestive of effective DNA repair. In lamin A/C-depleted cells I again observed 
increased levels of γ-H2AX even in the absence of genotoxic stress (Figure 5.8g). 
In response to IR, ATM-mediated signalling of γ-H2AX was increased above 
supra-physiological levels in cells depleted of A-type lamins (Figure 5.8g). 
Furthermore, lamin A/C-depleted cells still displayed elevated γ-H2AX levels 24 
hours post-IR compared to the untreated sample (Figure 5.8g). To assess the 
long-term effects on cellular fitness in response to DNA damage, colony forming 
assays revealed that depletion of A-type lamins significantly and reproducibly 
reduced cellular survival in response to even low doses of IR (Figure 5.8h and 
Supplementary Figure 8 for knockdown efficiencies). This data strongly suggests 
that fully processed A-type lamins have a functional role in the DNA repair 
process and are involved in the maintenance of genomic stability.  
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Figure 5.8. A-type lamin depletion inhibits DNA repair and reduces cellular 
fitness to DNA damage. (a-d) HDFs and Y259X cells were treated with IR (3 
Gy), fixed at the times indicated and processed for immunofluorescence before 
staining with anti-γ-H2AX antibody. (e) Quantification of data from (a-d). (f) HDFs 
and Y259X were subjected to laser micro-irradiation, fixed after 0.5 h and 
immunostained with anti-γ-H2AX and 53BP1 antibodies and DAPI. (g) U2OS 
were transfected twice in 24 h with control (siCon) or lamin A/C (siLMNA) siRNA 
and exposed to IR (5 Gy) 72 h later. Whole cell extracts were prepared and 
assessed by immunoblotting with the indicated antibodies. (h) U2OS cells were 
transfected as in (g) and plated onto 60mm plates 72 h later. The cells were then 
exposed to varying doses of IR. After 12 days, plates were fixed and stained with 
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crystal violet and viable colonies counted. Data in (e) and (h) represent the mean 
± s.d from three independent experiments. * p<0.05 relative to HDFs (e) or siCon 
(h) at each timepoint. Scale bars, 10 µm. 
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5.6 Discussion 
5.6.1 Lamin A/C as a chromatin binding protein 
Previous studies have shown that the production of mutant forms of lamin A, 
either in RD or HGPS cells, causes increased DNA damage, enhanced 
downstream signalling events and a failure to repair genotoxic stress-induced 
DNA damage (Liu et al., 2005; Liu et al., 2006; Liu et al., 2007). A recent study 
has shown that the DNA damage mediator protein, 53BP1, exhibits reduced 
protein stability in the absence of A-type lamins using Lmna-/- MEFs (Gonzalez-
Suarez et al., 2009). Based on this finding, I investigated whether A-type lamins in 
HDFs might have a similar role and thus implicate A-type lamins in the DDR. 
Biochemical fractionation results demonstrated that 53BP1 exists in three 
subpopulations in HDFs: soluble, chromatin-bound and insoluble. The latter pool 
of 53BP1 co-fractionated with both A- and B-types lamins, both of which are 
resistant to the fractionation process. In response to DNA damage, biochemical 
fractionation showed that 53BP1 is almost exclusively chromatin-bound, as 
described previously for MCF7 cells (Iwabuchi et al., 2003). As the largest pool of 
53BP1 in untreated proliferating HDFs was in the insoluble fraction, it seems that 
this fraction is induced to IRIF upon DNA damage. In contrast, lamin A showed no 
differential solubility properties in response to DNA damage and although some 
lamin A was evident in the DNase I digested fraction, this was variable between 
experiments and thus is likely an artefact. Immunostaining of in situ extracted 
HDFs in response to IR confirmed the loss of 53BP1 in the DNase I digested 
fraction in response to DNA damage. Again, immunostaining revealed no changes 
in lamin A/C solubility in response to DNA damage. As lamin A/C has been 
proposed to be a chromatin scaffold, how might lamin A/C participate in chromatin 
dynamics during DNA damage? Lamin A forms nucleoplasmic foci in G1-phase of 
the cell cycle that colocalises with areas of dense chromatin (Bridger et al., 1993). 
Furthermore, lamin A/C was shown to be a chromatin-binding protein and the 
region for this interaction has been mapped to a region after the α-helical coiled-
coil domain (Taniura et al., 1995). Interestingly, this region contains a potential 
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phosphorylation domain with SQ/TQ motifs that are phosphorylated in response to 
DNA damage (see Chapter 6). The possibility therefore arises that lamin A/C 
phosphorylation may regulate the ability of the protein to bind chromatin. Future 
work should seek to clarify the finding that lamin A/C binds core histones, and 
explore which specific histone lamin A/C interacts with. Recently, a proteomic 
study of Flag-H2AX-interacting proteins showed a peptide matching lamin A/C 
was among the proteins identified (Yang et al., 2010). Therefore, whether A-type 
lamins interact with γ-H2AX at DSBs could be addressed using chromatin 
immunoprecipitation (ChIP) assays and assessing the presence of lamin A/C in 
the immunoprecipitates. Mutating residues in the lamin A/C SQ/TQ motif will also 
provide proof if phosphorylation of lamin A/C regulates chromatin interactions in 
response to DNA damage. One particular function for any lamin A/C-histone 
interaction may be to aid chromatin relaxation during DNA damage. Chromatin 
remodelling and relaxation are essential for the effective recruitment of repair 
proteins in response to DNA damage (Bao and Shen, 2007; Peng et al., 2009). 
The role of known chromatin mobility proteins EXPAND1 and KAP1 might also be 
explored in lamin A/C depleted cells (Ziv et al., 2006; Huen et al., 2010). 
5.6.2 A-type lamins do not relocalise to IRIF 
One defining characteristic of DDR proteins is their accumulation at IRIF and yet 
there are a number of other proteins that do not accumulate at IRIF such as p53, 
Chk1, Chk2, Ku70 and DNA-PK (Bekker-Jensen and Mailand, 2010). These 
proteins are bona fide DDR proteins, and there is evidence to suggest that they 
only act transiently with areas of DNA damage before embarking on pan-nuclear 
signaling roles (e.g. for p53, Chk1, and Chk2). In the case of Ku70 and DNA-PK, 
as only a small number of molecules interact with DNA ends, it is likely that their 
presence is beyond the limitations of current microscopy techniques (Downs and 
Jackson, 2004). As a structural component of the nucleus, it is of no surprise that 
A-type lamins do not relocalise to IRIF. However, based on the observations that 
proteins such as p53 and Chk1 do not relocalise to IRIF, one mechanism not 
explored in this study is the potential role that A-type lamins have in various 
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signaling mechanisms in response to DNA damage (Pekovic and Hutchison, 
2009). Lamin A/C-LAP2α complexes tether the tumour suppressor pRb in the 
nucleoplasm via its C-terminal pocket C region (Markiewicz et al., 2002; Dechat et 
al., 2004; Dorner et al., 2006). A clear role for lamin A/C-LAP2α complexes in 
controlling cell cycle progression has therefore been established (Dorner et al., 
2006; Pekovic et al., 2007). One avenue of future research should therefore 
address the role of lamin A/C in controlling cell cycle progression in response to 
the DNA damage using flow cytometry to determine if loss of A-type lamins has 
any effects on the G1-S, intra-S and G2/M-phase checkpoints.  
5.6.3 A-type lamins mediate 53BP1 protein stability  
Having determined the biochemical properties of lamin A/C and 53BP1 in HDFs, I 
then utilised cells harbouring a homozygous Y259X mutation in LMNA, rendering 
these cells null for lamin A/C (Muchir et al., 2003). As has been shown for Lmna-/- 
MEFs, I found barely detectable protein levels of 53BP1, which seemed specific to 
53BP1 as analysis of another DDR protein, Rad51, exhibited similar protein 
levels. In addition, the levels of γ-H2AX were higher in Y259X cells versus wild 
type HDFs, suggesting increased levels of genomic instability in the absence of A-
type lamins. Notably, the effect of A-type loss on 53BP1 was recapitulated by 
RNAi of lamin A/C in both HDFs and U2OS, suggesting that this phenomenon is 
not cell-type specific. Moreover, 53BP1 protein levels were unchanged in HDFs in 
various proliferative states, arguing against cell cycle dependent effects on 53BP1 
protein levels. Inhibition of the proteasome rescued protein levels of 53BP1 in 
both Y259X cells and HDFs depleted of lamin A/C by RNAi. Importantly, even 
though protein levels were rescued, we did not observe nuclear localisation of 
53BP1 in Y259X cells in response to proteasome inhibition, underlining that A-
type lamins are important for both the correct nuclear localisation and protein 
stability of 53BP1. This relationship has striking similarities with the lamin A/C-pRb 
interaction (Markiewicz et al., 2002; Johnson et al., 2004). It was shown that 
Lmna-/- MEFs exhibit reduced levels of pRb protein levels that are recoverable by 
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proteasome inhibition, but, as with 53BP1, pRb nuclear localisation was not 
restored (Johnson et al., 2004).  
 
In order to account for 53BP1 protein loss, I probed whether A-type lamins bound 
53BP1. I observed an interaction between 53BP1 in HDFs, which clearly 
decreased to barely detectable levels 1 hour post-IR. As the antibody used for 
immunoprecipitation recognised both lamin A and C, I then performed co-
immunoprecipitation experiments to determine that 53BP1 was present in both 
GFP-lamin A and C immunoprecipitates. This is in agreement with previous 
findings that showed that depleting lamin A/C in wild MEFs followed by restoration 
of either lamin A or C by over-expressing tagged constructs was sufficient to 
restore 53BP1 protein levels (Gonzalez-Suarez et al., 2009). Indeed, when I over-
expressed GFP-lamin A or C in Y259X cells I observed that 53BP1 protein levels 
were restored to the nucleus. Together, this data and previous work highlight the 
importance of both lamin A and C in maintaining 53BP1 protein levels. 
Furthermore, I would suggest that if the interaction is direct (see below), then the 
53BP1 interaction of lamin A and C must be from position 1-572 amino acids, as 
these are the residues shared by both lamin A and C. Of course, I cannot rule out 
that the lamin A tail may harbour 53BP1 interacting domains.  
 
To explore the relationship between A-type lamins and 53BP1 in more detail, I 
generated a stable U2OS/GFP-lamin A cell line. Using these cells, I found that 
GFP-lamin A was able to efficiently pulldown fragments of HA-53BP1 that 
contained the Tudor domain. Furthermore, in response to DNA damage the ability 
of GFP-lamin A to immunoprecipitate endogenous 53BP1 was reduced in 
U2OS/GFP-lamin A cells, which was reversible by prior treatment with the 
ATM/ATR inhibitor, caffeine, a known inhibitor of DNA damage phosphorylation 
events. Future work should seek to confirm whether the relationship between 
lamin A/C and 53BP1 is direct or mediated by other proteins. This may be 
addressed by bacterially expressing differentially tagged fragments of lamin A/C 
and 53BP1 followed by pulldown experiments. Furthermore, to underline the 
phosphorylation-dependent interaction between lamin A/C and 53BP1 in 
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response to DNA damage, it will be important to repeat the immunoprecipitation 
experiments by pre-treating extracts with λ-phosphatase. Despite the need for 
further studies, these present findings highlight the dynamic phosphorylation-
dependent relationship between A-type lamins and 53BP1 in response to DNA 
damage, and opens the door for a more detailed investigation using the 
U2OS/GFP-lamin A cells produced here in a proteomic approach to identify 
proteins that may associate or dissociate with A-type lamins upon DNA damage, 
and thus might help contribute to effective DNA repair and genomic stability. 
5.6.4 A-type lamins promote genomic stability and efficient DNA repair 
Previous studies have implicated A-type lamins in preserving genomic integrity 
(Liu et al., 2005; Gonzalez-Suarez et al., 2009). The presence of a mutant lamin 
A, progerin or lamin AΔ50, in Hutchinson Gilford Progeria Syndrome (HGPS) cells 
and the complete absence of A-type lamins in Lmna-/- MEFs both lead to 
increased levels of γ-H2AX, a marker of DNA damage and thus genomic 
instability (Liu et al., 2005; Gonzalez-Suarez et al., 2009). Similarly, I have shown 
that Y259X cells have dramatically increased γ-H2AX levels, indicating that loss of 
A-type lamins in HDFs leads to increased genomic instability. What then is the 
mechanistic basis for increased genomic instability in cells lacking A-type lamins? 
The presence of increased γ-H2AX levels in Y259X cells may result from 
dysfunctional telomeres. It has been observed that HGPS cells have accelerated 
telomere shortening and progerin-induced DNA damage is correlated with 
telomeres (Huang et al., 2008; Decker et al., 2009; Benson et al., 2010). 
Moreover, expression of the catalytic subunit of telomerase, TERT, reduced DNA 
damage levels and both p53- and pRb-dependent signaling (Benson et al., 2010). 
Furthermore, Lmna-/- MEFs display mislocalised telomeres and accelerated 
telomeres shortening (Gonzalez-Suarez et al., 2009). Another alternative that I 
propose is that replication forks may collapse into DSBs in cells lacking A-type 
lamins. As A-type lamins reportedly bind PCNA and are associated with the 
initiation of DNA replication, it is possible that, in their absence, spontaneous 
DSBs may arise from defects in the replication process. Replication fork collapse 
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in combination with DNA repair defects (see below) may be a plausible 
suggestion for increased genomic instability in cells lacking A-type lamins. 
Regardless of the mechanism, it will be important to elucidate whether restoration 
of 53BP1 in A-type lamin depleted cells may restore genomic stability. These 
rescue experiments are vital to understanding whether there is more than one 
mechanism by which A-type lamin loss may affect genomic stability. 
 
Preservation of genomic integrity in somatic cells is vital to cellular function and 
whilst damage to other macromolecules may be tolerated by renewal, damage to 
nuclear DNA is irreplaceable. There is therefore a significant evolutionary 
investment in genomic surveillance and maintenance pathways to faithfully pass 
on genetic information to daughter cells. Thus, inherent within discussing the 
genomic instability exhibited in cells lacking A-type lamins should be an 
exploration of DNA damage repair pathways that may be affected in this genetic 
background. Based on current understanding of the role of cell cycle position in 
the choice between NHEJ and HR (i.e. G1 vs S/G2) I may now reassess the 
findings of Liu et al., 2005 (Bartek and Lukas, 2007; Wohlbold and Fisher, 2009). 
Using Zmpste24-/- MEFs, Liu et al. observed a reduced S-phase content and 
increased G1-phase content compared to wild type cells (Liu et al., 2005). As 
HGPS cells undergo premature senescence and have a reduced S-phase index 
(Goldman et al., 2004), I may conclude generally that unprocessed prelamin A 
causes proliferative defects that result in both Zmpste24-/- MEFs and HGPS cells 
to have a greater proportion of cells in G1-phase. As NHEJ is the repair pathway 
of choice in G1-phase, we would expect Zmpste24-/- MEFs and HGPS to engage 
this pathway. Indeed, using a fluorescence-based reporter assay, this was found 
to be the case (Liu et al., 2005). Furthermore, the reduced proportion of S-phase 
cells more than likely reflects the reduced number of Rad51 foci and impaired 
engagement of the HR repair pathway (Liu et al., 2005). Thus, as NHEJ is 
inherently error-prone, I would suggest that the genomic instability in these cells is 
in part caused by use of this repair pathway rather than the HR repair pathway. 
Entirely consistent with this is the finding of increased chromosomal aberrations 
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and in particular more telomere end-fusion products in HGPS cells, reflecting use 
of the NHEJ pathway (Benson et al., 2010).  
 
In contrast to Zmpste24-/- MEFs and HGPS cells, it was reported that Lmna-/- 
MEFs show impaired ability to process dysfunctional telomeres by NHEJ 
(Gonzalez-Suarez et al., 2009). Flow cytometry analysis in this study could not 
find any differences in cell cycle phases between immortalised wild type and 
Lmna-/- MEFs, therefore suggesting that it is specifically defects in NHEJ that 
cause dysfunctional telomere processing, rather due to differences in cell cycle 
phase (Gonzalez-Suarez et al., 2009). This latter finding is surprising considering 
a previous report showed a clear increase in the proportion of S-phase cells in 
Lmna-/- MEFs (Johnson et al., 2004). Despite this, the finding that A-type lamins 
promote 53BP1 stability as demonstrated here and previously, suggests a link 
between A-type lamins and NHEJ. 53BP1 is involved in the NHEJ pathway by 
increasing DNA end mobility, either DSBs or telomeres, therefore allowing their 
effective processing by NHEJ (Dimitrova et al., 2008). A further intriguing link 
between A-type lamins and NHEJ has come from recent work exploiting unbiased 
proteomic approaches to identify lamin A binding proteins (Kubben et al., 2010). 
Among the proteins identified was Ku70, which is part of the Ku70/80 heterodimer 
complex (Kubben et al., 2010). The Ku70/80 complex is an essential component 
of the NHEJ pathway and acts as the sensor protein in this pathway, binding to 
the end of the DSB (Mahaney et al., 2009; Roberts et al., 2010). Ku70/70 also 
possesses some end processing ability and functions to recruit DNA-dependent 
protein kinase catalytic subunit (DNA-PKcs) (Roberts et al., 2010). Interestingly, a 
MudPIT proteomic approach identified DNA-PKcs as a novel progerin-interacting 
protein in HGPS cells (Liu et al., 2011). Immunoprecipitation experiments 
confirmed this progerin-interaction was greater than between wild type lamin A 
and DNA-PKcs. However, analysis of HGPS protein extracts showed decreased 
levels of DNA-PKcs, suggesting that progerin destabilises DNA-PKcs protein 
levels (Liu et al., 2011). Furthermore, they also observed decreased levels of the 
Ku70/80 complex in HGPS. These findings again suggest that presence of mutant 
lamin A versus absence of A-type lamins has differential outcomes for repair 
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pathways. However, despite being identified as A-type lamin binding protein, both 
Ku70 and DNA-PKcs, two of the earliest temporal components of the NHEJ 
pathway, were found to be unchanged at the protein level in Lmna-/- MEFs 
(Gonzalez-Suarez et al., 2009). Indeed, when I challenged Y259X cells with a low 
dose of IR they exhibited defects in the repair of DSBs with late kinetics, 
suggesting that the sensing of DSBs, a role carried out by Ku70/80 and DNA-
PKcs, was not impaired in HDFs lacking A-type lamins. Rather than a defect in 
sensing DSBs, the impaired ability to repair DSBs at late timepoints post-IR in 
Y259X cells suggests defective repair of heterochromatin regions. Noon et al. 
showed that loss of 53BP1 conferred a DNA repair cellular phenotype that is 
epistatic with ATM inhibition, which is characterised by defective repair of 
heterochromatin regions (Noon et al., 2010). Furthermore, they showed that loss 
of 53BP1 inhibited the localisation of pKAP-1 at heterochromatin regions of DNA 
damage (Noon et al., 2010). Future work should thus seek to determine if cells 
null for lamin A/C exhibit defective repair of heterochromatin in response to DNA 
damage and the underlying mechanistic basis.  
 
How wild type A-type lamins are involved in the DDR pathways is of great 
importance as failure of DNA repair mechanisms contribute to cancer progression. 
In this chapter I have shown that A-type lamins are important for maintaining 
genomic stability and are involved in effective DNA repair through mechanisms 
not fully understood. Importantly, it will be of great clinical value to address 
whether promoter methylation of LMNA, and hence its silencing, is associated 
with an impaired DDR in cancer subtypes. 
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CHAPTER 6. MODELLING THE LAMIN A/C-53BP1 
INTERACTION AND EXPLORATION OF                         
DNA DAMAGE-DEPENDENT A-TYPE LAMIN 
PHOSPHORYLATION 
 
6.1 Introduction 
6.1.1 Lamin networks as indicators of molecular function 
The interaction between lamin A/C and various nuclear proteins have implicated 
A-type lamins in a broad spectrum of cellular processes (see 1.3) (Zastrow et al., 
2004; Vlcek and Foisner, 2007). One of these processes, the DNA damage 
response (DDR), was explored in Chapter 5. To extend these findings, I 
interrogated the literature and identified proteins implicated in the DNA damage 
response that interacted either directly with lamin A/C or indirectly via the lamin 
A/C interacting protein BAF. I found a large set of lamin A/C-interacting proteins, 
involved in various aspects of the DNA damage response and repair pathways 
(Figure 6.1). This DNA damage-specific lamin A/C interactome provides a 
potential mechanistic basis for the DNA repair defects observed in cells lacking 
Iamin A/C, and it is possible that, a priori, loss of A-type lamins in cells may affect 
the functions of these proteins. Despite the obvious need for validation in the 
context of the DDR, it does suggest that, together with the data in Chapter 5, 
lamin A/C may actively participate in the DDR. However, how A-type lamins are 
involved in the DDR remains somewhat elusive.  
 
Of the plethora of post-translational modifications that function within the DDR, 
one of the earliest and wide-ranging modifications is phosphorylation (Matsuoka 
et al., 2007; Stokes et al., 2007). Phosphorylation in the DDR activates proteins 
involved in, but not limited to, DNA repair, cell cycle progression, gene 
expression, RNA post-transcriptional regulation, nucleic acid metabolism, cell 
death and cell-cell signaling (Matsuoka et al., 2007). Interestingly, in a proteomic 
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study identifying proteins phosphorylated in response to UV damage, multiple 
peptides matching lamin A/C were found (Stokes et al., 2007). However, whether 
phosphorylation alters lamin A/C function in response to DNA damage remains to 
be determined.  
 
 
 
Figure 6.1. DNA damage response proteins that interact either directly or 
indirectly (via BAF) with lamin A/C. 
 
6.1.2 Current aims 
In Chapter 5, I demonstrated that loss of A-type lamins imparts a DNA repair 
defect on cells, thereby sensitising them to DNA damage. To further explore the 
role of A-type lamins in the DNA damage response, I assessed whether lamin A/C 
is phosphorylated in response to DNA damage and modelled the interaction 
between lamin A/C and 53BP1. 
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6.2 Modelling the 53BP1-lamin A/C interaction 
Based on the data from Chapter 5, in which I showed that lamin A/C interacts with 
a region surrounding the 53BP1 Tudor domain, I was intrigued by the possible 
structural relationship between the two. Although I have yet to map the 53BP1-
interacting domain of lamin A/C using lamin A or C deletion mutants, I predicted 
that the Ig-like fold in lamin A/C (Figure 6.2) – a well-known region that binds a 
variety of other proteins, including PCNA, emerin and LAP2α – might interact with 
53BP1 (Zastrow et al., 2004; Shumaker et al., 2008). To assess this potential 
interaction, I used the protein docking simulation server ClusPro 2.0, which 
models interactions with four different binding conditions – balanced; electrostatic; 
hydrophobic; Van der Waals and electrostatic (Kozakov et al., 2010). 
 
 
Figure 6.2. The type s Ig-like fold in the lamin A/C C-terminal. (Lower diagram 
of Ig-like fold taken from Dechat et al., 2010) 
 
The three-dimensional structure of the 53BP1 Tudor domain was previously 
characterised by X-ray crystallography (Huyen et al., 2004; Botuyan et al., 2006). 
The Tudor domain consists of two tandem folds with a deep pocket at their 
interface formed by evolutionarily conserved hydrophobic residues. The presence 
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of a deep hydrophobic pocket raised the possibility that 53BP1 binds to 
methylated lysine or arginine residues, because methylated lysine/arginine side 
chains are long and hydrophobic (Mochan et al., 2004). 
 
Using the lamin A/C Ig-like fold as a receptor (PDB: 1IFR; Dhe-Paganon et al., 
2002) and the 53BP1 Tudor domain as a ligand (PDB: 2G3R; Botuyan et al., 
2006), I used the protein docking simulation to examine potential interactions 
between the two. The four top outputs for each modelling condition are shown 
(Figure 6.3). With the exception of the Van der Waals and electrostatic model 
which placed the lamin Ig-like fold near to the entrance of the deep pocket of the 
Tudor domain, the ClusPro simulation results suggest that the lamin Ig-like fold 
may dock within the deep pocket of the Tudor domain (Figure 6.3).  
 
As previous studies have shown that the deep pocket of the tandem Tudor 
domain binds methylated lysine/arginine residues, I analysed whether any of the 
top outputs modelled contained any lysine or arginine residues in the lamin Ig-like 
fold (Figure 6.4). Using the top prediction from the hydrophobic docking 
simulation, analysis of the amino acids in closest proximity to the Tudor domain 
showed a clear absence of any lysine and arginine residues (Figure 6.4). 
Together with the data from Chapter 5, this modelling data suggests that the lamin 
A/C Ig-like fold may interact with the 53BP1 Tudor domain, either within the deep 
pocket or in close proximity to it, which dissociates upon DNA damage, most likely 
due to the high affinity of the 53BP1 Tudor domain for methylated histone H4, 
which is increased upon DNA damage (Botuyan et al., 2006; Pei et al., 2011).  
 
To further these findings, I performed a protein docking simulation again using the 
53BP1 Tudor domain (PDB; 2G3R), but with a different crystallographic structure 
of the lamin Ig-like fold (Krimm et al., 2002). The top outputs for each of the four 
conditions again modelled the lamin Ig-like fold to interact with Tudor domain 
pocket (Figure 6.5). However, using a different web-based docking simulation, 
GRAMM-X, the lamin A/C Ig-like fold was predicted to dock to the 53BP1 Tudor 
domain at a location behind the deep pocket (Figure 6.6). In this scenario, it would 
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be possible for the 53BP1 Tudor domain to interact with other substrates whilst at 
the same time interacting with lamin A/C. The predicted docking sites of the 
ClusPro and GRAMM-X simulations are by no means mutually exclusive, i.e. they 
may both occur given the correct cellular situation, however, it does underline the 
need for future experimental data to characterise fully the mode of interaction 
between lamin A/C and the 53BP1 Tudor domain.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3. The lamin A/C Ig-like fold is predicted to interact with the Tudor 
domain of 53BP1. Using Cluspro 2.0 protein docking simulation, the lamin A/C 
Ig-like fold (PDB: 1IFR) and the 53BP1 Tudor domain (PDB: 2G3R) were 
modelled for potential interactions. The top output in each of the four modelled 
conditions is shown for (a) balanced (b) hydrophobic (c) electrostatic (d) Van der 
Waals and electrostatic. 
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Figure 6.4. Lysine and arginine residues in the lamin A/C Ig-like fold.  The lamin Ig-fold is shown in green, the 53BP1 
Tudor domain in blue and the lamin A/C Ig-fold lysine and arginine residues are shown in red. 
 
 
 
 
223 
 
 
 
 
 
Figure 6.5. The lamin A/C Ig-like fold is predicted to interact with the Tudor 
domain of 53BP1. Using Cluspro 2.0 protein docking simulation, the lamin A/C 
Ig-like fold (PDB: 1IVT) and the 53BP1 Tudor domain (PDB: 2G3R) were 
modelled for potential interactions. The top output in each of the four modelled 
conditions is shown for (a) balanced (b) hydrophobic (c) electrostatic (d) Van der 
Waals and electrostatic. 
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Figure 6.6. Top result using GRAMM-X modeling server. The potential 
interaction between the lamin A/C Ig-like fold (PDB: 1IFR; Dhe-Paganon et al., 
2002) and the 53BP1 Tudor domain (PDB: 2G3R; Botuyan et al., 2006) was 
modeled using the GRAMM-X server.  
 
6.3 Potential for A-type lamins to be DNA damage-dependent 
targets of phosphorylation   
In response to genotoxic stress, a number of protein kinases are responsible for 
the phosphorylation of an extensive network of target substrates in a diverse 
range of cellular processes (Matsuoka et al., 2007; Stokes et al., 2007). Initial 
protein phosphorylation in the DDR is mainly carried out by the two kinases ATM 
(ataxia telangiectasia mutated) and ATR (ATM and Rad3-related). Both ATM and 
ATR prefer phosphorylating serine or theonine residues followed by gIutamine 
(SQ/TQ motifs) (Kim et al., 1999; O’Neil et al., 2000; Zhao et al., 2001). In order to 
investigate if A-type lamins were phosphorylated in response to DNA damage, I 
pursued a bioinformatics approach. Using the NetPhos 2.0 server, potential 
phosphorylation sites were identified, above the threshold, that were distributed 
throughout the protein. There appeared to be one region after the α-helical rod 
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domain that showed a large number of potential phosphorylation sites (i.e. above 
threshold) from position 390-437 (Figure 6.7). 
 
 
Figure 6.7. Predicted phosphorylation sites in lamin A/C. Potential 
phosphorylation sites in lamin A and C were generated using the NetPhos 2.0 
server (Blom et al., 1999). 
 
Multiple sequence alignments of lamins A, C, B1 and B2 revealed that lamin A/C 
contains four SQ/TQ motifs after the α-helical rod domain, which is present in both 
lamin A and C (Figure 6.8a,b). However, none of these SQ/TQ motifs are present 
in lamins B1 or B2 (Figure 6.8b). Importantly, these four SQ/TQ motifs are 
conserved throughout the mammalian phylogeny (Figure 6.8c). 
 
 
 
 
 
 
 
 
226 
 
 
 
 
 
 
 
Figure 6.8. SQ/TQ residues are conserved in the mammalian phylogeny. (a) 
Lamin A domain structure. (b) Sequence alignment of A-type lamins with lamin B1 
and lamin B2. SQ/TQ motifs are shown in red. (c) Sequence alignment of lamin A 
across multiple species. 
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Using two prediction algorithms to assess potential phosphorylation sites in 
response to DNA damage (http://elm.eu.org and http://scansite.mit.edu), three 
amino acids were identified as probable targets that were also found in the 390-
437 region: S395, S407, T409 (Figure 6.9a, highlighted red). Further bioinformatic 
dissection of this region using the Phosphosite protein phosphorylation database 
revealed that a large number of amino acid residues in this region were 
phosphorylated in both a DNA damage dependent (Figure 6.9a, in blue) and 
independent (Figure 6.9a, in pink) manner (www.phosphosite.org). Even though 
only three sites in this region were predicted to be phosphorylated in response to 
DNA damage, the database search revealed that up to 10 serine/threonine 
residues may be phosphorylated in vivo, suggesting a degree of promiscuity at 
the amino acid sequence level for phosphorylation by DNA damage related 
protein kinases (Supplementary Figure 9).  
 
In order to probe whether A-type lamins were phosphorylated in response to IR in 
vivo, HDFs were treated with IR (10 Gy) before immunoprecipitation of 
endogenous lamin A/C. Immunoblotting with an anti-phospho-SQ/TQ motif 
antibody revealed a increase in a band that corresponded to lamin A that was not 
present in the unspecific IgG (Figure 6.9b). Due to the nature of the antibody, a 
large unspecific band prevented assessment of lamin C phosphorylation. To 
further assess lamin A phosphorylation, U2OS/GFP-lamin A cells were treated 
with IR and extracts subjected to immunoprecipitation with GFP-Trap beads. At 
the predicted molecular weight there appeared no increase in the level of 
phosphorylated lamin A (Figure 6.9c). However, the validity of this finding is 
undermined as there was clearly a band in the control lane prepared from 
U2OS/GFP cells that the anti-phospho-SQ/TQ antibody recognised. One 
explanation for this may be that the anti-phospho-SQ/TQ antibody used in this 
study does not recognise the lamin A/C residues predicted and previously shown 
to be phosphorylated in response to DNA damage. Further to this, a comparison 
of the amino acids surrounding the three SQ/TQ residues in lamin A/C with 
ATM/ATR substrates known to be recognised by the phospho-SQ/TQ antibody 
shows that the antibody is unlikely to recognise the lamin A/C phospho-SQ/TQ 
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residues (Figure 6.10a,b). Moreover, a previous sequence analysis of all peptides 
pulled down by the phospho-SQ/TQ antibody revealed that leucine is the 
preferred amino acid in the -1 position, which is not present before any of the 
three potential lamin A/C SQ/TQ phosphorylation sites (Figure 6.10c) (Matsuoka 
et al., 2007). Therefore, further approaches will be needed in the future to resolve 
these issues and determine if A-type lamins are phosphorylated in vivo and what 
biological significance, if any, this has for DNA repair, checkpoint control and cell 
cycle progression.  
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Figure 6.9. Assessing A-type lamin phosphorylation in response to DNA 
damage. (a) Information from www.phosphosite.org was processed and amino 
acids phosphorylated in a DNA damage-dependent and independent manner are 
shown in blue and pink, respectively. Potential phospho-SQ/TQ sites and 
uncharacterised sites are shown in red and green, respectively. (b) HDFs were 
treated with IR (10 Gy) and extracts prepared after 1 hour. After 
immunoprecipitation, lamin A/C was assessed for phosphorylation by 
immunoblotting using an anti-phospho-SQ/TQ antibody. (c) U2OS/GFP-lamin A 
were treated with IR (10 Gy) and extracts subjected to immunoprecipitation with 
230 
 
 
GFP-Trap beads. GFP-lamin A phosphorylation was assessed by immunoblotting 
using an anti-phospho-SQ/TQ antibody.  
 
 
 
Figure 6.10. Comparison of potential ATM/ATR phosphorylation sites in 
lamin A/C with other known ATM/ATR targets. (a) The phospho-SQ/TQ 
antibody used in this study from Cell Signalling recognises phosphorylated serine 
or threonine residues preceded by leucine (L), or similar amino acid, in the -1 
position and glutamine (Q) in the +1 position. Corresponding ELISA data 
(signal:noise ratio) is shown (www.cellsignal.com). (b) Three potential phospho-
SQ/TQ residues in lamin A/C and neighboring amino acids. (c) Distribution of 
amino acids most commonly found surrounding phospho-SQ/TQ residues (taken 
from Matsuoka et al., 2007). 
231 
 
 
6.4 Discussion 
6.4.1 Modelling the 53BP1-lamin A/C interaction 
As I had determined that both lamin A and C may bind 53BP1, suggesting a 
binding region common to both, and that C-terminal fragments containing the 
Tudor domain of 53BP1 were present in GFP-lamin A immunoprecipitates, I 
postulated whether the Ig-like fold of lamin A/C, which is involved in the interaction 
with various other proteins, would be able to interact with the Tudor domain of 
53BP1. The three-dimensional structures of the lamin A/C Ig-like fold and the 
Tudor domain of 53BP1 have been characterised by X-ray crystallography (Dhe-
Paganon et al., 2002; Krimm et al., 2002; Huyen et al., 2004; Botuyan et al., 
2006). Using the ClusPro modelling server, results showed the possibility that the 
lamin A/C Ig-like fold could interact with the 53BP1 Tudor domain via the 
hydrophobic pocket of the Tudor domain, a region shown to interact with 
methylated H4K20. However, using the GRAMM-X server, it showed a 
contradictory result, underlining the need for direct experimental evidence to 
probe this hypothesis. Despite this, if the Tudor domain does indeed bind the 
lamin A/C Ig-like fold then is plausible that, upon DNA damage, methylation of 
H4K20, which has been shown to increase locally at sites of DSBs, competes for 
the Tudor domain binding site (Pei et al., 2011). The Tudor domain pocket 
preferentially binds to arginine and lysine residues (Huyen et al., 2004; Botuyan et 
al., 2006). However, lamin A/C does not contain any arginine or lysine residues in 
the vicinity of the proposed interaction based on the protein docking simulation. 
Therefore, I would suggest that even the lowest of levels of DNA damage would 
lead to dissociation between the two, allowing 53BP1 to be a sensitive participant 
of the DDR. A range of Tudor domain mutants that change the surface properties 
without changing the folding properties do not relocalise to IRIF (Huyen et al., 
2004) and whilst these mutants cannot interact with methylated histones, it would 
be of interest to determine whether they can interact with lamin A/C to help 
provide evidence for the above DNA damage dependent interaction hypothesis. 
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The decreased association observed between lamin A/C and 53BP1 in response 
to DNA damage is not without precedent within the current literature. The 
mediator protein MDC1 is a 53BP1-associated protein, and this interaction 
decreases upon DNA damage (Eliezer et al., 2009). Upon DNA damage, it was 
shown that γ-H2AX competes with the MDC1-interaction site of 53BP1 (Eliezer et 
al., 2009). As 53BP1 may be recruited by direct γ-H2AX binding and to 
methylated H4K20 at DSBs, it will be interesting to determine if a γ-H2AX peptide 
competition assay would disrupt the lamin A/C-53BP1 interaction. Furthermore, it 
will be of note to ascertain if MDC1 is present in lamin A/C-53BP1 complexes. 
Both lines of enquiry would help further the understanding of A-type lamins in the 
DDR and the mechanism by which DNA damage influences the interaction 
between lamin A/C and 53BP1. 
6.4.2 A-type lamins as targets of DNA damage-dependent post-translational 
modifications 
Protein phosphorylation is one of the earliest post-translational modifications that 
initiates the DDR, primarily through the action of the apical DDR kinases, ATM 
and ATR (Matsuoka et al., 2007). A database search revealed that A-type lamins 
may be phosphorylated at multiple residues in response to DNA damage 
(Supplementary Figure 9). However, there appeared one particular hotspot 
spanning residues 390-437 that contained 10 DNA damage-dependent 
phosphorylation residues, 3 of which were SQ/TQ sites. These three SQ/TQ sites 
were conserved in the mammalian phylogeny. Therefore, to address A-type 
lamins were phosphorylated in vivo in response to DNA damage, endogenous 
lamin A/C was immunoprecipitated from HDFs and the bound lamin A/C assessed 
for phosphorylation using an anti-phospho-SQ/TQ motif antibody. A band 
corresponding to lamin A appeared to show slightly increased reactivity using this 
antibody in response to DNA damage. However, when I further probed this finding 
using U2OS/GFP-lamin A cells, there was no difference between untreated and 
IR-treated GFP-lamin A immunoprecipitates. Furthermore, there was even a 
signal in the U2OS/GFP control lysates. Analysis of the potential phosphorylation 
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sites in residues 390-437 revealed that none of the SQ/TQ sites were preceded 
by a leucine residue, which is present in the antigen used to raise the anti-
phospho-SQ/TQ motif antibody. Therefore, whilst proteomic data has identified 
phosphorylated lamin A/C peptides, it remains to be verified directly. Future 
proteomic analysis of lamin A/C or GFP-lamin A immunoprecipitates should help 
uncover whether A-type lamins are indeed phosphorylated in response to DNA 
damage. I foresee that mutational analysis of serine or threonine residues will 
prove difficult as so many have been identified as being phosphorylated in 
response to DNA damage. Therefore, determining the functional significance of A-
type lamin phosphorylation will be important. Does it have a signalling role? Does 
it affect interactions with proteins involved in DNA repair and/or cell cycle 
progression? Answering such questions should provide a more in-depth 
understanding of A-type lamin function in the DDR. 
 
Two other post-translational modifications shown to influence the DDR are 
acetylation and SUMOylation (Polo and Jackson, 2011). Lamin A/C has a 
consensus SUMOylation site surrounding lysine 201, and is preferentially 
modified by SUMO-2 conjugates (Zhang and Sarge, 2008). Recent evidence has 
shown a role for SUMOylation in the regulation of DDR proteins (Galanty et al., 
2009; Morris et al., 2009). Ubc9 is the only E2 ligase of the SUMO-conjugation 
system. It has been shown by yeast two hybrid and subsequent 
immunoprecipitation experiments that lamin A/C is a Ubc9 binding protein (Zhong 
et al., 2005). In response to DNA damage Ubc9 forms at sites of double strand 
breaks and acts in concert with the E3 ligase PIAS4 to SUMOylate 53BP1 and 
with the E3 ligase PIAS1 to SUMOylate BRCA1. It would therefore be of note to 
investigate whether lamin A/C is itself SUMOylated in response to DNA damage 
and whether it has a role in the SUMOylation events of the DDR. 
 
Acetylation of histones and protein in the DDR has been shown to help contribute 
to effective sensing and repair of DNA damage (Polo and Jackson, 2011). A 
variety of acetyltransferases and deacetylases are recruited to DNA damage, for 
example SIRT6 deacetylates CtIP at DNA lesions to promote end resection (Kaidi 
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et al., 2010). Analysis of the lamin A protein sequence using an acetylation 
algorithm reveals that lamin A/C has four potential acetylation sites 
(Supplementary 10) (Basu et al., 2009). Furthermore, one of these sites has been 
validated, suggesting that acetylation may somehow regulate lamin A/C function 
(Basu et al., 2009). 
 
In Chapter 5 I provided evidence that A-type lamins are important components of 
the DDR. In this chapter, I attempted to delineate one mechanism by which A-type 
lamins may be implicated in the DDR, via phosphorylation, and modelled the 
53BP1-lamin A/C interaction as a means to understand their functional inter-
relationship. Whilst the latter proved fruitful, it appears that further work and 
approaches are necessary to understand the post-translational modifications that 
govern lamin A/C function in response to DNA damage. Thus, it seems that, 
despite the data presented here and in Chapter 5, our understanding of the role of 
A-type lamins in the DDR is still in its infancy and future work should seek to build 
on the insights provided here. 
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CHAPTER 7. GENERAL DISCUSSION 
 
7.1 A-type lamins and thesis aims 
A-type lamins are multifunctional nuclear proteins, involved in a wide range of 
cellular functions (Andres and Gonzalez, 2009). Mutations in LMNA give rise to a 
broad spectrum of tissue-specific diseases, termed laminopathies. Laminopathies 
include muscular dystrophy, cardiomyopathy, lipodystrophy, neuropathy and 
various premature aging syndromes (Broers et al., 2006). Hutchinson-Gilford 
Progeria Syndrome (HGPS) is one such premature aging syndrome and cells 
from these patients exhibit a wide range of dysfunctions, including nuclear 
disorganisation, increased DNA damage, impaired cell cycle progression and 
premature entry into senescence. Therefore, investigating the roles of lamin A and 
C in normal cellular processes is vital to understanding the etiology and molecular 
mechanism of laminopathies. To this end, I interrogated the following hypotheses:  
 
1. Does wild type lamin A/C have a role in normal cellular aging? 
2. How do lamin A/C and its nucleoplasmic binding partner LAP2α affect cell 
cycle progression? 
3. What is the role of mature wild type lamin A/C in the DNA damage 
response? 
These three aspects of mature wild type lamin A/C function have not previously 
been investigated fully. Here, I have provided evidence indicating novel roles for 
lamin A/C in the normal aging process, as part of an adaptive response to 
oxidative stress, control of cell cycle progression and the DNA damage response. 
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7.2 Lamin A function is impaired during normal aging and is a 
key component of the cellular response to oxidative stress  
The increasing life expectancy of individuals in industrialised countries is expected 
to lead to 1.2 billion people being aged 60 and over by 2025 (Sahin and DePinho, 
2010). Providing medical care for this aging population is therefore an important 
issue for healthcare systems across the world. However, due to the gradual and 
heterogeneous onset of aging, together with the complex and diverse cellular and 
tissue phenotypes, research of aging has been difficult. In this light, I sought to 
understand the role, if any, of wild type mature lamin A/C in the normal aging of 
human dermal fibroblasts (HDFs). Previous research has indicated that mutations 
in LMNA give rise to premature aging diseases, underlining a possible link 
between LMNA and the normal aging process. To interrogate this hypothesis, in 
Chapter 3 I have shown that lamin A/C protein levels do not change when HDFs 
age in vitro. Rather, lamin A, but not lamin C, is a target for irreversible oxidative 
modifications during cellular aging in vitro. This oxidation of the cysteine residues 
in the lamin A C-terminal impairs the ability of lamin A to form intra-molecular and 
inter-molecular disulfide bonds, resulting in the presence of a monomeric form of 
lamin A in senescent cells, which is correlated with an increased percentage of 
dysmorphic nuclei in senescent cells. Furthermore, this impaired disulfide bond 
formation is correlated with increased endogenous DNA damage, loss of 
nucleoplasmic lamin A/C, proteolysis of the lamin A C-terminal and loss of 
nucleoplasmic LAP2α into nuclear aggregates (Pekovic et al., 2007). Moreover, I 
also observed less lamin A disulfide bond formation in cells from old individuals, 
which may indicate that impaired lamin A disulfide bond formation may contribute 
to the aging phenotype in vivo. This last observation obviously requires further 
rigorous examination and mouse models could be generated harbouring various 
cysteine-to-alanine mutations to test this hypothesis.  
 
That lamin A intra- and inter-disulfide bond formation was readily observed in 
young cells, but not old cells, suggested that disulfide bond formation may act as 
a protective mechanism against oxidative stress. In response to low levels of 
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oxidative stress lamin A undergoes increased disulfide bond formation, which is 
correlated with a reversible cell cycle arrest. On the other hand, lamin A disulfide 
bond formation is by-passed at high levels of irreversible oxidative stress. This 
suggested that lamin A disulfide bond formation is part of a protective response to 
oxidative stress. Further to this, the expression of a triple lamin A mutant 
(C522/588/591A) inhibited both intra- and inter-disulfide bond formation in HDFs, 
which abrogated lamin A function and caused premature entry into senescence. 
This cellular phenotype was mirrored by loss of LMNA, suggesting that the 
cysteine residues are important for lamin A function in the oxidative stress 
response and ultimately preventing cellular senescence. Moreover, cells null for 
LMNA (Y259X cells) and cells expressing the C522/588/591A lamin A mutant 
exhibit high levels of intracellular ROS. HDFs expressing the C522/588/591A 
lamin A mutant exhibit a range of senescence-associated cellular phenotypes that 
are reversible by anti-oxidant treatment or growth of cells at low oxygen 
concentrations. This indicates that ROS are the primary cause of the premature 
entry into senescence of HDFs expressing the C522/588/591A mutant. How then 
does this link the role of wild type mature lamin A to the normal aging process? 
Several lines of evidence have shown that intracellular ROS levels increase with 
age in a variety of tissues and cellular models (Kregel and Zhang, 2007; Sahin 
and DePinho, 2010). Increased ROS levels are thought to be due to electrons 
leaking from the electron transport chain (ETC) in the mitochondria, which can 
lead to the formation of ROS (Kregel and Zhang, 2007). Oxidative damage to 
lipids, proteins and DNA all contribute to their age-related functional decline. 
Based on this, it is plausible to suggest that oxidative damage to wild type mature 
lamin A in senescent cells is a result of the increased oxidative cellular 
environment in which they function as cells age in vitro. This oxidative damage 
impairs the ability of the cells to adequately respond to oxidative stress as cells 
age, as shown here, which ultimately leads to the irreversible withdrawal from the 
cell cycle, resulting in cellular senescence. This simplistic explanation does not 
take into account various other mechanisms that contribute to cellular aging such 
as telomere erosion and DNA damage. Furthermore, it is likely that oxidative 
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damage to lamin A acts in concert with a broad spectrum of damage to other 
macromolecules. Therefore, age-related oxidative damage to lamin A may act 
synergistically with these other mechanisms to contribute to the aging phenotype. 
Interestingly, cells from normal young and old individuals activate the same cryptic 
splice site as that used in the premature aging disease Hutchinson-Gilford 
Progeria Syndrome (HGPS), albeit at much lower levels (Scaffidi and Misteli, 
2006). The combination of low levels of progerin and oxidatively damaged lamin A 
may act together to impair the function of lamin A/C at the nuclear envelope and 
within the nucleoplasm. Future work should seek to determine whether there is an 
A-type lamin-dependent decrease in the various signalling pathways controlled by 
lamin A (e.g. c-Fos), and whether this contributes to the aging phenotype.  
7.3 Lamin A/C and LAP2α are important for cell cycle 
progression 
De-regulated and chronic cell cycle progression is a hallmark of most cancers 
(Hanahan and Weinberg, 2011). During G1-phase, the decision is made to 
replicate DNA and complete the cell cycle. LAP2α and lamin A/C have been 
implicated in the control of the G1/S-phase transition via interaction with the 
tumour suppressor, pRb, which is a key factor required for G1/S-phase transition 
(Mancini et al., 1994; Mittnacht, 1998; Markiewicz et al., 2002). LAP2α-lamin A/C 
complexes have been shown to anchor the active hypophosphorylated pRb within 
G1-phase cells, which is associated with its tumour suppressor functions (Mancini 
et al., 1994; Markiewicz et al., 2002). To further explore these findings, in Chapter 
4 I have shown that loss of either LAP2α or lamin A/C in HDFs caused delayed 
G1/S-phase transition upon G0-G1-S-phase progression. This was characterised 
by altered cell cycle profiles, significantly reduced cellular proliferation rates and a 
reduced Ki67+ index, a marker of cell cycle arrest. Attempts to delineate the 
nature of this cell cycle arrest could not find a significant up-regulation of the DDR 
in response to loss of either LAP2α or lamin A/C in HDFs. However, only markers 
of double-stranded breaks were used, and future work should address if proteins 
involved in replication stress are activated in cells depleted of LAP2α or lamin 
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A/C. In further attempts to understand the nature of the observed cell cycle arrest, 
I demonstrated that intracellular ROS levels were nearly double in HDFs depleted 
of LAP2α or lamin A/C, which underlines the role of lamin A in regulating ROS 
levels, as outlined in Chapter 3. To investigate if increased ROS levels were the 
causative factor for the cell cycle arrest, cells depleted of LAP2α or lamin A/C 
were treated with the anti-oxidant NAC for three consecutive days. However, 
there was no increase in Ki67+ cells, suggesting that cell cycle arrest was 
independent of ROS levels. Thus, the exact mechanisms underlying the cell cycle 
arrest remain elusive at this stage. However, investigation of other cell cycle 
regulators proteins such as p21 and p53 may yield important answers.  
7.4 Lamin A/C is a novel regulator of the DNA damage response 
DNA damage, either from exogenous or endogenous factors, has been suggested 
to be a primary driver of aging (Garinis et al., 2008; Hoeijmakers, 2009). Cells 
have evolved a diverse and complex genomic maintenance system, called the 
DNA damage response, to sense damage to DNA, trigger signaling cascades and 
ultimately repair the DNA damage (Jackson and Bartek, 2009). In HGPS, cells 
exhibit increased endogenous DNA damage and constitutively activated 
checkpoint signalling, which is correlated with reduced proliferation (Liu et al., 
2005; Varela et al., 2005; Liu et al., 2006; Scaffidi and Misteli, 2006). Previous 
data has also shown that Lmna-/- MEFs exhibit decreased protein levels of 53BP1, 
a mediator protein of the DDR and important component of the NHEJ repair 
pathway (Gonzalez-Suarez et al., 2009). This implies that wild type lamin A/C may 
therefore function within the DDR in normal cells. In Chapter 5, I investigated this 
hypothesis and showed that cells functionally null for LMNA (Y259X cells) exhibit 
increased levels of endogenous DNA damage, suggesting that A-type lamins 
promote genomic stability. Furthermore, I showed that lamin A/C promotes the 
nuclear localisation of 53BP1 in undamaged cells and prevents its accumulation in 
the cytoplasm where it is degraded by the proteasome. Interaction studies 
revealed that lamin A/C associates with a region surrounding the 53BP1 Tudor 
domain, a well-known protein-protein interacting module (Fitzgerald et al., 2009). 
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This interaction decreased in response to DNA damage, in a phosphorylation-
dependent manner. Cells depleted of endogenous lamin A/C by siRNA or Y259X 
cells exhibited a DNA repair defect at late timepoints post-IR, which ultimately led 
to reduced cellular fitness in response to DNA damage. This last finding is 
intriguing as loss of 53BP1 in cells confers a DNA repair defect that is epistatic 
with ATM inhibition in wild type cells (Noon et al., 2010). Moreover, this repair 
defect in 53BP1 depleted cells is caused by an inability to localise the protein 
pKAP-1 at sites of DNA damage and heterochromatin is not repaired efficiently 
(Noon et al., 2010). Based on these findings, it will be of interest to compare 
Y259X cells, which lack 53BP1, with the cellular phenotype of 53BP1-depleted 
cells to compare the DNA repair phenotypes. It is possible that the repair defect in 
Y259X cells actually represents a defect in the repair of heterochromatin. 
Moreover, it will be important to understand which repair pathways, i.e. 
homologous recombination (HR) repair or non-homologous end joining (NHEJ) 
repair, is engaged in cells null for lamin A/C. As NHEJ is associated with the 
repair of heterochromatin, I would predict that absence of A-type lamins would 
result in a decrease in NHEJ pathways, although this does not necessarily 
facilitate a concomitant increase in the HR repair pathway. Future work using 
widely employed HR and NHEJ fluorescence-based assays in combination with 
flow cytometry would provide evidence for these predictions. 
 
Based on the finding that A-type lamins are required for genomic stability in 
normal human fibroblasts, what is the relationship between A-type lamin status 
and cancer progression? This is not a simple question to answer as various 
reports have shown that lamin A/C can be down-regulated or up-regulated 
depending on the cancer subtype. For example, lamin A was shown to be a 
biomarker of colorectal cancer with patients nearly twice as likely to die if their 
tumours were lamin A/C positive (Willis et al., 2008). Moreover, lamin A has been 
identified as a biomarker of prostate cancer (Skvortsov et al., 2011). In contrast, 
lamin A/C is absent from ovarian cancer cells and tissues, which was correlated 
with dysmorphic nuclei in these cells (Capo-Chichi et al., 2011). Furthermore, 
siRNA depletion of lamin A/C in non-cancerous primary ovarian cells promoted 
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dysmorphic nuclei and aneuploidy, suggesting that loss of A-type lamins is 
correlated with promotion of ovarian cancer (Capo-Chichi et al., 2011). Therefore, 
together these contradictory reports suggest that the genetic background of the 
cancer subtype influences whether lamin A/C status has functional roles in cancer 
progression. Importantly, lamin A/C positive tumours could be targeted by 
depleting lamin A/C in combination with radiotherapy, as I have shown in Chapter 
5 that cells depleted of lamin A/C exhibit increased sensitivity to DNA damage.  
7.5 Linking aging, lamins and the DNA damage response 
DNA damage repair pathways are organismal longevity mechanisms that 
preserve genomic integrity. Failure to repair DNA damage may lead to cell death 
or cellular senescence, which contributes to tissue and organ decline with age. 
Alternatively, failure to repair DNA damage can lead to mutations that can drive 
cancer (Garinis et al., 2008). As organisms age, DNA repair pathways exhibit age-
related decline in efficiency, suggesting that DNA damage may be a causative 
factor of aging (Gorbunova et al., 2007). Indeed, it has been shown that DSBs 
accumulate with age in mouse tissues (Sedelnikova et al., 2004). In parallel to 
this, a variety of genetically engineered mouse models with knockouts of genes 
involved in the DDR give rise to premature aging phenotypes, which suggests that 
DNA damage is a bona fide cause of aging (Garinis et al., 2008). Therefore, 
linking the findings of Chapter 3, which suggests that lamin A has a role in normal 
aging process, to the findings in Chapter 5 and 6, it will be interesting to 
investigate the role of lamin A/C in DNA repair pathways during cellular aging. I 
would predict that oxidative damage to lamin A would impair its ability to 
participate in DNA repair in old cells. Does the lamin A/C-53BP1 interaction 
exhibit age-dependent alterations? Does lamin A form disulfide bonds in response 
to DNA damage as part of an adaptive protective response, analogous to the 
oxidative stress response? What levels of DNA damage would lead to disulfide 
bond formation or by-pass disulfide bond formation?  There are thus many 
questions to answer from the inter-weaving threads from Chapters 3, 5 and 6, 
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which should provide novel insights into the role of A-type lamins in both the aging 
process and DNA damage response. 
While Chapter 5 focussed on wild type lamin A, I will end by discussing the DDR 
in the context of mutant lamin A production, which causes the premature aging 
syndrome HGPS, as this is what stimulated my investigation of the role of wild 
type A-type lamins in the DDR (Liu et al., 2005). The cascade of signaling events 
that regulate the recruitment of DDR proteins to DNA lesions has progressed 
rapidly over the last few years (Bekker-Jensen and Mailand, 2010). Therefore, I 
may reassess the findings of Liu et al., 2005, in which they showed a distinct 
delay in the recruitment of 53BP1 in HGPS cells in response to IR. This suggests 
that the upstream signaling cascade at DSBs in HGPS is impaired somehow. 
Recently, a study showed that whilst the protein levels of two members of the 
DNA damage sensing MRN complex, NBS1 and Mre11, were unchanged, their 
recruitment to sites of IR-induced DNA damage was impaired in a minority of cells 
(Constantinescu et al., 2010). Is this subtle delay in the recruitment of the MRN 
complex enough to delay the recruitment of 53BP1 so dramatically in HGPS 
cells? I would suggest not as only 9% of γ-H2AX foci colocalised with 53BP1 10 
minutes after IR (Liu et al., 2005). Therefore, it seems probable that downstream 
proteins, such as MDC1, RNF8, RNF168 or HERC2 may be destabilised or show 
reduced activity in the presence of mutant lamin A as these proteins are essential 
for 53BP1 recruitment (Bekker-Jensen and Mailand, 2010). As well as ubiquitin-
adduct formation, the ability to form SUMO-adducts should also be investigated in 
HGPS to see if they contribute to the delay in 53BP1 recruitment (Galanty et al., 
2009; Morris et al., 2009). 
 
Recruitment of 53BP1 to sites of DNA damage appears to be regulated by two 
independent pathways. One is via the RNF8-RNF168 ubiquitin-dependent 
signaling axis, even though, paradoxically, 53BP1 has thus far not been shown to 
bind ubiquitin chains. The other is via the direct methylation of histone H4K20 by 
MMSET, which in turn is bound directly by the 53BP1 Tudor domain (Botuyan et 
al., 2006; Pei et al., 2011). This is important because HGPS cells exhibit 
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epigenetic alterations, including the loss of histone H4K20 methylation (Scaffidi 
and Misteli, 2006; Shumaker et al., 2006; Gonzalez-Suarez et al., 2009). I would 
therefore suggest that epigenetic defects in HGPS may also contribute to the 
delayed recruitment of 53BP1 in these cells.  
 
Together, these defects in DNA damage repair in HGPS cells more than likely 
contributes to the premature aging phenotype in this disease as a result of tissue 
wasting and impaired stem cell renewal capabilities (Espada et al., 2008; Scaffidi 
and Misteli, 2008). Indeed, there is a substantial body of evidence to suggest that 
defects in DDR genes give rise to an array of premature aging diseases, as 
mentioned above (Garinis et al., 2008; Jackson and Bartek, 2009; Ciccia and 
Elledge, 2010). These premature aging diseases suggest that the DDR forms part 
of normal anti-aging mechanisms. At the cellular level, replicative senescence of 
cells is caused by telomere erosion which in turn leads to their uncapping and 
initiates a permanent cell cycle arrest orchestrated by the DDR machinery 
(D’Adda di Fagana et al., 2003). It has been well documented that HGPS cells 
undergo premature senescence when grown in culture (Bridger and Kill, 2004). 
Thus, it seems likely that the progerin-dependent DNA damage seen in HGPS 
cells contributes to this premature senescence by permanently activating the DDR 
machinery (Liu et al., 2006). Indeed, transcriptional analyses carried out on 
tissues from Zmpste24-null MEFs showed an up-regulation of classical p53 target 
genes, which is involved in a pathway that induces cell and tissue senescence 
and eventually leads to accelerated aging (Campisi, 2005; Varela et al., 2005). 
That mutations in lamin A give rise to premature aging disorders such as HGPS, 
which is characterised by increased DNA damage, again suggests that lamin A is 
a key determinant in aging. 
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7.6 Conclusion 
In this thesis, I have provided evidence to extend previous data implicating A-type 
lamins in a diverse range of cellular processes. Here, I have underlined a role for 
lamin A/C and its nucleoplasmic binding partner LAP2α in cell cycle progression. I 
have provided novel evidence that lamin A is a key determinant in the normal 
aging process. Furthermore, I have also provided novel evidence to suggest that 
lamin A/C is required for effective DNA repair and preservation of genomic 
maintenance. Together, these findings underline the importance of A-type lamins 
in the maintenance of cellular integrity and ultimately organismal longevity and 
reflect their fundamental roles as ‘guardians of the soma’.  
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CHAPTER 8. SUPPLEMENTARY FIGURES 
 
 
Figure 1. Age-dependent changes in nuclear architecture in HDFs. (a) p40 
HDFs were immuno-stained with anti-lamin C (RαLC) antibody and DAPI. 
Micrographs are displayed as black and white or as two-colour merged images 
(lamin C-green; DAPI-blue). Scale bar 8µm. (b) The fractions of total and 
individual types of dysmorphic nuclei or (c) fractions of total Ki67+, normal Ki67+ 
and dysmorphic Ki67+ nuclei were determined by scoring 300 nuclei on duplicate 
slides in 4 independent experiments. Means ± S.D. are shown. * p<0.05. (d) 
Protein extracts from p7-p44 HDFs were subjected to reducing SDS-PAGE and 
immunoblotted with anti-lamin A/C (Jol2), anti-lamin B2 (LN43) or anti-β-actin 
(AC-40) antibodies (Kindly provided by Dr V Pekovic). 
246 
 
 
 
Figure 2. Cysteine sulfenic acid cycles. R-S(H), protein cysteine thiol. R-SO(H), 
sulfenic acid. R-SO2(H), sulfinic acid. R-SO3(H), sulfonic acid. R-S-S-R, protein 
disulfide. R-SNO, S-nitrosothiols. XH2, reducing agent. (Poole et al., 2004) 
 
 
Figure 3. Effect of NAC on lamin A disulfide bond formation. HDFs were pre-
treated with 10mM NAC before stimulation with 150 or 2x350µM H2O2. Cell 
extracts were prepared in the presence of NEM, resolved by non-reducing or 
reducing SDS-PAGE and probed with anti-lamin A (Jol4) antibody. 
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Figure 4. HDFs expressing Flag-C522A lamin A are phenotypically similar to 
HDFs expressing Flag-wt lamin A. (a) Flag-wt, C522A or C552/588/591A (Cys) 
lamin A were transfected into young (p12) HDFs and immuno-stained with anti-
Flag M5 and anti-γ-H2AX antibodies. The fractions of Flag +ve nuclei showing γ-
H2AX DNA damage foci were calculated by scoring 300 cells on triplicate 
coverslips in three independent experiments. (b) Transfected Flag-wt and Flag-
C522A lamin A HDFs were assessed for basal intracellular ROS levels by 
measuring DCF fluorescence using flow cytometry. DCF fluorescence is 
expressed as % relative to Flag-wt HDFs which is set at 100%. Means ± S.D. are 
shown. *, p<0.05 relative to Flag-wt HDFs (a), ns-not significant. 
 
 
Figure 5. Endogenous ROS levels in LBR and emerin-null HDFs. Basal 
intracellular ROS levels were determined by measuring relative DCF fluorescence 
in lamin B receptor (LBR)-null (a) and emerin-null (b) HDFs. Representative 
cytograms are shown. Cell control without DCF dye is represented by filled blue 
peak. 
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Figure 6. Cysteine residues in the LAP2α-specific C-terminal domain. 
Multiple sequence alignment of three isoforms of human LAP2: α, β and γ. 
Cysteine residues are labelled as follows: a single cysteine common to all three 
LAP2 isoforms (blue), LAP2α specific cysteines (red). 
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Figure 7. LAP2α protein levels are down-regulated in quiescent HDFs. 
Protein extracts were prepared from proliferating (P) or quiescent (Q) HDFs and 
subjected to reducing SDS-PAGE before immunoblotting with anti-LAP2α or β-
actin antibodies. 
 
 
 
Figure 8. Knockdown efficiencies for clonogenic assay. U2OS cells were 
transfected with either non-targeting control siRNA or siRNA targeting LMNA. 
After 72 hours, cells were then counted and plated for colony forming assays as 
shown in Figure 5.8. Remaining cells were pelleted and whole cell extracts were 
prepared and subjected to reducing SDS-PAGE before immunoblotting with anti-
lamin A/C (Jol2) or anti-β-tubulin antibodies to assess knockdown efficiencies.  
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Amino acid 
# 
Amino 
acid 
Reference(s) 
390 S Beausoleil et al., (2006); Trinidad et al., (2006); 
Dephoure et al., (2008); Wang et al., (2008); 
Tweedie-Cullen et al., (2009); Bennetzen et al., 
(2010); Chen et al., (2010); Moritz et al., (2010)  
392 S Beausoleil et al., (2006); Wang et al., (2008); 
Tweedie-Cullen et al., (2009); Bennetzen et al., 
(2010); Chen et al., (2010); Dephoure et al., (2008); 
Moritz et al., (2010) 
394 T Beausoleil et al., (2006); Tweedie-Cullen et al., 
(2009) 
395 S Beausoleil et al., (2006); Stokes et al., (2007); 
Dephoure et al., (2008); Bennetzen et al., (2010)  
398 S Dephoure et al., (2008); Moritz et al., (2010) 
403 S Yang et al., (2006); Tweedie-Cullen et al., (2009); 
Moritz et al., (2010) 
404 S Yang et al., (2006); Tweedie-Cullen et al., (2009); 
Moritz et al., (2010); 
406 S Yang et al., (2006); Wang et al., (2008); Moritz et al., 
(2010) 
407 S Yang et al., (2006); Wang et al., (2008); Tweedie-
Cullen et al., (2009); Moritz et al., (2010) 
409 T Yang et al., (2006): Moritz et al., (2010) 
414 S Moritz et al., (2010) 
416 T Yang et al., (2006); Moritz et al., (2010) 
423 S Trinidad et al., (2006);  Yang et al., (2006) 
424 T Trinidad et al., (2006); Yang et al., (2006); Chen et 
al., (2010) 
426 S Trinidad et al., (2006); Chen et al., (2010) 
428 S Trinidad et al., (2006) 
429 S Trinidad et al., (2006) 
431 S (No experimental data) 
436 T (No experimental data) 
437 S (No experimental data) 
 
Note: not all references have been included. For a more thorough reference list, 
see www.phosphosite.org 
 
Table 3. Literature based search for A-type lamin phosphorylation sites. 
Using database searches (www.pubmed.com and www.phosphosite.org) 
previously identified phosphorylated residues in lamin A/C have been collated with 
the indicated references. 
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Figure 9. Potential acetylation sites in lamin A/C. Using a prediction algorithm, 
Basu et al. (2009) identified acetylation sites in lamin A/C, residue 418 was 
predicted and validated, whilst residues 90, 180 and 316 were only predicted. 
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